BC Partners Lending (BCPL) 10-Q 6 Nov 24 2024 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2024	Nov. 04, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Registrant Name	BC Partners Lending Corporation
Entity Central Index Key	0001726548
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	814-01269
Entity Tax Identification Number	82-4654271
Entity Incorporation, State or Country Code	MD
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Address, Address Line One	650 Madison Avenue
Entity Address, Address Line Two	3rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	891-2880
Title of 12(b) Security	None
No Trading Symbol Flag	true
Entity Common Stock, Shares Outstanding		3,349,201

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands	Sep. 30, 2024		Dec. 31, 2023
Assets
Investments at fair value	$ 132,848		$ 133,675
Cash and cash equivalents	5,069		1,268
Restricted cash	7,046		5,672
Receivable for unsettled trades			284
Interest and dividends receivable	2,145		1,630
Prepaid expenses and other assets	76		58
Total assets	147,184		142,587
Liabilities
Credit facility (net of deferred financing costs of $581 and $663, respectively)	72,419		70,337
Payable for unsettled trades			283
Due to affiliate	186		481
Management fees payable	378		344
Incentive fees payable	318		348
Interest expense payable	1,334		1,212
Directors' fees payable	38		38
Accounts payable and other liabilities	274		308
Distribution payable			1,089
Total liabilities	74,947		74,440
Commitments and contingencies (Note 9)
Net Assets
Common stock, $0.001 par value, 1,000,000,000 shares authorized; 3,349,201 and 3,024,976 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	3		3
Capital in excess of par	79,044		71,964
Total distributable (loss) earnings	(6,810)		(3,820)
Total net assets	72,237		68,147
Total liabilities and net assets	$ 147,184		$ 142,587
Net asset value per share	$ 21.57	[1]	$ 22.53
Non-control/non-affiliate investments
Assets
Investments at fair value	$ 130,885		$ 133,449
Non-control affiliate investments
Assets
Investments at fair value	$ 1,963		$ 226
[1] Represents the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the year or period and certain per share data on shares outstanding as of a year or period end or transaction date.

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Amortized cost	$ 136,492	$ 135,332
Deferred financing costs, net	$ 581	$ 663
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized	1,000,000,000	1,000,000,000
Common stock, issued	3,349,201	3,024,976
Common stock, outstanding	3,349,201	3,024,976
Non-control/non-affiliate investments
Amortized cost	$ 134,531	$ 135,108
Non-control affiliate investments
Amortized cost	$ 1,961	$ 224

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest income:
Total interest income	$ 4,280,000	$ 4,221,000	$ 13,220,000	$ 11,393,000
Total fee and other income	152,000	13,000	299,000	317,000
Total investment income	4,432,000	4,234,000	13,519,000	11,710,000
Operating expenses:
Organization and offering costs			0	30,000
Management fees	336,000	329,000	1,021,000	898,000
Incentive fees	309,000	283,000	909,000	798,000
Administrative fees	149,000	132,000	427,000	457,000
Interest and debt expenses	1,560,000	1,443,000	4,684,000	3,790,000
Audit fees	55,000	50,000	165,000	165,000
Legal fees	100,000	107,000	282,000	324,000
Professional fees	70,000	147,000	226,000	330,000
Directors' fees	38,000	38,000	113,000	113,000
Other expenses	18,000	71,000	456,000	224,000
Total expenses before expense support	2,635,000	2,600,000	8,283,000	7,129,000
Expense Support Repayment to Related Parties		221,000		1,383,000
Total expenses	2,635,000	2,821,000	8,283,000	8,512,000
Net investment income	1,797,000	1,413,000	5,236,000	3,198,000
Realized and unrealized gain (loss):
Net realized gain (loss) on investment transactions	(668,000)	101,000	(708,000)	290,000
Derivatives		0		(55,000)
Net realized and unrealized gain (loss)	(1,448,000)	1,915,000	(2,695,000)	2,178,000
Net increase (decrease) in net assets resulting from operations	$ 349,000	$ 3,328,000	$ 2,541,000	$ 5,376,000
Net investment income per share - basic	$ 0.57	$ 0.47	$ 1.69	$ 1.16
Net investment income per share - diluted	0.57	0.47	1.69	1.16
Net increase (decrease) in net assets resulting from operations per share - basic	0.11	1.11	0.82	1.95
Net increase (decrease) in net assets resulting from operations per share - diluted	$ 0.11	$ 1.11	$ 0.82	$ 1.95
Weighted average shares of common stock outstanding - basic	3,168,711	3,003,201	3,092,149	2,755,930
Weighted average shares of common stock outstanding - diluted	3,168,711	3,003,201	3,092,149	2,755,930
Non-control/non-affiliate investments
Interest income:
Total interest income	$ 4,280,000	$ 4,221,000	$ 13,220,000	$ 11,393,000
Total fee and other income	140,000	13,000	260,000	317,000
Realized and unrealized gain (loss):
Net realized gain (loss) on investment transactions	(668,000)	101,000	(708,000)	290,000
Net change in unrealized appreciation (depreciation) on investments	(777,000)	$ 1,814,000	(1,987,000)	$ 1,943,000
Non-control affiliate investments
Interest income:
Total fee and other income	12,000		39,000
Realized and unrealized gain (loss):
Net change in unrealized appreciation (depreciation) on investments	$ (3,000)		$ 0

Consolidated Statements of Chan

Consolidated Statements of Changes in Net Assets - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Beginning balance			$ 68,147			$ 48,772	$ 68,147	$ 48,772
Beginning balance, Share			3,024,976				3,024,976
Net investment income	$ 1,797	$ 1,800	$ 1,637	$ 1,413	$ 931	854	$ 5,236	3,198
Net realized gain (loss) on investments	(668)	(142)	102	101	138	51	$ (708)	$ 290
Net change in unrealized depreciation/appreciation on investments and derivatives	(780)	(1,133)	(74)	1,814	698	(624)
Issuance of common shares, Value	4,450	1,000			5,000	11,500
Distributions declared and payable to stockholders	(1,873)	(1,834)	(1,822)	(930)	(927)	(853)
Stock issued in connection with dividend reinvestment plan	469	899	262	219	216	213
Stock issued in connection with dividend reinvestment plan, Share							11,736	9,874
Ending balance	$ 72,237	$ 68,842	68,252	$ 68,586	$ 65,969	59,913	$ 72,237	$ 68,586
Ending balance, Share	3,349,201						3,349,201
Common Stock [Member]
Beginning balance			$ 3			$ 2	$ 3	$ 2
Beginning balance, Share	3,122,442	3,036,712	3,024,976	2,999,799	2,761,194	2,232,134	3,024,976	2,232,134
Issuance of common shares, Share	204,880	44,623			228,519	519,186
Issuance of common shares, Value						$ 1
Stock issued in connection with dividend reinvestment plan, Share	21,879	41,107	11,736	10,096	10,086	9,874
Ending balance	$ 3	$ 3	$ 3	$ 3	$ 3	$ 3	$ 3	$ 3
Ending balance, Share	3,349,201	3,122,442	3,036,712	3,009,895	2,999,799	2,761,194	3,349,201	3,009,895
Capital in excess of par [Member]
Beginning balance			$ 71,964			$ 54,480	$ 71,964	$ 54,480
Issuance of common shares, Value	$ 4,450	$ 1,000			$ 5,000	11,499
Stock issued in connection with dividend reinvestment plan	469	899	262	$ 219	216	213
Ending balance	79,044	74,125	72,226	71,627	71,408	66,192	79,044	71,627
Total distributable earnings [Member]
Beginning balance			(3,820)			(5,710)	(3,820)	(5,710)
Net investment income	1,797	1,800	1,637	1,413	931	854
Net realized gain (loss) on investments	(668)	(142)	102	101	138	51
Net change in unrealized depreciation/appreciation on investments and derivatives	(780)	(1,133)	(74)	1,814	698	(624)
Distributions declared and payable to stockholders	(1,873)	(1,834)	(1,822)	(930)	(927)	(853)
Ending balance	$ (6,810)	$ (5,286)	$ (3,977)	$ (3,044)	$ (5,442)	$ (6,282)	$ (6,810)	$ (3,044)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net increase (decrease) in net assets resulting from operations	$ 2,541	$ 5,376
Adjustments to reconcile net increase (decrease) in net assets from operations to net cash used in operating activities:
Net realized (gain) loss from investments	708	(290)
Net change in unrealized (appreciation) depreciation on investments	1,987	(1,943)
Net change in unrealized (appreciation) depreciation on derivatives		55
Net accretion of discount on investments	(566)	(425)
Amortization of deferred financing costs	82	82
Payment-in-kind interest income	(696)	(361)
Sales and repayments of investments	29,058	15,163
Purchases of investments	(29,666)	(40,021)
(Increase) decrease in operating assets:
Receivable for unsettled trades	284	(3,026)
Interest and dividends receivable	(515)	(752)
Prepaid expenses	(18)	(112)
Increase (decrease) in operating liabilities:
Payable for unsettled trades	(283)	4,865
Due to affiliate	(295)	289
Management fees payable	34	87
Incentive fees payable	(30)	81
Interest expense payable	122	427
Directors' fees payable		(75)
Accounts payable and accrued expenses	(34)	124
Net cash used in operating activities	2,713	(20,456)
Financing activities:
Proceeds from issuance of shares of common stock	5,450	16,500
Stockholder distributions paid	(4,988)	(2,062)
Borrowings from credit facility	2,000	10,000
Net cash provided by financing activities	2,462	24,438
Net increase (decrease) in restricted and unrestricted cash	5,175	3,982
Cash and restricted cash at beginning of year	6,940	7,949
Cash and restricted cash at end of period	12,115	11,931
Reconciliation of cash and restricted cash
Cash	5,069	1,027
Restricted Cash	7,046	10,904
Total cash and restricted cash	12,115	11,931
Supplemental information:
Interest paid during the period	4,724	4,135
Supplemental disclosure of non-cash information:
Reinvestment of dividends	$ 1,630	$ 648

Consolidated Schedule of Invest

Consolidated Schedule of Investments - USD ($)		Sep. 30, 2024		Dec. 31, 2023
Schedule of Investments [Line Items]
Interest Rate		5%		5%
Investment, interest rate, paid in kind		8%		8%
Amortized cost		$ 136,492,000		$ 135,332,000
Fair Value		$ 132,848,000		133,675,000
Investment, Identifier [Axis]: Investment in Derivatives - 0.0%, Princeton Medspa Partners LLC, Professional Services, Maturity Date 5/31/2029
Schedule of Investments [Line Items]
Maturity	[1],[2],[3],[4],[5]	May 31, 2029
Par / Shares	[1],[2],[3],[4],[5],[6]	$ 250,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Advantage Capital Holdings LLC, Financials
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			0
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			0
Fair Value	[7],[8],[9],[10],[11],[12]			1,524,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, American Academy Holdings, Common, Healthcare
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			0
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			0
Fair Value	[7],[8],[9],[10],[11],[12]			151,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, American Academy Holdings, Preferred, Healthcare One
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			45,000
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			0
Fair Value	[7],[8],[9],[10],[11],[12]			60,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Aperture Dodge 18, Industrials
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			511,000
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			511,000
Fair Value	[7],[8],[9],[10],[11],[12]			540,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Great Lakes II Funding LLC - unfunded, Financials
Schedule of Investments [Line Items]
Par / Shares	[4],[7],[8],[9],[10],[11],[12],[15]			10,000
Amortized cost	[4],[7],[8],[9],[10],[11],[12],[13],[14],[15]			0
Fair Value	[4],[7],[8],[9],[10],[11],[12],[15]			0
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Great Lakes II Funding LLC, Financials - One
Schedule of Investments [Line Items]
Par / Shares	[4],[7],[8],[9],[10],[11],[12],[16]			88,000
Amortized cost	[4],[7],[8],[9],[10],[11],[12],[13],[14],[16]			89,000
Fair Value	[4],[7],[8],[9],[10],[11],[12],[16]			92,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Green Park M-1 Series - Unfunded, Industrials - One
Schedule of Investments [Line Items]
Par / Shares	[4],[7],[8],[9],[10],[11],[12],[15]			366,000
Amortized cost	[4],[7],[8],[9],[10],[11],[12],[13],[14],[15]			0
Fair Value	[4],[7],[8],[9],[10],[11],[12],[15]			0
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Green Park M-1 Series, Industrials
Schedule of Investments [Line Items]
Par / Shares	[4],[7],[8],[9],[10],[11],[12]			0
Amortized cost	[4],[7],[8],[9],[10],[11],[12],[13],[14]			34,000
Fair Value	[4],[7],[8],[9],[10],[11],[12]			34,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Green Park, Infrastructure A Series Industrials - Two
Schedule of Investments [Line Items]
Par / Shares	[4],[7],[8],[9],[10],[11],[12]			0
Amortized cost	[4],[7],[8],[9],[10],[11],[12],[13],[14]			100,000
Fair Value	[4],[7],[8],[9],[10],[11],[12]			100,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Lucky Bucks, Gaming
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			67,000
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			996,000
Fair Value	[7],[8],[9],[10],[11],[12]			996,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, Morae Global Inc, Financials
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			0
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			122,000
Fair Value	[7],[8],[9],[10],[11],[12]			139,000
Investment, Identifier [Axis]: Investment in Equity/Other - 5.5%, VBC Spine Opco LLC, Healthcare
Schedule of Investments [Line Items]
Par / Shares	[7],[8],[9],[10],[11],[12]			79,000
Amortized cost	[7],[8],[9],[10],[11],[12],[13],[14]			129,000
Fair Value	[7],[8],[9],[10],[11],[12]			$ 129,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Advantage Capital Holdings LLC, Financials
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	0
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	0
Fair Value	[1],[2],[3],[6],[17],[18]	1,019,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, American Academy Holdings, Common, Healthcare
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	0
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	0
Fair Value	[1],[2],[3],[6],[17],[18]	131,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, American Academy Holdings, Preferred, Healthcare One
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	45,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	0
Fair Value	[1],[2],[3],[6],[17],[18]	67,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Aperture Dodge 18, Industrials
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	512,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	512,000
Fair Value	[1],[2],[3],[6],[17],[18]	486,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Great Lakes II Funding LLC, Financials
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[5],[6],[17],[18],[21]	77,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20],[21]	77,000
Fair Value	[1],[2],[3],[5],[6],[17],[18],[21]	79,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Green Park M-1 Series, Industrials
Schedule of Investments [Line Items]
Amortized cost	[1],[2],[3],[5],[6],[17],[18],[19],[20]	34,000
Fair Value	[1],[2],[3],[5],[6],[17],[18]	34,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, GreenPark Infrastructure A Series, Industrials
Schedule of Investments [Line Items]
Amortized cost	[1],[2],[3],[5],[6],[17],[18],[19],[20]	100,000
Fair Value	[1],[2],[3],[5],[6],[17],[18]	100,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Lucky Bucks, Gaming
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	67,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	996,000
Fair Value	[1],[2],[3],[6],[17],[18]	842,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Morae Global Inc, Financials
Schedule of Investments [Line Items]
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	122,000
Fair Value	[1],[2],[3],[6],[17],[18]	184,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Princeton Medspa Partners LLC Warrant, Professional Services
Schedule of Investments [Line Items]
Fair Value	[1],[2],[3],[6]	11,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Princeton Medspa Partners LLC, Professional Services
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	258,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	250,000
Fair Value	[1],[2],[3],[6],[17],[18]	247,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, Riddell, Inc, Consumer Staples
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	1,050,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	1,037,000
Fair Value	[1],[2],[3],[6],[17],[18]	1,048,000
Investment, Identifier [Axis]: Investment in Equity/Other - 6.1%, VBC Spine Opco LLC, Healthcare
Schedule of Investments [Line Items]
Par / Shares	[1],[2],[3],[6],[17],[18]	79,000
Amortized cost	[1],[2],[3],[6],[17],[18],[19],[20]	129,000
Fair Value	[1],[2],[3],[6],[17],[18]	$ 137,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.27%, Florida Foods Products, LLC, Consumer Staples, Interest Rate 10.32%, Reference Rate and Spread S + 5.00%, Floor 1.00%, Maturity Date 10/18/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.32%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Oct. 18, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 983,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	940,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 860,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7% Monroe Engineering Group, Industrials, Interest Rate 12.09%, Reference Rate and Spread S + 6.75%, Floor 0.00%, Maturity Date 12/20/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.09%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Dec. 20, 2028
Par / Shares	[1],[2],[3],[6],[23]	$ 1,970,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,922,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,948,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, AG Parent Holdings, Information Technology, Interest Rate 10.32%, Reference Rate and Spread S + 5.00%, Floor 1.00%, Maturity Date 7/30/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23],[25]	10.32%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24],[25]	5%
Floor	[1],[2],[3],[6],[22],[23],[25]	1%
Maturity	[1],[2],[3],[6],[22],[23],[25]	Jul. 30, 2026
Par / Shares	[1],[2],[3],[6],[22],[23],[25]	$ 995,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23],[25]	978,000
Fair Value	[1],[2],[3],[6],[22],[23],[25]	$ 925,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, ALCV Purchaser, Inc., Consumer Discretionary, Interest Rate 12.09%, Reference Rate and Spread S + 6.75%, Floor 1.00%, Maturity Date 2/26/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Feb. 26, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 2,063,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,052,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,021,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, AMCP PET HOLDINGS, INC., Consumer Staples, Interest Rate 11.57%, Reference Rate and Spread S + 6.25%, Floor 1.00%, Maturity Date 10/05/2026 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.57%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.25%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 05, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 1,944,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,927,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,902,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, AMCP PET HOLDINGS, INC., Consumer Staples, Interest Rate 11.57%, Reference Rate and Spread S + 6.25%, Floor Rate 1.00%, Maturity Date 10/5/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.57%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.25%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 05, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 502,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	499,000
Fair Value	[1],[2],[3],[6],[23]	$ 492,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Accordion Partners LLC, Financials, Interest Rate 11.84%, Reference Rate and Spread S + 6.50%, Floor 0.00%, Maturity Date 8/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.84%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Aug. 29, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 2,393,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,336,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,393,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Accordion Partners LLC, Financials, Interest Rate 11.84%, Reference Rate and Spread S + 6.50%, Floor 0.00%, Maturity Date 8/29/2029 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.84%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Aug. 29, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 1,580,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,540,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,580,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Accurate Background LLC, Information Technology, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 0.00%, Maturity Date 3/26/2029 Two
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Mar. 26, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 490,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	458,000
Fair Value	[1],[2],[3],[6],[23]	$ 485,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Accurate Background LLC, Information Technology, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 3/26/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Mar. 26, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 998,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	983,000
Fair Value	[1],[2],[3],[6],[23]	$ 986,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Accurate Background LLC, Information Technology, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 3/26/2029 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Mar. 26, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 2,909,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,731,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,876,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, American Academy Holdings, Healthcare, Interest Rate 14.50%, Reference Rate and Spread NA, Floor 0.00%, Maturity Date 3/01/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	14.50%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Mar. 01, 2028
Par / Shares	[1],[2],[3],[6],[23]	$ 2,018,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,989,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,902,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, American Academy Holdings, Healthcare, Interest Rate 16.32%, Reference Rate and Spread S + 11.00%, Floor 1.00%, Maturity Date 6/30/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	16.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	11%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 30, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 198,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	198,000
Fair Value	[1],[2],[3],[6],[23]	$ 198,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, American Academy Holdings, Healthcare, Interest Rate 16.32%, Reference Rate and Spread S + 11.00%, Floor 1.00%, Maturity Date 6/30/2027 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	16.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	11%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 30, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 996,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	989,000
Fair Value	[1],[2],[3],[6],[23]	$ 997,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Ancile Solutions, Inc., Information Technology, Interest Rate 12.32%, Reference Rate and Spread S + 7.00%, Floor 1.00%, Maturity Date 6/11/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	7%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 11, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 1,743,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,721,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,786,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Astro Acquisition, LLC, Industrials, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 12/13/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 13, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 1,990,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,972,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,977,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Beta Plus Technologies, Inc, Information Technology, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 0.00%, Maturity Date 6/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jun. 29, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 4,711,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	4,534,000
Fair Value	[1],[2],[3],[6],[23]	$ 4,522,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Beta Plus Technologies, Inc, Information Technology, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 0.00%, Maturity Date 7/01/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26],[27]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26],[27]	5.75%
Floor	[1],[2],[3],[6],[23],[26],[27]	0%
Maturity	[1],[2],[3],[6],[23],[26],[27]	Jul. 01, 2027
Par / Shares	[1],[2],[3],[6],[23],[26],[27]	$ 252,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26],[27]	252,000
Fair Value	[1],[2],[3],[6],[23],[26],[27]	$ 231,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, C.P. Converters Inc., 7th Amendment, Industrials, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 9/30/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Sep. 30, 2024
Par / Shares	[1],[2],[3],[6],[23]	$ 1,780,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,780,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,691,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, C.P. Converters, Inc., 12th Amendment Acquisition Loan, Industrials, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 6/30/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 30, 2024
Par / Shares	[1],[2],[3],[6],[23]	$ 379,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	380,000
Fair Value	[1],[2],[3],[6],[23]	$ 361,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, CenExcel Clinicial Research Holdings, Inc, Healthcare, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 0.00%, Maturity Date 11/10/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Nov. 10, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 361,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	361,000
Fair Value	[1],[2],[3],[6],[23]	$ 360,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Colonade Intermediate, LLC, Information Technology, Interest Rate 12.32%, Reference Rate and Spread S + 7.00%, Floor 0.00%, Maturity Date 6/30/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	7%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jun. 30, 2024
Par / Shares	[1],[2],[3],[6],[23]	$ 205,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	205,000
Fair Value	[1],[2],[3],[6],[23]	$ 144,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Colonade Intermediate, LLC, Information Technology, Interest Rate 12.32%, Reference Rate and Spread S + 7.00%, Floor 1.00%, Maturity Date 4/27/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[28]	12.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[28]	7%
Floor	[1],[2],[3],[6],[23],[28]	1%
Maturity	[1],[2],[3],[6],[23],[28]	Apr. 27, 2024
Par / Shares	[1],[2],[3],[6],[23],[28]	$ 1,965,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[28]	1,965,000
Fair Value	[1],[2],[3],[6],[23],[28]	$ 1,384,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Colonade Intermediate, LLC, Information Technology, Interest Rate 12.32%, Reference Rate and Spread S + 7.00%, Floor 1.00%, Maturity Date 4/27/2024 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[28]	12.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[28]	7%
Floor	[1],[2],[3],[6],[23],[28]	1%
Maturity	[1],[2],[3],[6],[23],[28]	Apr. 27, 2024
Par / Shares	[1],[2],[3],[6],[23],[28]	$ 1,851,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[28]	1,851,000
Fair Value	[1],[2],[3],[6],[23],[28]	$ 1,304,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Critical Nurse Staffing LLC, Healthcare, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 10/30/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 30, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 668,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	663,000
Fair Value	[1],[2],[3],[6],[23]	$ 671,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Critical Nurse Staffing LLC, Healthcare, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 10/30/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 30, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 3,960,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	3,901,000
Fair Value	[1],[2],[3],[6],[23]	$ 3,975,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, DRI Holdings Inc, Information Technology, Interest Rate 10.59%, Reference Rate and Spread S + 5.25%, Floor 0.50%, Maturity Date 12/21/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.59%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5.25%
Floor	[1],[2],[3],[6],[22],[23]	0.50%
Maturity	[1],[2],[3],[6],[22],[23]	Dec. 21, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 4,890,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	4,621,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 4,735,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Datalink, LLC, Healthcare, Interest Rate 11.59%, Reference Rate and Spread S + 6.25%, Floor 1.00%, Maturity Date 11/23/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.59%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.25%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Nov. 23, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 3,039,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	3,004,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,807,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Florida Foods Products, LLC, Consumer Staples, Interest Rate 10.32%, Reference Rate and Spread S + 5.00%, Floor 1.00%, Maturity Date 10/18/2028 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.32%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Oct. 18, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 3,945,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	3,742,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 3,483,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Global IID Parent LLC, Consumer Staples, Interest Rate 9.82%, Reference Rate and Spread S + 4.50%, Floor 0.00%, Maturity Date 12/08/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	9.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	4.50%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Dec. 08, 2028
Par / Shares	[1],[2],[3],[6],[23]	$ 977,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	929,000
Fair Value	[1],[2],[3],[6],[23]	$ 968,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, H-CA II T/L, Financials, Interest Rate 16.00%, Reference Rate and Spread NA, Floor 0.00%, Maturity Date 6/30/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	16%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jun. 30, 2024
Par / Shares	[1],[2],[3],[6],[23]	$ 1,808,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,808,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,804,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, H.W. Lochner T/L (Elysium Infrastructure), Industrials, Interest Rate 11.07%, Reference Rate and Spread S + 5.75%, Floor 1.00%, Maturity Date 7/02/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.07%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jul. 02, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 2,910,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,880,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,859,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, HW Lochner, Industrials, Interest Rate 12.07%, Reference Rate and Spread S + 6.75%, Floor 0.00%, Maturity Date 7/02/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.07%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jul. 02, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 1,389,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,360,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,381,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Ivanti Software, Inc., Information Technology, Interest Rate 12.57%, Reference Rate and Spread S + 7.25%, Floor 0.75%, Maturity Date 12/01/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	12.57%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	7.25%
Floor	[1],[2],[3],[6],[22],[23]	0.75%
Maturity	[1],[2],[3],[6],[22],[23]	Dec. 01, 2027
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 985,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	835,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 839,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Ivanti Software, Inc., Information Technology, Interest Rate 9.57%, Reference Rate and Spread S + 4.25%, Floor 1.00%, Maturity Date 12/01/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	9.57%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	4.25%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Dec. 01, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 4,000,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	3,924,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 2,587,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, KL Charlie Acquisition, Healthcare, Interest Rate 12.09%, Reference Rate and Spread S + 6.75%, Floor 1.00%, Maturity Date 12/30/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 30, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 1,243,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,227,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,234,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, KL Charlie Acquisition, Healthcare, Interest Rate 12.09%, Reference Rate and Spread S + 6.75%, Floor 1.00%, Maturity Date 12/30/2026 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 30, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 932,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	920,000
Fair Value	[1],[2],[3],[6],[23]	$ 925,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Leonard Valve Company LLC, Construction, Interest Rate 10.32%, Reference Rate and Spread S + 5.00%, Floor 1.00%, Maturity Date 09/29/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	10.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Sep. 29, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 2,000,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,981,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,980,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, MAG DS CORP., Industrials, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 4/01/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Apr. 01, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 2,725,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,663,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,576,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, MSM Acquisitions, Inc., Information Technology, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 12/09/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 09, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 1,163,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,163,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,080,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, MSM Acquisitions, Inc., Information Technology, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 12/09/2026 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 09, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 2,788,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,774,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,589,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Money Transfer Acquisition, Inc, Financials, Interest Rate 13.59%, Reference Rate and Spread S + 8.25%, Floor 1.00%, Maturity Date 12/14/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[27]	13.59%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[27]	8.25%
Floor	[1],[2],[3],[6],[23],[27]	1%
Maturity	[1],[2],[3],[6],[23],[27]	Dec. 14, 2027
Par / Shares	[1],[2],[3],[6],[23],[27]	$ 3,469,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[27]	3,412,000
Fair Value	[1],[2],[3],[6],[23],[27]	$ 3,395,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Monroe Engineering Group, Industrials, Interest Rate 12.07%, Reference Rate and Spread S + 6.75%, Floor 0.00%, Maturity Date 12/20/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23],[26]	12.07%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	6.75%
Floor	[1],[2],[3],[6],[22],[23]	0%
Maturity	[1],[2],[3],[6],[22],[23]	Dec. 20, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 1,978,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	1,932,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 1,955,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Morae Global Inc, Financials, Interest Rate 13.32%, Reference Rate and Spread S + 8.00%, Floor 1.00%, Maturity Date 10/26/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26],[29]	13.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26],[29]	8%
Floor	[1],[2],[3],[6],[23],[26],[29]	1%
Maturity	[1],[2],[3],[6],[23],[26],[29]	Oct. 26, 2026
Par / Shares	[1],[2],[3],[6],[22],[23],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26],[29]	6,000
Fair Value	[1],[2],[3],[6],[23],[26],[29]	$ (5,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Morae Global Inc, Financials, Interest Rate 13.32%, Reference Rate and Spread S + 8.00%, Floor 1.00%, Maturity Date 10/26/2026 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	13.32%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	8%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 26, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 3,088,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,934,000
Fair Value	[1],[2],[3],[6],[23]	$ 3,030,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Neptune Bidco US Inc, Communication Services, Interest Rate 10.34%, Reference Rate and Spread S + 5.00%, Floor 0.00%, Maturity Date 4/11/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.34%
Reference Rate and Spread	[1],[2],[3],[12],[22],[23],[24]	5%
Floor	[1],[2],[3],[6],[22],[23]	0%
Maturity	[1],[2],[3],[6],[22],[23]	Apr. 11, 2029
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 4,938,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	4,555,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 4,648,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, PhyNet Dermatology LLC, Healthcare, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 0.75%, Maturity Date 8/16/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26]	11.82%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24],[26]	6.50%
Floor	[1],[2],[3],[6],[23],[26]	0.75%
Maturity	[1],[2],[3],[6],[23],[26]	Aug. 16, 2024
Par / Shares	[1],[2],[3],[6],[22],[23],[26]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26]	0
Fair Value	[1],[2],[3],[6],[23],[26]	$ (13,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, PhyNet Dermatology LLC, Healthcare, Interest Rate 11.82%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 10/20/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.82%
Reference Rate and Spread	[1],[2],[3],[12],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Oct. 20, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 2,269,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	2,228,000
Fair Value	[1],[2],[3],[6],[23]	$ 2,252,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Premier Imaging, LLC, Healthcare, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 0.00%, Maturity Date 1/02/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jan. 02, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 94,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	94,000
Fair Value	[1],[2],[3],[6],[23]	$ 84,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Premier Imaging, LLC, Healthcare, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 1.00%, Maturity Date 1/02/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jan. 02, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 937,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	937,000
Fair Value	[1],[2],[3],[6],[23]	$ 835,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Premier Imaging, LLC, Healthcare, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 1.00%, Maturity Date 1/02/2025 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jan. 02, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 26,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	26,000
Fair Value	[1],[2],[3],[6],[23]	$ 23,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Premier Imaging, LLC, Healthcare, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 1.00%, Maturity Date 1/02/2025 Three
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jan. 02, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 1,754,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,753,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,562,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Premier Imaging, LLC, Healthcare, Interest Rate 11.09%, Reference Rate and Spread S + 5.75%, Floor 1.00%, Maturity Date 1/02/2025 Two
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.09%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jan. 02, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 957,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	957,000
Fair Value	[1],[2],[3],[6],[23]	$ 853,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Princeton Medspa Partners LLC, Professional Services, Interest Rate 13.82%, Reference Rate and Spread S + 8.50%, Floor 2.00%, Maturity Date 5/31/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26],[29]	13.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26],[29]	8.50%
Floor	[1],[2],[3],[6],[23],[26],[29]	2%
Maturity	[1],[2],[3],[6],[23],[26],[29]	May 31, 2029
Par / Shares	[1],[2],[3],[6],[23],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26],[29]	10,000
Fair Value	[1],[2],[3],[6],[23],[26],[29]	$ (19,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Princeton Medspa Partners LLC, Professional Services, Interest Rate 13.82%, Reference Rate and Spread S + 8.50%, Floor 2.00%, Maturity Date 5/31/2029 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26],[29]	13.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26],[29]	8.50%
Floor	[1],[2],[3],[6],[23],[26],[29]	2%
Maturity	[1],[2],[3],[6],[23],[26],[29]	May 31, 2029
Par / Shares	[1],[2],[3],[6],[23],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26],[29]	3,000
Fair Value	[1],[2],[3],[6],[23],[26],[29]	$ (3,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Princeton Medspa Partners LLC, Professional Services, Interest Rate 13.82%, Reference Rate and Spread S + 8.50%, Floor 2.00%, Maturity Date 5/31/2029 Two
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	13.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	8.50%
Floor	[1],[2],[3],[6],[23]	2%
Maturity	[1],[2],[3],[6],[23]	May 31, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 1,543,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,513,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,514,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Project Castle T/L, Information Technology, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 6/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5.50%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Jun. 29, 2029
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 1,894,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	1,727,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 1,738,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Project Leopard Holdings Company Inc, Information Technology, Interest Rate 10.69%, Reference Rate and Spread S + 5.35%, Floor 1.00%, Maturity Date 7/20/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	10.69%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5.35%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Jul. 20, 2029
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 3,930,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	3,718,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 3,543,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, RN Enterprises, LLC, Healthcare, Interest Rate 11.84%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 12/23/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.84%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 23, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 985,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	976,000
Fair Value	[1],[2],[3],[6],[23]	$ 985,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, RN Enterprises, LLC, Healthcare, Interest Rate 11.84%, Reference Rate and Spread S + 6.50%, Floor 1.00%, Maturity Date 12/23/2025 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.84%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Dec. 23, 2025
Par / Shares	[1],[2],[3],[6],[23]	$ 502,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	495,000
Fair Value	[1],[2],[3],[6],[23]	$ 502,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Reception Purchaser, LLC, Transportation, Interest Rate 11.34%, Reference Rate and Spread S + 6.00%, Floor 1.50%, Maturity Date 3/24/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	11.34%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	6%
Floor	[1],[2],[3],[6],[22],[23]	1.50%
Maturity	[1],[2],[3],[6],[22],[23]	Mar. 24, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 1,950,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	1,930,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 917,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Riddell, Inc, Consumer Staples, Interest Rate 11.34%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 3/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[26],[29]	11.34%
Reference Rate and Spread	[1],[2],[3],[6],[24],[26],[29]	6%
Floor	[1],[2],[3],[6],[26],[29]	1%
Maturity	[1],[2],[3],[6],[26],[29]	Mar. 29, 2029
Par / Shares	[1],[2],[3],[6],[22],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[26],[29]	2,000
Fair Value	[1],[2],[3],[6],[26],[29]	$ (4,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Riddell, Inc, Consumer Staples, Interest Rate 11.34%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 3/29/2029 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.34%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[8],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Mar. 29, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 3,591,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	3,509,000
Fair Value	[1],[2],[3],[6],[23]	$ 3,551,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Russell Investments, Financials, Interest Rate 12.32%, Reference Rate and Spread S + 7.00%, Floor 0.00%, Maturity Date 5/30/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	12.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	7%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	May 30, 2027
Par / Shares	[1],[2],[3],[6],[23]	$ 4,344,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	4,056,000
Fair Value	[1],[2],[3],[6],[23]	$ 3,772,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, SePRO Corporation, Chemicals, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 7/26/2030
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[26],[29]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[24],[26],[29]	5.50%
Floor	[1],[2],[3],[6],[26],[29]	1%
Maturity	[1],[2],[3],[6],[26],[29]	Jul. 26, 2030
Par / Shares	[1],[2],[3],[6],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[20],[26],[29]	2,000
Fair Value	[1],[2],[3],[6],[26],[29]	$ (5,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, SePRO Corporation, Chemicals, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 7/26/2030 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26],[29]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26],[29]	5.50%
Floor	[1],[2],[3],[6],[26],[29]	1%
Maturity	[1],[2],[3],[6],[26],[29]	Jul. 26, 2030
Par / Shares	[1],[2],[3],[6],[26],[29]	$ 0
Amortized cost	[1],[2],[3],[6],[19],[20],[26],[29]	5,000
Fair Value	[1],[2],[3],[6],[26],[29]	$ (5,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, SePRO Corporation, Chemicals, Interest Rate 10.82%, Reference Rate and Spread S + 5.50%, Floor 1.00%, Maturity Date 7/26/2030 Two
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	10.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	5.50%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jul. 26, 2030
Par / Shares	[1],[2],[3],[6],[23]	$ 1,767,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,733,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,732,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, SeQuel Response LLC, Insurance Services, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.25%, Maturity Date 5/21/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[5],[6],[26]	11.32%
Reference Rate and Spread	[1],[2],[3],[5],[6],[24],[26]	6%
Floor	[1],[2],[3],[5],[6],[26]	1.25%
Maturity	[1],[2],[3],[5],[6],[26]	May 21, 2029
Par / Shares	[1],[2],[3],[5],[6],[26]	$ 0
Amortized cost	[1],[2],[3],[5],[6],[19],[20],[26]	2,000
Fair Value	[1],[2],[3],[5],[6],[26]	$ (2,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, SeQuel Response LLC, Insurance Services, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.25%, Maturity Date 5/21/2029 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26]	6%
Floor	[1],[2],[3],[6],[23]	1.25%
Maturity	[1],[2],[3],[6],[23]	May 21, 2029
Par / Shares	[1],[2],[3],[6],[23]	$ 1,696,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23]	1,663,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,671,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Symplr Software Inc, Information Technology, Interest Rate 9.84%, Reference Rate and Spread S + 4.50%, Floor 0.75%, Maturity Date 12/22/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	9.84%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23]	4.50%
Floor	[1],[2],[3],[6],[22],[23]	0.75%
Maturity	[1],[2],[3],[6],[22],[23]	Dec. 22, 2027
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 1,105,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	1,103,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 1,012,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Synaemedia Americas Holdings, Inc, Information Technology, Interest Rate 13.07%, Reference Rate and Spread S + 7.75% , Floor Rate 1.00%, Maturity Date 12/5/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[21],[23]	13.07%
Reference Rate and Spread	[1],[2],[3],[6],[21],[23],[24]	7.75%
Floor	[1],[2],[3],[6],[21],[23]	1%
Maturity	[1],[2],[3],[6],[21],[23]	Dec. 05, 2028
Par / Shares	[1],[2],[3],[6],[21],[23]	$ 2,645,000
Amortized cost	[1],[2],[3],[6],[19],[20],[21],[23]	2,563,000
Fair Value	[1],[2],[3],[6],[21],[23]	$ 2,589,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, TA/WEG Holdings, LLC, Financials, Interest Rate 0.00%, Reference Rate and Spread 0.00%, Floor 0.00%, Maturity Date 1/24/2030
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[26]	0%
Reference Rate and Spread	[1],[2],[3],[6],[24],[26]	0%
Floor	[1],[2],[3],[6],[26]	0%
Maturity	[1],[2],[3],[6],[26]	Jan. 24, 2030
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, TLE Holdings, LLC, Consumer Discretionary, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 1.00%, Maturity Date 6/29/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	6%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 29, 2026
Par / Shares	[1],[2],[3],[6],[23]	$ 949,000
Amortized cost	[1],[2],[3],[6],[14],[19],[23]	948,000
Fair Value	[1],[2],[3],[6],[23]	$ 948,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Tactical Air Support, Inc, Industrials, Interest Rate 13.82%, Reference Rate and Spread S + 8.50%, Floor Rate 1.00%, Maturity Date 12/22/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[26]	13.82%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24],[26]	8.50%
Floor	[1],[2],[3],[6],[23],[26]	1%
Maturity	[1],[2],[3],[6],[23],[26]	Dec. 22, 2028
Par / Shares	[1],[2],[3],[6],[23],[26]	$ 571,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[26]	571,000
Fair Value	[1],[2],[3],[6],[23],[26]	$ 566,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Tactical Air Support, Inc, Industrials, Interest Rate 13.82%, Reference Rate and Spread S + 8.50%, Floor Rate 1.00%, Maturity Date 12/22/2028 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[21],[23]	13.82%
Reference Rate and Spread	[1],[2],[3],[6],[21],[23],[24]	8.50%
Floor	[1],[2],[3],[6],[21],[23]	1%
Maturity	[1],[2],[3],[6],[21],[23]	Dec. 22, 2028
Par / Shares	[1],[2],[3],[6],[21],[23]	$ 3,429,000
Amortized cost	[1],[2],[3],[6],[19],[20],[21],[23]	3,352,000
Fair Value	[1],[2],[3],[6],[21],[23]	$ 3,394,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Tank Holding Corp DDTL, Industrials, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor Rate 0.75%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	6%
Floor	[1],[2],[3],[6],[22],[23]	0.75%
Maturity	[1],[2],[3],[6],[22],[23]	Mar. 31, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 134,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	130,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 130,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Tank Holding Corp Revolver, Industrials, Interest Rate 11.07%, Reference Rate and Spread S + 5.75%, Floor Rate 1.00%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[5],[6],[22],[26]	11.07%
Reference Rate and Spread	[1],[2],[3],[5],[6],[22],[24],[26]	5.75%
Floor	[1],[2],[3],[5],[6],[22],[26]	1%
Maturity	[1],[2],[3],[5],[6],[22],[26]	Mar. 31, 2028
Par / Shares	[1],[2],[3],[5],[6],[22],[26]	$ 49,000
Amortized cost	[1],[2],[3],[5],[6],[19],[20],[22],[26]	46,000
Fair Value	[1],[2],[3],[5],[6],[22],[26]	$ 48,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, Tank Holding Corp, Industrials, Interest Rate 11.07%, Reference Rate and Spread S + 5.75%, Floor Rate 1.00%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	11.07%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	5.75%
Floor	[1],[2],[3],[6],[22],[23]	1%
Maturity	[1],[2],[3],[6],[22],[23]	Mar. 31, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 3,892,000
Amortized cost	[1],[2],[3],[6],[19],[20],[22],[23]	3,747,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 3,837,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.32%, Reference Rate and Spread S + 8.00%, Floor 1.00%, Maturity Date 6/13/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[26]	13.32%
Reference Rate and Spread	[1],[2],[3],[6],[24],[26]	8%
Floor	[1],[2],[3],[6],[26]	1%
Maturity	[1],[2],[3],[6],[26]	Jun. 13, 2028
Par / Shares	[1],[2],[3],[6],[26]	$ 569,000
Amortized cost	[1],[2],[3],[6],[14],[19],[26]	555,000
Fair Value	[1],[2],[3],[6],[26]	$ 560,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.32%, Reference Rate and Spread S + 8.00%, Floor 1.00%, Maturity Date 6/13/2028 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[26],[29]	13.32%
Reference Rate and Spread	[1],[2],[3],[6],[24],[26],[29]	8%
Floor	[1],[2],[3],[6],[26],[29]	1%
Maturity	[1],[2],[3],[6],[26],[29]	Jun. 13, 2028
Par / Shares	[1],[2],[3],[6],[26]	$ 0
Amortized cost	[1],[2],[3],[6],[14],[19],[26],[29]	3,000
Fair Value	[1],[2],[3],[6],[26],[29]	$ (2,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 177.7%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.32%, Reference Rate and Spread S + 8.00%, Floor 1.00%, Maturity Date 6/13/2028 Two
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	13.32%
Reference Rate and Spread	[1],[2],[3],[6],[23],[24]	8%
Floor	[1],[2],[3],[6],[23]	1%
Maturity	[1],[2],[3],[6],[23]	Jun. 13, 2028
Par / Shares	[1],[2],[3],[6],[23]	$ 1,737,000
Amortized cost	[1],[2],[3],[6],[14],[19],[23]	1,695,000
Fair Value	[1],[2],[3],[6],[23]	$ 1,719,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, AMCP PET HOLDINGS, INC., Consumer Staples, Interest Rate 11.58%, Reference Rate and Spread S + 6.25%, Floor Rate 1.00%, Maturity Date 10/5/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[26]			11.58%
Reference Rate and Spread	[1],[2],[3],[12],[26],[30]			6.25%
Floor	[1],[2],[3],[12],[26]			1%
Maturity	[1],[2],[3],[12],[26]			Oct. 05, 2026
Par / Shares	[1],[2],[3],[12],[26]			$ 326,000
Amortized cost	[1],[2],[3],[12],[13],[14],[26]			321,000
Fair Value	[1],[2],[3],[12],[26]			$ 315,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, AMCP PET HOLDINGS, INC., Consumer Staples, Interest Rate 11.58%, Reference Rate and Spread S + 6.25%, Floor Rate 1.00%, Maturity Date 10/5/2026 One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23],[26]			11.58%
Reference Rate and Spread	[1],[2],[3],[12],[23],[26],[30]			6.25%
Floor	[1],[2],[3],[12],[23],[26]			1%
Maturity	[1],[2],[3],[12],[23],[26]			Oct. 05, 2026
Par / Shares	[1],[2],[3],[12],[23],[26]			$ 1,947,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23],[26]			1,926,000
Fair Value	[1],[2],[3],[12],[23],[26]			$ 1,906,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Accordion Partners LLC ,Financials , Interest Rate 11.85%, Reference Rate and Spread S + 6.50%, Floor Rate 0.00%, Maturity Date 8/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			11.85%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			6.50%
Floor	[1],[2],[3],[12],[23]			0%
Maturity	[1],[2],[3],[12],[23]			Aug. 29, 2029
Par / Shares	[1],[2],[3],[12],[23]			$ 1,592,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			1,547,000
Fair Value	[1],[2],[3],[12],[23]			$ 1,606,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, American Academy Holdings , Healthcare, Interest Rate 14.50%, Reference Rate and Spread NA, Floor Rate 0.00%, Maturity Date 3/1/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			14.50%
Floor	[1],[2],[3],[12],[23]			0%
Maturity	[1],[2],[3],[12],[23]			Mar. 01, 2028
Par / Shares	[1],[2],[3],[12],[23]			$ 1,814,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			1,784,000
Fair Value	[1],[2],[3],[12],[23]			$ 1,608,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, American Academy Holdings, Healthcare, Interest Rate 16.33%, Reference Rate and Spread S + 11.00%, Floor Rate 1.00%, Maturity Date 3/1/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			16.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			11%
Floor	[1],[2],[3],[12],[23]			1%
Maturity	[1],[2],[3],[12],[23]			Mar. 01, 2028
Par / Shares	[1],[2],[3],[12],[23]			$ 190,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			190,000
Fair Value	[1],[2],[3],[12],[23]			$ 191,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, American Academy Holdings., Healthcare, Interest Rate 16.33%, Reference Rate and Spread S + 11.00%, Floor Rate 1.00%, Maturity Date 3/1/2028 - One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			16.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			11%
Floor	[1],[2],[3],[12],[23]			1%
Maturity	[1],[2],[3],[12],[23]			Mar. 01, 2028
Par / Shares	[1],[2],[3],[12],[23]			$ 959,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			951,000
Fair Value	[1],[2],[3],[12],[23]			$ 965,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Ancile Solutions, Inc., Information Technology, Interest Rate 12.33%, Reference Rate and Spread S + 7.00%, Floor Rate 1.00%, Maturity Date 6/11/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			12.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			7%
Floor	[1],[2],[3],[12],[23]			1%
Maturity	[1],[2],[3],[12],[23]			Jun. 11, 2026
Par / Shares	[1],[2],[3],[12],[23]			$ 1,793,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			1,763,000
Fair Value	[1],[2],[3],[12],[23]			$ 1,802,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Florida Foods Products, LLC, Consumer Staples, Interest Rate 10.33%, Reference Rate and Spread S + 5.00%, Floor Rate 1.00%, Maturity Date 10/18/2028
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			10.33%
Reference Rate and Spread	[12],[23]			5%
Floor	[12],[23]			1%
Maturity	[12],[23]			Oct. 18, 2028
Par / Shares	[12],[23]			$ 990,000
Amortized cost	[12],[23]			941,000
Fair Value	[12],[23]			$ 869,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Global IID Parent LLC, Consumer Staples, Interest Rate 9.83%, Reference Rate and Spread S + 4.50%, Floor Rate 0.00%, Maturity Date 12/8/2028
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			9.83%
Reference Rate and Spread	[12],[23]			4.50%
Floor	[12],[23]			0%
Maturity	[12],[23]			Dec. 08, 2028
Par / Shares	[12],[23]			$ 1,990,000
Amortized cost	[12],[23]			1,879,000
Fair Value	[12],[23]			$ 1,907,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, H-CA II T/L, Financials, Interest Rate 16.00%, Floor Rate 0.00%, Maturity Date 2/16/2024
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			16%
Floor	[12],[23]			0%
Maturity	[12],[23]			Feb. 16, 2024
Par / Shares	[12],[23]			$ 1,854,000
Amortized cost	[12],[13],[14],[23]			1,854,000
Fair Value	[12],[23]			$ 1,854,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, H.W. Lochner T/L (Elysium Infrastructure), Industrials, Interest Rate 11.08%, Reference Rate and Spread S + 5.75%, Floor Rate 1.00%, Maturity Date 7/2/2027
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.08%
Reference Rate and Spread	[12],[23]			5.75%
Floor	[12],[23]			1%
Maturity	[12],[23]			Jul. 02, 2027
Par / Shares	[12],[23]			$ 2,933,000
Amortized cost	[12],[23]			2,895,000
Fair Value	[12],[23]			$ 2,830,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, HW Lochner, Industrials, Interest Rate 12.08%, Reference Rate and Spread S + 6.75%, Floor Rate 0.00%, Maturity Date 7/2/2027
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			12.08%
Reference Rate and Spread	[12],[23]			6.75%
Floor	[12],[23]			0%
Maturity	[12],[23]			Jul. 02, 2027
Par / Shares	[12],[23]			$ 1,400,000
Amortized cost	[12],[23]			1,363,000
Fair Value	[12],[23]			$ 1,377,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Idera, Inc., Information Technology, Interest Rate 12.08%, Reference Rate and Spread S + 6.75%, Floor Rate 0.75%, Maturity Date 2/5/2029
Schedule of Investments [Line Items]
Interest Rate	[12],[23],[31]			12.08%
Reference Rate and Spread	[12],[23],[31]			6.75%
Floor	[12],[23],[31]			0.75%
Maturity	[12],[23],[31]			Feb. 05, 2029
Par / Shares	[12],[23],[31]			$ 4,000,000
Amortized cost	[12],[23],[31]			3,975,000
Fair Value	[12],[23],[31]			$ 3,874,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Inmar, Inc., Information Technology, Interest Rate 10.83%, Reference Rate and Spread S + 5.50% , Floor Rate 1.00%, Maturity Date 5/1/2026
Schedule of Investments [Line Items]
Interest Rate	[2],[7],[9],[12],[31]			10.83%
Reference Rate and Spread	[7],[9],[12],[30],[31]			5.50%
Floor	[7],[9],[12],[30],[31]			1%
Maturity	[7],[9],[12],[30],[31]			May 01, 2026
Par / Shares	[7],[9],[12],[30],[31]			$ 1,990,000
Amortized cost	[7],[9],[12],[30],[31]			1,931,000
Fair Value	[7],[9],[12],[30],[31]			$ 1,970,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Ivanti Software, Inc., Information Technology, Interest Rate 12.58%, Reference Rate and Spread S + 7.25% , Floor Rate 0.75%, Maturity Date 12/1/2027
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31],[32]			12.58%
Reference Rate and Spread	[7],[9],[12],[30],[31],[32]			7.25%
Floor	[7],[9],[12],[30],[31],[32]			0.75%
Maturity	[7],[9],[12],[30],[31],[32]			Dec. 01, 2027
Par / Shares	[7],[9],[12],[30],[31],[32]			$ 992,000
Amortized cost	[7],[9],[12],[30],[31],[32]			816,000
Fair Value	[7],[9],[12],[30],[31],[32]			$ 945,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Ivanti Software, Inc., Information Technology, Interest Rate 9.58%, Reference Rate and Spread S + 4.25% , Floor Rate 1.00%, Maturity Date 12/1/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31],[32]			9.58%
Reference Rate and Spread	[7],[9],[12],[30],[31],[32]			4.25%
Floor	[7],[9],[12],[30],[31],[32]			1%
Maturity	[7],[9],[12],[30],[31],[32]			Dec. 01, 2028
Par / Shares	[7],[9],[12],[30],[31],[32]			$ 4,000,000
Amortized cost	[7],[9],[12],[30],[31],[32]			3,914,000
Fair Value	[7],[9],[12],[30],[31],[32]			$ 3,247,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, KL Charlie Acquisition, Healthcare, Interest Rate 12.10%, Reference Rate and Spread S + 6.75% , Floor Rate 1.00%, Maturity Date 12/30/2026
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31]			12.10%
Reference Rate and Spread	[7],[9],[12],[30],[31]			6.75%
Floor	[7],[9],[12],[30],[31]			1%
Maturity	[7],[9],[12],[30],[31]			Dec. 30, 2026
Par / Shares	[7],[9],[12],[30],[31]			$ 1,252,000
Amortized cost	[7],[9],[12],[30],[31]			1,232,000
Fair Value	[7],[9],[12],[30],[31]			$ 1,235,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, KL Charlie Acquisition, Healthcare, Interest Rate 12.10%, Reference Rate and Spread S + 6.75% , Floor Rate 1.00%, Maturity Date 12/30/2026 - One
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31]			12.10%
Reference Rate and Spread	[7],[9],[12],[30],[31]			6.75%
Floor	[7],[9],[12],[30],[31]			1%
Maturity	[7],[9],[12],[30],[31]			Dec. 30, 2026
Par / Shares	[7],[9],[12],[30],[31]			$ 1,607,000
Amortized cost	[7],[9],[12],[30],[31]			1,581,000
Fair Value	[7],[9],[12],[30],[31]			$ 1,585,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Lucky Bucks, Gaming, Interest Rate 12.98%, Reference Rate and Spread S + 7.65% , Floor Rate 1.00%, Maturity Date 10/2/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31]			12.98%
Reference Rate and Spread	[7],[9],[12],[30],[31]			7.65%
Floor	[7],[9],[12],[30],[31]			1%
Maturity	[7],[9],[12],[30],[31]			Oct. 02, 2028
Par / Shares	[7],[9],[12],[30],[31]			$ 245,000
Amortized cost	[7],[9],[12],[30],[31]			239,000
Fair Value	[7],[9],[12],[30],[31]			$ 248,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Lucky Bucks, Gaming, Interest Rate 12.98%, Reference Rate and Spread S + 7.65% , Floor Rate 1.00%, Maturity Date 10/2/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[9],[12],[30],[31]			12.98%
Reference Rate and Spread	[7],[9],[12],[30],[31]			7.65%
Floor	[7],[9],[12],[30],[31]			1%
Maturity	[7],[9],[12],[30],[31]			Oct. 02, 2029
Par / Shares	[7],[8],[9],[12],[30],[31]			$ 488,000
Amortized cost	[7],[8],[9],[12],[30],[31]			488,000
Fair Value	[7],[8],[9],[12],[30],[31]			$ 466,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, MAG DS CORP., Industrials, Interest Rate 10.83%, Reference Rate and Spread S + 5.50% , Floor Rate 1.00%, Maturity Date 4/1/2027
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			10.83%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.50%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Apr. 01, 2027
Par / Shares	[7],[8],[9],[12],[31]			$ 2,748,000
Amortized cost	[7],[8],[9],[12],[31]			2,670,000
Fair Value	[7],[8],[9],[12],[31]			$ 2,640,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, MSM Acquisitions, Inc., Information Technology, Interest Rate 11.33%, Reference Rate and Spread S + 6.00% , Floor Rate 1.00%, Maturity Date 12/9/2026
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Dec. 09, 2026
Par / Shares	[7],[8],[9],[12],[31]			$ 1,157,000
Amortized cost	[7],[8],[9],[12],[31]			1,157,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,109,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, MSM Acquisitions, Inc., Information Technology, Interest Rate 11.33%, Reference Rate and Spread S + 6.00% , Floor Rate 1.00%, Maturity Date 12/9/2026 One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Dec. 09, 2026
Par / Shares	[7],[8],[9],[12],[31]			$ 2,774,000
Amortized cost	[7],[8],[9],[12],[31]			2,756,000
Fair Value	[7],[8],[9],[12],[31]			$ 2,660,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Money Transfer Acquisition, Inc, Financials, Interest Rate 13.60%, Reference Rate and Spread S + 8.25% , Floor Rate 1.00%, Maturity Date 12/14/2027
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[33]			13.60%
Reference Rate and Spread	[7],[8],[9],[12],[31],[33]			8.25%
Floor	[7],[8],[9],[12],[31],[33]			1%
Maturity	[7],[8],[9],[12],[31],[33]			Dec. 14, 2027
Par / Shares	[7],[8],[9],[12],[31],[33]			$ 3,900,000
Amortized cost	[7],[8],[9],[12],[31],[33]			3,824,000
Fair Value	[7],[8],[9],[12],[31],[33]			$ 3,803,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Monroe Engineering Group, Industrials, Interest Rate 12.08%, Reference Rate and Spread S + 6.75% , Floor Rate 0.00%, Maturity Date 12/20/2026
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			12.08%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			6.75%
Floor	[7],[8],[9],[12],[31],[32]			0%
Maturity	[7],[8],[9],[12],[31],[32]			Dec. 20, 2026
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 1,993,000
Amortized cost	[7],[8],[9],[12],[31],[32]			1,941,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 1,993,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Monroe Engineering Group, Industrials, Interest Rate 12.10%, Reference Rate and Spread S + 6.75% , Floor Rate 0.00%, Maturity Date 12/20/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			12.10%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			6.75%
Floor	[7],[8],[9],[12],[31],[32]			0%
Maturity	[7],[8],[9],[12],[31],[32]			Dec. 20, 2028
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 1,985,000
Amortized cost	[7],[8],[9],[12],[31],[32]			1,931,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 1,985,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Morae Global Inc, Financials, Interest Rate 13.33%, Reference Rate and Spread S + 8.00% , Floor Rate 1.00%, Maturity Date 10/24/2030
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[31],[34]			13.33%
Reference Rate and Spread	[7],[8],[9],[12],[15],[31],[34]			8%
Floor	[7],[8],[9],[12],[15],[31],[34]			1%
Maturity	[7],[8],[9],[12],[15],[31],[34]			Oct. 24, 2030
Par / Shares	[7],[8],[9],[12],[31],[32],[34]			$ 0
Amortized cost	[7],[8],[9],[12],[15],[31],[34]			8,000
Fair Value	[7],[8],[9],[12],[15],[31],[34]			$ (14,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Morae Global Inc, Financials, Interest Rate 13.33%, Reference Rate and Spread S + 8.00% , Floor Rate 1.00%, Maturity Date 10/24/2030 One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			13.33%
Reference Rate and Spread	[7],[8],[9],[12],[30],[31]			8%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Oct. 24, 2030
Par / Shares	[7],[8],[9],[12],[31]			$ 3,188,000
Amortized cost	[7],[8],[9],[12],[31]			3,097,000
Fair Value	[7],[8],[9],[12],[31]			$ 3,037,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, NAVIGA INC., Information Technology, Interest Rate 12.33%, Reference Rate and Spread S + 7.00% , Floor Rate 1.00%, Maturity Date 3/28/2024
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			12.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			7%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Mar. 28, 2024
Par / Shares	[7],[8],[9],[12],[31]			$ 1,970,000
Amortized cost	[7],[8],[9],[12],[31]			1,969,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,957,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, NAVIGA INC., Information Technology, Interest Rate 12.33%, Reference Rate and Spread S + 7.00% , Floor Rate 1.00%, Maturity Date 3/28/2024 One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			12.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			7%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Mar. 28, 2024
Par / Shares	[7],[8],[9],[12],[31]			$ 1,856,000
Amortized cost	[7],[8],[9],[12],[31]			1,854,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,843,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, NAVIGA INC., Information Technology, Interest Rate 12.33%, Reference Rate and Spread S + 7.00% , Floor Rate 1.60%, Maturity Date 3/28/2024
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			12.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			7%
Floor	[7],[8],[9],[12],[31]			1.60%
Maturity	[7],[8],[9],[12],[31]			Mar. 28, 2024
Par / Shares	[7],[8],[9],[12],[31]			$ 205,000
Amortized cost	[7],[8],[9],[12],[31]			205,000
Fair Value	[7],[8],[9],[12],[31]			$ 204,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Neptune Bidco US Inc, Communication Services, Interest Rate 10.35%, Reference Rate and Spread S + 5.00% , Floor Rate 0.00%, Maturity Date 4/11/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			10.35%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			5%
Floor	[7],[8],[9],[12],[31],[32]			0%
Maturity	[7],[8],[9],[12],[31],[32]			Apr. 11, 2029
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 4,975,000
Amortized cost	[7],[8],[9],[12],[31],[32]			4,544,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 4,557,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, PhyNet Dermatology LLC, Healthcare, Interest Rate 11.83%, Reference Rate and Spread S + 6.50% , Floor Rate 0.00%, Maturity Date 10/20/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.83%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6.50%
Floor	[7],[8],[9],[12],[31]			0%
Maturity	[7],[8],[9],[12],[31]			Oct. 20, 2029
Par / Shares	[7],[8],[9],[12],[31]			$ 2,287,000
Amortized cost	[7],[8],[9],[12],[31]			2,240,000
Fair Value	[7],[8],[9],[12],[31]			$ 2,264,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, PhyNet Dermatology LLC, Healthcare, Interest Rate 11.83%, Reference Rate and Spread S + 6.50% , Floor Rate 0.75%, Maturity Date 8/16/2024
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[31],[34]			11.83%
Reference Rate and Spread	[7],[8],[9],[12],[15],[31],[34]			6.50%
Floor	[7],[8],[9],[12],[15],[31],[34]			0.75%
Maturity	[7],[8],[9],[12],[15],[31],[34]			Aug. 16, 2024
Par / Shares	[7],[8],[9],[12],[15],[31],[34]			$ 0
Amortized cost	[7],[8],[9],[12],[13],[14],[15],[31],[34]			8,000
Fair Value	[7],[8],[9],[12],[15],[31],[34]			$ (17,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Premier Imaging, LLC, Healthcare, Interest Rate 11.10%, Reference Rate and Spread S + 5.75% , Floor Rate 0.00%, Maturity Date 12/29/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.10%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.75%
Floor	[7],[8],[9],[12],[31]			0%
Maturity	[7],[8],[9],[12],[31]			Dec. 29, 2028
Par / Shares	[7],[8],[9],[12],[31]			$ 94,000
Amortized cost	[7],[8],[9],[12],[31]			94,000
Fair Value	[7],[8],[9],[12],[31]			$ 91,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Premier Imaging, LLC, Healthcare, Interest Rate 11.10%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00%, Maturity Date 1/2/2025
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.10%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.75%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jan. 02, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 937,000
Amortized cost	[7],[8],[9],[12],[31]			935,000
Fair Value	[7],[8],[9],[12],[31]			$ 901,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Premier Imaging, LLC, Healthcare, Interest Rate 11.10%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00%, Maturity Date 1/2/2025 - One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.10%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.75%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jan. 02, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 26,000
Amortized cost	[7],[8],[9],[12],[31]			26,000
Fair Value	[7],[8],[9],[12],[31]			$ 25,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Premier Imaging, LLC, Healthcare, Interest Rate 11.10%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00%, Maturity Date 1/2/2025 - Three
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.10%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.75%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jan. 02, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 1,754,000
Amortized cost	[7],[8],[9],[12],[31]			1,748,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,686,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Premier Imaging, LLC, Healthcare, Interest Rate 11.10%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00%, Maturity Date 1/2/2025 - Two
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.10%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.75%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jan. 02, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 957,000
Amortized cost	[7],[8],[9],[12],[31]			955,000
Fair Value	[7],[8],[9],[12],[31]			$ 920,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Priority Holdings, LLC, Information Technology, Interest Rate 12.08%, Reference Rate and Spread S + 6.75% , Floor Rate 1.00%, Maturity Date 4/27/2027
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			12.08%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6.75%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Apr. 27, 2027
Par / Shares	[7],[8],[9],[12],[31]			$ 4,972,000
Amortized cost	[7],[8],[9],[12],[31]			4,954,000
Fair Value	[7],[8],[9],[12],[31]			$ 4,953,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Project Castle T/L, Information Technology, Interest Rate 10.83%, Reference Rate and Spread S + 5.50% , Floor Rate 1.00%, Maturity Date 6/29/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			10.83%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5.50%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jun. 29, 2029
Par / Shares	[7],[8],[9],[12],[31]			$ 4,942,000
Amortized cost	[7],[8],[9],[12],[31]			4,485,000
Fair Value	[7],[8],[9],[12],[31]			$ 4,390,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Project Leopard Holdings Company Inc, Information Technology, Interest Rate 10.70%, Reference Rate and Spread S + 5.35% , Floor Rate 1.00%, Maturity Date 7/20/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			10.70%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			5.35%
Floor	[7],[8],[9],[12],[31],[32]			1%
Maturity	[7],[8],[9],[12],[31],[32]			Jul. 20, 2029
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 3,960,000
Amortized cost	[7],[8],[9],[12],[31],[32]			3,722,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 3,600,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, RN Enterprises, LLC, Healthcare, Interest Rate 11.85%, Reference Rate and Spread S + 6.50% , Floor Rate 1.00%, Maturity Date 12/23/2025
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.85%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6.50%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Dec. 23, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 982,000
Amortized cost	[7],[8],[9],[12],[31]			969,000
Fair Value	[7],[8],[9],[12],[31]			$ 954,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, RN Enterprises, LLC, Healthcare, Interest Rate 11.85%, Reference Rate and Spread S + 6.50% , Floor Rate 1.00%, Maturity Date 12/23/2025 - One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.85%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6.50%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Dec. 23, 2025
Par / Shares	[7],[8],[9],[12],[31]			$ 500,000
Amortized cost	[7],[8],[9],[12],[31]			490,000
Fair Value	[7],[8],[9],[12],[31]			$ 486,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, RSA Security, LLC, Information Technology, Interest Rate 13.08%, Reference Rate and Spread S + 7.75% , Floor Rate 0.75%, Maturity Date 4/27/2029
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			13.08%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			7.75%
Floor	[7],[8],[9],[12],[31],[32]			0.75%
Maturity	[7],[8],[9],[12],[31],[32]			Apr. 27, 2029
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 4,000,000
Amortized cost	[7],[8],[9],[12],[31],[32]			3,946,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 2,480,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Reception Purchaser, LLC, Transportation, Interest Rate 11.35%, Reference Rate and Spread S + 6.00% , Floor Rate 1.50%, Maturity Date 5/31/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.35%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6%
Floor	[7],[8],[9],[12],[31]			1.50%
Maturity	[7],[8],[9],[12],[31]			May 31, 2028
Par / Shares	[7],[8],[9],[12],[31]			$ 1,970,000
Amortized cost	[7],[8],[9],[12],[31]			1,946,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,458,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Symplr Software Inc, Information Technology, Interest Rate 9.85%, Reference Rate and Spread S + 4.50% , Floor Rate 0.75%, Maturity Date 12/22/2027
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			9.85%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			4.50%
Floor	[7],[8],[9],[12],[31],[32]			0.75%
Maturity	[7],[8],[9],[12],[31],[32]			Dec. 22, 2027
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 1,113,000
Amortized cost	[7],[8],[9],[12],[31],[32]			1,111,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 1,001,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Synaemedia Americas Holdings, Inc, Information Technology, Interest Rate 13.08%, Reference Rate and Spread S + 7.75% , Floor Rate 1.00%, Maturity Date 12/5/2030
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[16],[31]			13.08%
Reference Rate and Spread	[7],[8],[9],[12],[16],[31]			7.75%
Floor	[7],[8],[9],[12],[16],[31]			1%
Maturity	[7],[8],[9],[12],[16],[31]			Dec. 05, 2030
Par / Shares	[7],[8],[9],[12],[16],[31]			$ 2,759,000
Amortized cost	[7],[8],[9],[12],[16],[31]			2,662,000
Fair Value	[7],[8],[9],[12],[16],[31]			$ 2,662,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, TLE Holdings, LLC, Consumer Discretionary, Interest Rate 11.33%, Reference Rate and Spread S + 6.00% , Floor Rate 1.00%, Maturity Date 6/28/2024
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jun. 28, 2024
Par / Shares	[7],[8],[9],[12],[31]			$ 957,000
Amortized cost	[7],[8],[9],[12],[31]			957,000
Fair Value	[7],[8],[9],[12],[31]			$ 955,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tactical Air Support, Inc, Industrials, Interest Rate 13.83%, Reference Rate and Spread S + 8.50% , Floor Rate 0.00%, Maturity Date 12/22/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[16],[31],[34]			13.83%
Reference Rate and Spread	[7],[8],[9],[12],[15],[16],[30],[31],[34]			8.50%
Floor	[7],[8],[9],[12],[15],[16],[31],[34]			0%
Maturity	[7],[8],[9],[12],[15],[16],[31],[34]			Dec. 22, 2028
Par / Shares	[7],[8],[9],[12],[15],[16],[31],[34]			$ 0
Amortized cost	[7],[8],[9],[12],[13],[14],[15],[16],[31]			14,000
Fair Value	[7],[8],[9],[12],[15],[16],[31],[34]			$ 0
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tactical Air Support, Inc, Industrials, Interest Rate 13.83%, Reference Rate and Spread S + 8.50% , Floor Rate 1.00%, Maturity Date 12/22/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[16],[31]			13.83%
Reference Rate and Spread	[7],[8],[9],[12],[16],[31]			8.50%
Floor	[7],[8],[9],[12],[16],[31]			1%
Maturity	[7],[8],[9],[12],[16],[31]			Dec. 22, 2028
Par / Shares	[7],[8],[9],[12],[16],[31]			$ 3,429,000
Amortized cost	[7],[8],[9],[12],[16],[31]			3,343,000
Fair Value	[7],[8],[9],[12],[16],[31]			$ 3,343,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tank Holding Corp DDTL, Industrials, Interest Rate 11.33%, Reference Rate and Spread S + 6.00% , Floor Rate 0.75%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[31]			11.33%
Reference Rate and Spread	[7],[8],[9],[12],[15],[31]			6%
Floor	[7],[8],[9],[12],[15],[31]			0.75%
Maturity	[7],[8],[9],[12],[15],[31]			Mar. 31, 2028
Par / Shares	[7],[8],[9],[12],[16],[31]			$ 101,000
Amortized cost	[7],[8],[9],[12],[15],[31]			97,000
Fair Value	[7],[8],[9],[12],[15],[31]			$ 91,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tank Holding Corp, Industrials, Interest Rate 11.08%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00 Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31],[32]			11.08%
Reference Rate and Spread	[7],[8],[9],[12],[31],[32]			5.75%
Floor	[7],[8],[9],[12],[31],[32]			1%
Maturity	[7],[8],[9],[12],[31],[32]			Mar. 31, 2028
Par / Shares	[7],[8],[9],[12],[31],[32]			$ 3,922,000
Amortized cost	[7],[8],[9],[12],[31],[32]			3,751,000
Fair Value	[7],[8],[9],[12],[31],[32]			$ 3,765,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tank Holding Corp, Industrials, Interest Rate 11.08%, Reference Rate and Spread S + 5.75% , Floor Rate 1.00%, Maturity Date 3/31/2028 - One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[31]			11.08%
Reference Rate and Spread	[7],[8],[9],[12],[15],[31]			5.75%
Floor	[7],[8],[9],[12],[15],[31]			1%
Maturity	[7],[8],[9],[12],[15],[31]			Mar. 31, 2028
Par / Shares	[7],[8],[9],[12],[15],[31]			$ 18,000
Amortized cost	[7],[8],[9],[12],[15],[31]			15,000
Fair Value	[7],[8],[9],[12],[15],[31]			$ 16,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Tank Holding Corp, Industrials, Interest Rate 11.33%, Reference Rate and Spread S + 6.00% , Floor Rate 0.75%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			11.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			6%
Floor	[7],[8],[9],[12],[31]			0.75%
Maturity	[7],[8],[9],[12],[31]			Mar. 31, 2028
Par / Shares	[7],[8],[9],[12],[31]			$ 695,000
Amortized cost	[7],[8],[9],[12],[31]			676,000
Fair Value	[7],[8],[9],[12],[31]			$ 667,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.33%, Reference Rate and Spread S + 8.00% , Floor Rate 1.00%, Maturity Date 6/13/2030
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15],[34]			13.33%
Reference Rate and Spread	[7],[8],[9],[12],[15],[30],[34]			8%
Floor	[7],[8],[9],[12],[15],[34]			1%
Maturity	[7],[8],[9],[12],[15],[34]			Jun. 13, 2030
Amortized cost	[7],[8],[9],[12],[15],[34]			$ 18,000
Fair Value	[7],[8],[9],[12],[15],[34]			$ (12,000)
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.33%, Reference Rate and Spread S + 8.00% , Floor Rate 1.00%, Maturity Date 6/13/2030 - One
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[15]			13.33%
Reference Rate and Spread	[7],[8],[9],[12],[15]			8%
Floor	[7],[8],[9],[12],[15]			1%
Maturity	[7],[8],[9],[12],[15]			Jun. 13, 2030
Par / Shares	[7],[8],[9],[12],[15]			$ 65,000
Amortized cost	[7],[8],[9],[12],[15]			61,000
Fair Value	[7],[8],[9],[12],[15]			$ 62,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, VBC Spine Opco LLC, Healthcare, Interest Rate 13.33%, Reference Rate and Spread S + 8.00% , Floor Rate 1.00%, Maturity Date 6/13/2030 - Two
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			13.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			8%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Jun. 13, 2030
Par / Shares	[7],[8],[9],[12],[31]			$ 1,750,000
Amortized cost	[7],[8],[9],[12],[13],[31]			1,700,000
Fair Value	[7],[8],[9],[12],[31]			$ 1,728,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan - 185.0%, Wonder Love Inc, Communication Services, Interest Rate 10.33%, Reference Rate and Spread S + 5.00% , Floor Rate 1.00%, Maturity Date 11/18/2024
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[31]			10.33%
Reference Rate and Spread	[7],[8],[9],[12],[31]			5%
Floor	[7],[8],[9],[12],[31]			1%
Maturity	[7],[8],[9],[12],[31]			Nov. 18, 2024
Par / Shares	[7],[8],[9],[12],[31]			$ 375,000
Amortized cost	[7],[8],[9],[12],[13],[31]			373,000
Fair Value	[7],[8],[9],[12],[31]			$ 375,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan -177.7 %, Tank Holding Corp, Industrials, Interest Rate 11.32%, Reference Rate and Spread S + 6.00%, Floor 0.75%, Maturity Date 3/31/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[22],[23]	11.32%
Reference Rate and Spread	[1],[2],[3],[6],[22],[23],[24]	6%
Floor	[1],[2],[3],[6],[22],[23]	0.75%
Maturity	[1],[2],[3],[6],[22],[23]	Mar. 31, 2028
Par / Shares	[1],[2],[3],[6],[22],[23]	$ 690,000
Amortized cost	[1],[2],[3],[6],[14],[19],[22],[23]	673,000
Fair Value	[1],[2],[3],[6],[22],[23]	$ 681,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 177.7%, Advantage Capital Holdings LLC, Financials, Interest Rate 13.00%, Reference Rate and Spread NA, Floor Rate 0.00%, Maturity Date 4/14/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23],[25]	13%
Floor	[1],[2],[3],[6],[23],[25]	0%
Maturity	[1],[2],[3],[6],[23],[25]	Apr. 14, 2027
Par / Shares	[1],[2],[3],[6],[23],[25]	$ 4,694,000
Amortized cost	[1],[2],[3],[6],[19],[20],[23],[25]	4,694,000
Fair Value	[1],[2],[3],[6],[23],[25]	$ 4,576,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, AG Parent Holdings , Information Technology, Interest Rate 10.33 %, Reference Rate and Spread S + 5.00% %, Floor Rate 1.00%, Maturity Date 7/30/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23],[32],[34],[35]			10.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30],[32],[34],[35]			5%
Floor	[1],[2],[3],[12],[23],[32],[34],[35]			1%
Maturity	[1],[2],[3],[12],[23],[32],[34],[35]			Jul. 30, 2026
Par / Shares	[1],[2],[3],[12],[23],[32],[34],[35]			$ 1,003,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23],[32],[34],[35]			980,000
Fair Value	[1],[2],[3],[12],[23],[32],[34],[35]			$ 983,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, ALCV Purchaser, Inc., Consumer Discretionary, Interest Rate 12.10%, Reference Rate and Spread S + 6.75%, Floor 1.00%, Maturity Date 2/26/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			12.10%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			6.75%
Floor	[1],[2],[3],[12],[23]			1%
Maturity	[1],[2],[3],[12],[23]			Feb. 26, 2026
Par / Shares	[1],[2],[3],[12],[23]			$ 2,125,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			2,109,000
Fair Value	[1],[2],[3],[12],[23]			$ 2,101,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Accordion Partners LLC 1, Financials , Interest Rate 11.85%, Reference Rate and Spread S + 6.50%, Floor Rate 0.00%, Maturity Date 9/30/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23],[26]			11.85%
Reference Rate and Spread	[1],[2],[3],[12],[23],[26],[30]			6.50%
Floor	[1],[2],[3],[12],[23],[26]			0%
Maturity	[1],[2],[3],[12],[23],[26]			Sep. 30, 2028
Par / Shares	[1],[2],[3],[12],[23],[26]			$ 768,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23],[26]			704,000
Fair Value	[1],[2],[3],[12],[23],[26]			$ 789,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Accurate Background LLC , Information Technology, Interest Rate 11.33%, Reference Rate and Spread S + 6.00%, Floor Rate 0.00%, Maturity Date 3/26/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			11.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			6%
Floor	[1],[2],[3],[12],[23]			0%
Maturity	[1],[2],[3],[12],[23]			Mar. 26, 2027
Par / Shares	[1],[2],[3],[12],[23]			$ 494,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			462,000
Fair Value	[1],[2],[3],[12],[23]			$ 475,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Accurate Background LLC, Information Technology, Interest Rate 11.33%, Reference Rate and Spread S + 6.00%, Floor Rate 1.00%, Maturity Date 3/26/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			11.33%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			6%
Floor	[1],[2],[3],[12],[23]			1%
Maturity	[1],[2],[3],[12],[23]			Mar. 26, 2027
Par / Shares	[1],[2],[3],[12],[23]			$ 2,931,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			2,758,000
Fair Value	[1],[2],[3],[12],[23]			$ 2,818,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Advantage Capital Holdings LLC , Financials, Interest Rate 13.00%, Reference Rate and Spread NA , Floor Rate 0.00%, Maturity Date 4/14/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23],[34],[35]			13%
Floor	[1],[2],[3],[12],[23],[34],[35]			0%
Maturity	[1],[2],[3],[12],[23],[34],[35]			Apr. 14, 2027
Par / Shares	[1],[2],[3],[12],[23],[34],[35]			$ 4,400,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23],[34],[35]			4,400,000
Fair Value	[1],[2],[3],[12],[23],[34],[35]			$ 4,318,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Beta Plus Technologies, Inc, Information Technology, Interest Rate 11.10%, Reference Rate and Spread S + 5.75%, Floor Rate 0.00%, Maturity Date 6/29/2029
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23],[26],[27]			11.10%
Reference Rate and Spread	[1],[2],[3],[12],[23],[26],[27],[30]			5.75%
Floor	[1],[2],[3],[12],[23],[26],[27]			0%
Maturity	[1],[2],[3],[12],[23],[26],[27]			Jun. 29, 2029
Par / Shares	[1],[2],[3],[12],[23],[26],[27]			$ 53,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23],[26],[27]			53,000
Fair Value	[1],[2],[3],[12],[23],[26],[27]			$ 32,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Beta Plus Technologies, Inc., Information Technology, Interest Rate 11.10%, Reference Rate and Spread S + 5.75%, Floor Rate 0.00%, Maturity Date 6/29/2029 - One
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[12],[23]			11.10%
Reference Rate and Spread	[1],[2],[3],[12],[23],[30]			5.75%
Floor	[1],[2],[3],[12],[23]			0%
Maturity	[1],[2],[3],[12],[23]			Jun. 29, 2029
Par / Shares	[1],[2],[3],[12],[23]			$ 2,742,000
Amortized cost	[1],[2],[3],[12],[13],[14],[23]			2,595,000
Fair Value	[1],[2],[3],[12],[31]			$ 2,633,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, C.P. Converters, Inc., 12th Amendment Acquisition Loan, Industrials, Interest Rate 11.83%, Reference Rate and Spread S + 6.50%, Floor Rate 1.00%, Maturity Date 9/30/2024
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.83%
Reference Rate and Spread	[12],[23]			6.50%
Floor	[12],[23]			1%
Maturity	[12],[23]			Sep. 30, 2024
Par / Shares	[12],[23]			$ 375,000
Amortized cost	[12],[23]			370,000
Fair Value	[12],[31]			$ 378,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, C.P. Converters, Inc., Seventh Amendment Acquisition Loan, Industrials, Interest Rate 11.83%, Reference Rate and Spread S + 6.50%, Floor Rate 1.00%, Maturity Date 9/30/2024
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.83%
Reference Rate and Spread	[12],[23],[30]			6.50%
Floor	[12],[23]			1%
Maturity	[12],[23]			Sep. 30, 2024
Par / Shares	[12],[23]			$ 1,741,000
Amortized cost	[12],[13],[14],[23]			1,730,000
Fair Value	[12],[31]			$ 1,759,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, CenExcel Clinical Research Holdings, Inc, Inc, Healthcare, Interest Rate 11.83%, Reference Rate and Spread S + 6.50%, Floor Rate 0.00%, Maturity Date 11/10/2025
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.83%
Reference Rate and Spread	[12],[23]			6.50%
Floor	[12],[23]			0%
Maturity	[12],[23]			Nov. 10, 2025
Par / Shares	[12],[23]			$ 361,000
Amortized cost	[12],[23]			361,000
Fair Value	[12],[31]			$ 361,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Critical Nurse Staffing LLC 1, Healthcare, Interest Rate 11.33%, Reference Rate and Spread S + 6.00%, Floor Rate 1.00%, Maturity Date 10/30/2026 - One
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.33%
Reference Rate and Spread	[12],[23]			6%
Floor	[12],[23]			1%
Maturity	[12],[23]			Oct. 30, 2026
Par / Shares	[12],[23]			$ 674,000
Amortized cost	[12],[23]			666,000
Fair Value	[12],[31]			$ 663,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Critical Nurse Staffing LLC, Healthcare, Interest Rate 11.83%, Reference Rate and Spread S + 6.50%, Floor Rate 1.00%, Maturity Date 10/30/2026
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.83%
Reference Rate and Spread	[12],[23]			6.50%
Floor	[12],[23]			1%
Maturity	[12],[23]			Oct. 30, 2026
Par / Shares	[12],[23]			$ 3,990,000
Amortized cost	[12],[23]			3,911,000
Fair Value	[12],[31]			$ 3,930,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Critical Nurse Staffing LLC., Healthcare, Interest Rate 11.33%, Reference Rate and Spread S + 6.00%, Floor Rate 1.00%, Maturity Date 10/30/2026
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.33%
Reference Rate and Spread	[12],[23]			6%
Floor	[12],[23]			1%
Maturity	[12],[23]			Oct. 30, 2026
Par / Shares	[12],[23]			$ 52,000
Amortized cost	[12],[23]			52,000
Fair Value	[12],[31]			$ 51,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, DRI Holdings Inc, Information Technology, Interest Rate 10.60%, Reference Rate and Spread S + 5.25%, Floor Rate 0.50%, Maturity Date 12/21/2028
Schedule of Investments [Line Items]
Interest Rate	[12],[22],[23]			10.60%
Reference Rate and Spread	[12],[22],[23]			5.25%
Floor	[12],[22],[23]			0.50%
Maturity	[12],[22],[23]			Dec. 21, 2028
Par / Shares	[12],[22],[23]			$ 4,927,000
Amortized cost	[12],[22],[23]			4,622,000
Fair Value	[12],[22],[23]			$ 4,515,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Datalink, LLC, Healthcare, Interest Rate 11.60%, Reference Rate and Spread S + 6.25%, Floor Rate 1.00%, Maturity Date 11/23/2026
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			11.60%
Reference Rate and Spread	[12],[23]			6.25%
Floor	[12],[23]			1%
Maturity	[12],[23]			Nov. 23, 2026
Par / Shares	[12],[23]			$ 3,103,000
Amortized cost	[12],[23]			3,056,000
Fair Value	[12],[31]			$ 3,102,000
Investment, Identifier [Axis]: Investment in Senior Secured Loan – 185.0%, Florida Foods Products, LLC, Consumer Staples, Interest Rate 10.33%, Reference Rate and Spread S + 5.00%, Floor Rate 1.00%, Maturity Date 10/18/2028 - One
Schedule of Investments [Line Items]
Interest Rate	[12],[23]			10.33%
Reference Rate and Spread	[12],[23]			5%
Floor	[12],[23]			1%
Maturity	[12],[23]			Oct. 18, 2028
Par / Shares	[12],[23]			$ 1,965,000
Amortized cost	[12],[23]			1,936,000
Fair Value	[12],[23]			$ 1,724,000
Investment, Identifier [Axis]: Investment in Structured Note - 5.7%, Churchill Middle Market CLO IV Ltd., Class E-2 Notes, Collateralized Loan Obligation - Debt Class, Interest Rate 14.33%, Reference Rate and Spread S + 9.00%, Floor Rate 0.00%, Maturity Date 1/23/2032
Schedule of Investments [Line Items]
Interest Rate	[7],[8],[9],[12],[16],[31]			14.33%
Reference Rate and Spread	[7],[8],[9],[12],[16],[31]			9%
Floor	[7],[8],[9],[12],[16],[31]			0%
Maturity	[7],[8],[9],[12],[16],[31]			Jan. 23, 2032
Par / Shares	[7],[8],[9],[12],[16],[31]			$ 3,900,000
Amortized cost	[7],[8],[9],[12],[16],[31]			3,840,000
Fair Value	[7],[8],[9],[12],[16],[31]			3,860,000
Investment, Identifier [Axis]: Investment in Unsecured Note - 0.1%, Delta DX Purchaser, Inc, Financials, Interest Rate 15.00%, Reference Rate and Spread NA, Floor 0.00%, Maturity Date 6/14/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[6],[23]	15%
Floor	[1],[2],[3],[6],[23]	0%
Maturity	[1],[2],[3],[6],[23]	Jun. 14, 2028
Par / Shares	[1],[2],[3],[6],[23]	$ 81,000
Amortized cost	[1],[2],[3],[6],[23]	81,000
Fair Value	[1],[2],[3],[6],[23]	81,000
Investment, Identifier [Axis]: Total Equity/Other
Schedule of Investments [Line Items]
Amortized cost		3,257,000	[1],[2],[3],[6],[19],[20]	1,981,000	[7],[8],[9],[12],[13],[14]
Fair Value		4,385,000	[1],[2],[3],[6]	3,765,000	[7],[8],[9],[12]
Investment, Identifier [Axis]: Total Investments - 196.2%
Schedule of Investments [Line Items]
Amortized cost	[7],[8],[9],[12],[13],[14],[16]			135,332,000
Fair Value	[7],[8],[9],[12],[16]			133,675,000
Investment, Identifier [Axis]: Total Investments - 183.9.%
Schedule of Investments [Line Items]
Amortized cost	[1],[2],[3],[6],[19],[20],[21]	136,492,000
Fair Value	[1],[2],[3],[6],[21]	132,848,000
Investment, Identifier [Axis]: Total Senior Secured Loan
Schedule of Investments [Line Items]
Amortized cost		133,154,000	[1],[2],[3],[6],[19],[20]	129,511,000	[7],[8],[9],[12]
Fair Value		128,382,000	[1],[2],[3],[6]	126,050,000	[7],[8],[9],[12]
Investment, Identifier [Axis]: Total Structured Note
Schedule of Investments [Line Items]
Amortized cost	[7],[8],[9],[12]			3,840,000
Fair Value	[7],[8],[9],[12]			$ 3,860,000
Investment, Identifier [Axis]: Total Unsecured Note
Schedule of Investments [Line Items]
Amortized cost	[1],[2],[3],[6]	81,000
Fair Value	[1],[2],[3],[6]	$ 81,000
[1] All investments are non-controlled/non-affiliated investments as defined by the 1940 Act. The provisions of the 1940 Act classify investments based on the level of control that the Comp any maintains in a particular portfolio company unless otherwise noted. All of the Company's investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940 (the “1940 Act”), unless otherwise noted. All of the Company's investments are issued by U.S. portfolio companies unless otherwise noted. Except as otherwise noted, certain of the Company’s portfolio company investments are subject to legal restrictions on sales. Under the 1940 Act, the Company is deemed to be an “Affiliated Person” of, as defined in the 1940 Act, this portfolio company as the Company owns at least 5% of the portfolio company’s outstanding voting securities or is under common control with such portfolio company. Under the 1940 Act, the Company is deemed to be an “Affiliated Person” of, as defined in the 1940 Act, this portfolio company as the Company owns at least 5 % of the portfolio company’s outstanding voting securities or is under common control with such portfolio company. Percentages are based on the net assets. All investments are non-controlled/non-affiliated investments as defined by the 1940 Act. The provisions of the 1940 Act classify investments based on the level of control that the Comp any maintains in a particular portfolio company unless otherwise noted. All of the Company's investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940 (the “1940 Act”), unless otherwise noted. All of the Company's investments are issued by U.S. portfolio companies unless otherwise noted. Except as otherwise noted, certain of the Company’s portfolio company investments are subject to legal restrictions on sales. Non-income producing investment. Ownership of equity investments may occur through a wholly-owned, consolidated taxable subsidiary. Percentages are based on the net assets. As of December 31, 2023, the estimated cost basis of investments for U.S. federal tax purposes was $ 135,332 , resulting in estimated gross unrealized appreciation and depreciation of $ 2,652 and $( 4,309 ), respectively. The amortized cost represents the initial cost adjusted for the accretion of discount or amortization of premium, as applicable, on debt investments using the effective interest method. All or a portion of this commitment was unfunded at December 31, 2023. Investments the Company has determined are not qualifying assets under Section 55(a) of the 1940 Act. The status of these assets under the 1940 Act is subject to change. The Company monitors the status of these assets on an ongoing basis. Under the 1940 Act, the Company may not acquire any non-qualifying asset unless, at the time such acquisition is made, qualifying assets represent at least 70 % of total assets. Non-qualifying assets represented 4.2 % of total assets as of December 31, 2023. Non-income producing investment. Ownership of equity investments may occur through a wholly-owned, consolidated taxable subsidiary. As of September 30, 2024 , the estimated cost basis of investments for U.S. federal tax purposes was $ 136,492 , resulting in estimated gross unrealized appreciation and depreciation of $ 2,472 and $( 6,116 ), respectively. The amortized cost represents the initial cost adjusted for the accretion of discount or amortization of premium, as applicable, on debt investments using the effective interest method. Investments the Company has determined are not qualifying assets under Section 55(a) of the 1940 Act. The status of these assets under the 1940 Act is subject to change. The Company monitors the status of these assets on an ongoing basis. Under the 1940 Act, the Company may not acquire any non-qualifying asset unless, at the time such acquisition is made, qualifying assets represent at least 70 % of total assets. Non-qualifying assets represented 1 .1 % of total assets as of September 30, 2024 . Other than the investments noted by this footnote, the fair value of each of the Company’s investments is determined in good faith using significant unobservable inputs by the Adviser in its role as “valuation designee” in accordance with Rule 2a-5 under the 1940 Act, pursuant to valuation policies and procedures that have been approved by the Company’s board of directors (the "Board"). Security, or a portion thereof, is held through Great Lakes BCPL Funding Ltd., a wholly-owned subsidiary and a bankruptcy remote special purpose entity, and is pledged as collateral supporting the amounts outstanding under the debt financing facility at Great Lakes BCPL Funding Ltd. (See Note 5 in the accompanying consolidated unaudited financial statements). Represents the actual interest rate for p artially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor of the reference to Secured Overnight Financing Rate ("SOFR" or "S") or alternate base rate (commonly known as the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower's option, which reset periodically based on the terms of the credit agreement. As of September 30, 2024 , rates for 3 months and 1 month S ("SOFR") are 4.59 % and 4.85 %. Investment bears interest at 12 % per year with such interest to be paid, at the election of the borrower in cash or paid-in kind (“PIK”) interest. To the extent that any portion of interest is in the form of PIK interest, the interest rate is increased to 13 % with a minimum of 5 % of the total interest in the form of cash interest (i.e., 5 % cash interest and 8 % PIK interest). All or a portion of this commitment was unfunded at September 30, 2024 . The date disclosed represents the commitment period of the unfunded term loan. As of September 30, 2024 , this investment is pledged to secure the Company's debt obligations. The negative cost is the result of the capitalized discount being greater than the principal amount outstanding on the loan. The negative fair value is the result of the capitalized discount on the loan. Represents the actual interest rate for p artially or fully funded debt in effect as of the reporting date. Variable rate loans bear interest at a rate that may be determined by the larger of the floor of the reference to Secured Overnight Financing Rate ("SOFR" or "S") or alternate base rate (commonly known as the U.S. Prime Rate ("P"), unless otherwise noted) at the borrower's option, which reset periodically based on the terms of the credit agreement. As of December 31, 2023, rates for 3 months and 1 month S ("SOFR") are 5.33 % and 5.35 %. Security, or a portion thereof, is held through Great Lakes BCPL Funding Ltd., a wholly-owned subsidiary and a bankruptcy remote special purpose entity, and is pledged as collateral supporting the amounts outstanding under the debt financing facility at Great Lakes BCPL Funding Ltd. (See Note 5 in the accompanying consolidated unaudited financial statements). Other than the investments noted by this footnote, the fair value of each of the Company’s investments is determined in good faith using significant unobservable inputs by the Adviser in its role as “valuation designee” in accordance with Rule 2a-5 under the 1940 Act, pursuant to valuation policies and procedures that have been approved by the Company’s board of directors (the "Board"). The date disclosed represents the commitment period of the unfunded term loan. The Company may sell any of the referenced securities in whole or in part to any third-party prior to the settlement date of the forward contracts without consent of the counterparty. Upon such sale to a third-party, the Company and counterparty shall have no further obligations in resp ect of that specific amount of referenced security sold. Investment bears interest at 12 % per year with such interest to be paid, at the election of the borrower in cash or paid-in kind (“PIK”) interest. To the extent that any portion of interest is in the form of PIK interest, the interest rate is increased to 13 % with a minimum of 5 % of the total interest in the form of cash interest (i.e., 5 % cash interest and 8 % PIK interest).

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments (Parenthetical) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Secured overnight financing rate, percentage	4.85%	5.35%	4.59%	5.33%
Unrealized appreciation	$ 0		$ 0		$ 0
Unrealized depreciation		$ (4,309)		$ (4,309)		$ (4,309)
Qualifying assets, percentage					70%	70%
Non-qualifying assets, percentage					0.10%	4.20%
Investment interest rate	12%	12%	12%	12%	12%	12%
Investment, increase in interest rate, paid in kind					13%	13%
Investment total interest rate paid In kind					5%	5%
Investment, interest rate, paid in kind	8%	8%	8%	8%	8%	8%
Investment, interest rate, paid in cash	5%	5%	5%	5%	5%	5%
Qualifying outstanding voting securities, percentage	5%		5%		5%
Domestic Tax Authority [Member]
Schedule of Investments [Line Items]
Cost basis of investments	$ 136,492	$ 135,332	$ 136,492	$ 135,332	$ 136,492	$ 135,332
Unrealized appreciation	2,472	$ 2,652	2,472	$ 2,652	2,472	$ 2,652
Unrealized depreciation	$ (6,116)		$ (6,116)		$ (6,116)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 349	$ 3,328	$ 2,541	$ 5,376

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Sep. 30, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization

Organization	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization BC Partners Lending Corporation (“BCPL” or the “Company”) is a Maryland corporation formed on December 22, 2017. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). In addition, the Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company is an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and the Company will take advantage of the extended transition period for complying with certain new or revised accounting standards provided for emerging growth companies in Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”). The Company’s investment objective is to make investments that generate current income and, to a lesser extent, capital appreciation. The Company intends to invest primarily in private middle-market companies in the form of secured debt, unsecured debt, other debt and/or equity securities. In addition, to a lesser extent, the Company may invest in securities of public companies and in structured products. The Company was formed primarily to invest in the U.S. middle-market credit sector. On October 25, 2019, the Company formed a wholly-owned, special-purpose, bankruptcy-remote subsidiary, Great Lakes BCPL Funding Ltd. (“BCPL Funding”), a Cayman Islands exempted company, which holds certain of the Company’s portfolio loan investments that are used as collateral for the debt financing facility at BCPL Funding. On January 28, 2020, the Company formed a wholly-owned, bankruptcy-remote subsidiary, BCPL Sub Holdings LLC, a Delaware limited liability company, which holds the Company’s equity investment. The Company is managed by BC Partners Advisors L.P. (the “Adviser”), an affiliate of BC Partners LLP (“BC Partners”). BC Partners Management LLC (the “Administrator”), also an affiliate of BC Partners, provides administrative services necessary for the Company to operate. The Company conducts private offerings (each, a “Private Offering”) of its common stock to accredited investors in reliance on exemptions from the registration requirements of the Securities Act. At the closing of each Private Offering, each investor makes a capital commitment (a “Capital Commitment”) to purchase shares of the Company’s common stock pursuant to a subscription agreement entered into with the Company. Investors are required to fund drawdowns to purchase shares of the Company’s common stock up to the amount of their respective Capital Commitment on an as-needed basis each time the Company delivers a drawdown notice to its investors. The Company’s initial Private Offering closed on September 26, 2019 (the “Initial Closing Date”). In April 2020 the Company submitted to the SEC an application for exemptive relief intended, if granted, to provide investors with liquidity options with respect to their investments in shares of the Company’s common stock. In August 2022, the SEC Staff informed the Company that it did not intend to grant the Company's application at the current time, and the Company withdrew its application. The Company's board of directors (the "Board") continues to consider alternative means of liquidity for the Company's stockholders, including potentially listing the shares of the Company on a national securities exchange or commencing periodic repurchase or tender offers in the future (a "Liquidity Action"). The Company will wind down its operations within ten years after the after the Initial Closing Date, unless the Board and/or stockholders determine to take a Liquidity Action. The Company’s fiscal year ends on December 31.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2. Significant Accounting Policies Basis of Presentation The unaudited consolidated financial statements and notes should be read in conjunction with the audited consolidated financial statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 12, 2024. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. These consolidated financial statements reflect adjustments that in the opinion of the Company are necessary for the fair presentation of the financial position and results of operations as of and for the periods presented herein. The Company is an investment company under U.S. GAAP and therefore applies the accounting and reporting guidance applicable to investment companies. The Company has evaluated subsequent events through the date of issuance of the consolidated financial statements. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates, and such differences could be material. Consolidation In accordance with U.S. GAAP guidance on consolidation, the Company will generally not consolidate its investment in a portfolio company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the accounts of the Company’s wholly-owned subsidiaries in its consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation. Segments In accordance with U.S. GAAP guidance on segment reporting, the Company has determined that its operations comprise a single reporting segment. Cash and Restricted Cash Cash consists of deposits held at a custodian bank. Restricted cash consists of deposits pledged as collateral. Cash and restricted cash are held at major financial institutions and, at times, may exceed the insured limits under applicable law. Investments Investment transactions are recorded on the trade date. Realized gains or losses on investments are calculated using the specific identification method as the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments charged off during the period, net of recoveries. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation when gains or losses are recognized. Investments for which market quotations are available are typically valued at those market quotations. To validate market quotations, the Company will utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations. Debt that is not publicly traded but for which there are external pricing sources available as of the valuation date is valued using independent broker-dealer, market maker quotations or independent pricing services. The valuation committee, comprised of members of the Adviser, (the “Valuation Committee”) subjects these quotes to various criteria including, but not limited to, the number and quality of quotes, the deviation among the quotes and information derived from analyzing the Company's own transactions in such investments throughout the reporting period. Generally, such investments are categorized in level 2 of the fair value hierarchy, unless the Valuation Committee determines that the quality, quantity or deviation among quotes warrants significant adjustment to the inputs utilized. The Board has designated the Adviser as its "valuation designee" pursuant to Rule 2a-5 under the 1940 Act, and in that role the Adviser is responsible for performing fair value determinations relating to all of the Company's investments, including periodically assessing and managing any material valuation risks and establishing and applying fair value methodologies, in accordance with valuation policies and procedures that have been approved by the Board. The Board remains ultimately responsible for fair value determinations under the 1940 Act and satisfies its responsibility through oversight of the valuation designee in accordance with Rule 2a-5. Investments that are not publicly traded or whose market prices are not readily available, as is expected to be the case for substantially all of the Company’s investments, are valued at fair value as determined in good faith by the Adviser, based on, among other things, input of independent third-party valuation firm(s). The Adviser undertakes a multi-step valuation process, which includes, among other procedures, the following: • The Company’s quarterly valuation process begins with each portfolio company or investment being initially valued using certain inputs, among others, provided by the investment professionals responsible for the portfolio investment in conjunction with the Company’s portfolio management team. The Company utilizes an independent valuation firm to provide valuation on each material illiquid security at least once every trailing 12-month period; • Preliminary valuations are reviewed and discussed with management of the Adviser and investment professionals; and • The Adviser will review the valuations and determine the fair value of each investment. Valuations that are not based on readily available market quotations will be valued in good faith based on, among other things, the input of, where applicable, third parties. As part of the valuation process, the Adviser may consider other information and may use valuation methods including but not limited to (i) market quotes for similar investments, (ii) recent trading activity, (iii) discounting forecasted cash flows of the investment, (iv) models that consider the implied yields from comparable debt, (v) third party appraisal, (vi) sale negotiations and purchase offers received from independent parties and (vii) estimated value of underlying assets to be received in liquidation or restructuring. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected herein. Under existing accounting guidance, fair value is defined as the price that the Company would receive upon selling an investment or pay to transfer a liability in an orderly transaction to a market participant in the principal or most advantageous market for the investment. This accounting guidance emphasizes valuation techniques that maximize the use of observable market inputs and minimize the use of unobservable inputs. Inputs refer broadly to the assumptions that market participants would use in pricing an asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on the best information available in the circumstances. The Company classifies the inputs used to measure these fair values into the following hierarchy as defined by current accounting guidance: Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible to the Company. Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. Level 3: Significant inputs that are unobservable for an asset or liability. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Investments for which no external pricing sources are available as of the valuation date are included in level 3 of the fair value hierarchy. Forward Contracts The Company may enter into forward purchase contracts primarily to manage credit risk. When entering into a forward purchase contract, the Company agrees to deliver a fixed quantity of securities for an agreed-upon price on an agreed future date. Forward contracts entered into by the Company are not designated as hedging instruments, and as a result, the Company presents changes in fair value through net change in unrealized appreciation (depreciation) on derivative instruments in the consolidated statements of operations. Realized and unrealized gains and losses of derivative instruments are included in the consolidated statements of operations. These instruments involve market risk, credit risk, or both kinds of risks. Risks arise from the possible inability of counterparties to meet the terms of their contracts and movements in fair value. The Company attempts to limit counterparty risk by only dealing with well-known counterparties. Revenue Recognition Interest income is recorded on an accrual basis and includes the accretion of discounts and amortization of premiums. Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method. The amortized cost of debt investments represents the original cost, including origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any. Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. The Company considers many factors relevant to an investment when placing it on or removing it from non-accrual status including, but not limited to, the delinquency status of the investment, economic and business conditions, the overall financial condition of the underlying investment, the value of the underlying collateral, bankruptcy status, if any, and any other facts or circumstances relevant to the investment. Accrued interest is generally reversed when a loan is placed on non-accrual status. Payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability of the outstanding principal and interest. Non-accrual loans may be restored to accrual status when past due principal and interest is paid current and are likely to remain current based on management’s judgment. Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies. Loan origination fees, original issue discount and market discount are capitalized, and the Company amortizes such amounts as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. The Company records prepayment premiums on loans and securities as fee income when it receives such amounts. Payment-in-Kind Interest Payment-in-kind (“PIK”) interest, computed at the contractual rate specified in each loan agreement, is added to the principal balance of the loan and recorded as interest income and generally becomes due at maturity. To maintain the Company’s tax treatment as a RIC, this non-cash source of income may be required to be paid out to stockholders in the form of distributions, even though the Company has not yet collected the cash. Deferred Financing Costs Origination and other expenses related to the Company’s borrowings are recorded as deferred financing costs and amortized as part of interest expense using the straight-line method over the stated life of the debt instrument. Unamortized deferred financing costs are presented as a direct deduction to the respective debt instrument. There were no new financing costs related to the Company's borrowings during the nine months ended September 30, 2024 . Organization and Offering Costs Organization costs include, among other things, the cost of incorporating, including the cost of legal services and other fees pertaining to the Company’s organization. Costs associated with the organization of the Company are expensed as incurred. Offering costs include, among other things, marketing expenses and printing, legal fees, due diligence fees, and other costs in connection with the Company’s offering of shares of its common stock, including the preparation of the Company’s registration statement, and salaries and direct expenses of the Adviser’s personnel, employees of its affiliates and others while engaged in such activities. Offering costs are capitalized as deferred offering expenses and are amortized over twelve months from incurrence. There were no new organization and offering costs during the nine months ended September 30, 2024 . Earnings per Share Basic earnings per share is calculated by dividing net income or loss attributable to common stockholders by the weighted average number of common stock outstanding during the period. Income Taxes The Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. So long as the Company maintains its tax treatment as a RIC, it will generally not pay corporate-level U.S. federal income or excise taxes on any ordinary income or capital gains that it distributes at least annually to its stockholders as distributions. Any tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected in the consolidated financial statements of the Company. To qualify for and maintain status as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its stockholders, for each taxable year, at least 90 % of its “investment company taxable income” (which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses) and net tax-exempt income for that year. In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98 % of its ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2 % of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year, and (iii) any ordinary income and net capital gains for preceding years that were not distributed during such years and on which the Company paid no U.S. federal income tax. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4 % nondeductible U.S. federal excise tax on this income. The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. The Company has analyzed the tax positions taken on federal and state income tax returns for all open tax years and has concluded that no provision for income tax for uncertain tax positions is required in the Company’s consolidated financial statements. The Company’s major tax jurisdictions are U.S. federal, New York State, and foreign jurisdictions where the Company makes significant investments. The Company’s federal and state income and federal excise tax returns for tax years for which the applicable statutes of limitations have not expired are subject to examination by the Internal Revenue Service and state departments of revenue. Distributions to Common Stockholders Distributions to the Company’s stockholders are recorded on the record date. The amount to be paid out as a distribution is determined by the Board and is generally based upon earnings estimated by the Adviser. Net realized capital gains, if any, would generally be distributed at least annually, although the Company may decide to retain such capital gains. The Company has adopted an “opt out” dividend reinvestment plan (“DRP”) for its stockholders. As a result, if the Company makes a cash distribution, its stockholders will have their cash distributions reinvested in additional shares of the Company’s common stock, including fractional shares as necessary, unless they specifically “opt out” of the DRP to receive the distribution in cash. Under the DRP, cash distributions to participating stockholders will be reinvested in additional shares of the Company’s common stock at a purchase price equal to the net asset value per share as of the last day of the calendar quarter immediately preceding the date such distribution was declared. The Company may distribute taxable distributions that are payable in cash or shares of its common stock, at the election of each shareholder. In accordance with certain applicable U.S. Treasury regulations and published guidance issued by the Internal Revenue Service, a publicly offered RIC may treat a distribution of its own stock as fulfilling the RIC distribution requirements if each shareholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash available to be distributed to all shareholders must be at least 20.0 % of the aggregate declared distribution. If too many shareholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any shareholder electing to receive cash receive less than 20.0 % of its entire distribution in cash. If these and certain other requirements are met for U.S. federal income tax purposes, the amount of the distribution paid in stock will be equal to the amount of cash that could have been received instead of stock. Taxable shareholders receiving such distributions will be required to include the amount of the distribution as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of the Company’s current or accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. shareholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. shareholder sells the stock it receives in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of the Company’s stock at the time of the sale. Furthermore, with respect to non-U.S. shareholders, the Company may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in common stock. The current published guidance that allows certain stock distributions of a RIC to fulfill the RIC’s own distribution requirements applies only to publicly offered RICs. The Company believes that it currently does not qualify as a publicly offered RIC, although the Company may qualify as a publicly offered RIC for future years. Recent Accounting Pronouncements In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update 2022-03, Fair Value Measurement (Topic 820) – Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03). The accounting standard update clarifies the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions and measured at fair value in accordance with Topic 820. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Adopting this new accounting standard will have no material impact on the Company's consolidated financial statements. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures. The accounting standard update clarifies the segment disclosure requirements in Topic 280 and requires public entities to disclose significant segment expenses, provide all annual disclosures about a reportable segment's profit or loss and assets in interim periods, and clarify the reporting of additional measures of segment profit or loss. The amendments aim to improve consistency and comparability in segment reporting. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company has evaluated the impact of adopting this new accounting standard and has concluded that the impact of the adoption will not be material to the consolidated financial statements.

N-2

N-2 - $ / shares	9 Months Ended
	Sep. 30, 2024		Dec. 31, 2023	Sep. 30, 2023	[1]	Dec. 31, 2022
Cover [Abstract]
Entity Central Index Key	0001726548
Amendment Flag	false
Securities Act File Number	814-01269
Document Type	10-Q
Entity Registrant Name	BC Partners Lending Corporation
Entity Address, Address Line One	650 Madison Avenue
Entity Address, Address Line Two	3rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	891-2880
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Other Transaction Expenses [Abstract]
Annual Expenses [Table Text Block]	Expenses Expenses for the three and nine months ended September 30, 2024 and 2023 were as follows: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Organization and offering costs $ — $ — $ — $ 30 Management fees 336 329 1,021 898 Incentive fees 309 283 909 798 Administrative fees 149 132 427 457 Interest and debt expenses 1,560 1,443 4,684 3,790 Audit fees 55 50 165 165 Legal fees 100 107 282 324 Professional fees 70 147 226 330 Directors' fees 38 38 113 113 Other expenses 18 71 456 224 Total expenses before expense support 2,635 2,600 8,283 7,129 Expense support repayment to related parties — 221 - 1,383 Net expenses $ 2,635 $ 2,821 $ 8,283 $ 8,512 Total expenses before expense support repayments were $2.6 million and $2.6 million for the three months ended September 30, 2024 and 2023, respectively. Management fees were $0.3 million and $0.3 million, for the three months ended September 30, 2024 and 2023. All organization and offering costs since inception through September 30, 2024 were funded by the Adviser and we will have no responsibility for such costs until the Adviser submits such costs, or a portion thereof, for reimbursement, subject to a cap of 1.50% of our total commitments and provided further that the Adviser or its affiliates may not be reimbursed for payment of excess organization and offering expenses that were incurred more than three years prior to the proposed reimbursement. For the three months ended September 30, 2024 and 2023 we accrued organization and offering costs of $0 and $0, respectively. During the three months ended September 30, 2024 and 2023, we incurred $1.6 million and $1.4 million, respectively, of interest and debt expenses related to our facility. For the three months ended September 30, 2024 and 2023, legal fees were $0.1 million and $0.1 million, respectively. Total expenses before expense support repayments were $8.3 million and $7.1 million, for the nine months ended September 30, 2024 and 2023, respectively. Management fees were $1.0 million and $0.9 million, for the nine months ended September 30, 2024 and 2023. All organization and offering costs since inception through September 30, 2023 were funded by the Adviser and we will have no responsibility for such costs until the Adviser submits such costs, or a portion thereof, for reimbursement, subject to a cap of 1.50% of our total commitments and provided further that the Adviser or its affiliates may not be reimbursed for payment of excess organization and offering expenses that were incurred more than three years prior to the proposed reimbursement. For the nine months ended September 30, 2024 and 2023, we accrued organization and offering costs of $0 and $30.0 thousand, respectively. During the nine months ended September 30, 2024 and 2023, we incurred $4.7 million and $3.8 million, respectively, of interest and debt expenses related to our facility. For the nine months ended September 30, 2024 and 2023, legal fees were $0.3 million and $0.3 million, respectively. We expect our operating expenses related to our ongoing operations to increase in the next several quarters because of the anticipated growth in the size of our asset base. We expect operating expenses as a percentage of our total assets to decrease during periods of asset growth. On August 22, 2019, we entered into an Expense Support Agreement with the Adviser to ensure that no portion of distributions made to our stockholders would be paid from our offering proceeds or borrowings. Commencing with the fourth quarter 2019 and on a quarterly basis thereafter, pursuant to the Expense Support Agreement between us and the Adviser, the Adviser would reimburse us for operating expenses in an amount that was sufficient to ensure that our net investment income and net short-term capital gains would be equal to or greater than the cumulative distributions paid to our stockholders in each quarter. The Expense Support Agreement expired pursuant to its terms on September 26, 2022, other than with respect to reimbursement payments that the Adviser may be entitled to from the Company pursuant to the Expense Support Agreement, for a period of three years following the last business day of the calendar quarter in which the Adviser reimbursed the Company. The specific amount of expenses reimbursed by the Adviser was determined at the end of each quarter. During the three and nine months September 30, 2023, reimbursements to the Adviser totaled $0.2 million and $1.4 million, respectively. There were no reimbursements or payments to or from the Adviser during the three or nine months September 30, 2024. Amounts due to the Adviser for the expected recoveries of organization, offering and operating expenses incurred on behalf of the Company, and amounts due from the Adviser under the Expense Support Agreement for such amounts, are reflected on a net basis in amounts due to/from affiliates on the consolidated statements of assets and liabilities. Net Realized and Unrealized Gains or Losses Our investments are generally purchased at a discount to par. We sold and received principal repayments of $8.4 million during the three months ended September 30, 2024, from which we realized net loss totaling $(668.0) thousand. We sold and received principal repayments of $29.1 million during the nine months ended September 30, 2024, from which we realized net loss totaling $(708.0) thousand. We sold and received principal repayments of $8.5 million during the three months ended September 30, 2023, from which realized net gains totaling $101.0 thousand. We sold and received principal repayments of $15.2 million during the nine months ended September 30, 2023, from which we realized net gain totaling $290.2 thousand. We recognized gains on partial principal repayments we received at par value. For the three months ended September 30, 2024 and 2023, the net change in unrealized appreciation (depreciation) on investments totaled $(0.8) million and $1.8 million, respectively, which was primarily due the elevated rates environment during the three months ended September 30, 2024. For the nine months ended September 30, 2024 and 2023, the net change in unrealized appreciation (depreciation) on investments totaled $(2.0) million and $1.9 million, respectively, which was primarily due to the elevated rates environment during the nine months ended September 30, 2024. Net Increase in Net Assets Resulting from Operations For the three months ended September 30, 2024 and 2023 the net increase (decrease) in net assets resulting from operations was $0.3 million and $3.3 million or $0.11 per share and $0.47 per share, respectively. For the nine months ended September 30, 2024 and 2023 the net increase (decrease) in net assets resulting from operations was $2.5 million and $5.4 million or $0.82 per share and $1.16 per share, respectively.
General Description of Registrant [Abstract]
Risk Factors [Table Text Block]	Item 1A. Risk Factors. There have been no material changes from the risk factors described in Part I, I tem 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 12, 2024.
NAV Per Share	$ 21.57	[1]	$ 22.53	$ 22.79		$ 21.85
Capital Stock, Long-Term Debt, and Other Securities [Abstract]
Capital Stock [Table Text Block]	Item 5. Other Information.
Security Dividends [Text Block]	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. Refer to “Item 1. Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 6. Share Transactions” in this quarterly report on Form 10-Q for issuances of our shares during the quarter. Such issuances were part of a private offering pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D thereunder.
Long Term Debt, Structuring [Text Block]	On December 16, 2019, we, through BCPL Funding, entered into a debt financing facility with UBS AG, London Branch (“UBS”), as amended on March 12, 2021, pursuant to which the Facility was made available to us. The interest rate applicable to borrowings under the Facility is based on the one month SOFR plus a spread of 291 basis points. The Facility is secured by a security interest in virtually all of our portfolio investments (including cash), subject to certain exceptions. We have provided a make-whole guarantee to the lender in the event that the pledged assets were insufficient to satisfy the repayment of the Facility.
[1] Represents the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the year or period and certain per share data on shares outstanding as of a year or period end or transaction date.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Note 3. Related Party Transactions Administration Agreement On April 23, 2018, the Company entered into an Administration Agreement (the “Administration Agreement”) with the Administrator. Under the terms of the Administration Agreement, the Administrator will perform (or oversee, or arrange for, the performance of) the administrative services necessary for the operation of the Company, which includes office facilities, equipment, bookkeeping and recordkeeping services and such other services as the Administrator, subject to review by the Board, shall from time to time determine to be necessary or useful to perform its obligations under this Administration Agreement. The Company will reimburse the Administrator for services performed under the terms of the Administration Agreement. In addition, pursuant to the Administration Agreement, the Administrator may delegate its obligations under the Administration Agreement to affiliates or third-parties and the Company pays or reimburses the Administrator for certain expenses incurred by any such affiliates or third-parties for work done on its behalf. The Administration Agreement had an initial term of two years from its effective date and will remain in effect from year-to-year thereafter if approved annually by (i) the vote of the Board, or by the vote of a majority of the outstanding voting securities of the Company, and (ii) the vote of a majority of the Company’s Board who are not parties to the Administration Agreement or “interested persons” of the Company, of the Adviser or of any of their respective affiliates, as defined in the 1940 Act. The Administration Agreement was most recently approved on November 6, 2024. The Administration Agreement may be terminated at any time, without the payment of any penalty, upon 60 days’ written notice, by the vote of a majority of the outstanding voting shares of the Company or by the vote of the Board or by the Administrator. No person who is an officer, director or employee of the Adviser or its affiliates and who serves as a director of the Company receives any compensation from the Company for his or her services as a director. However, the Company reimburses the Administrator (or its affiliates) for an allocable portion of the compensation paid by the Administrator (or its affiliates) to the Company’s Chief Compliance Officer and Chief Financial Officer and their respective staffs (based on a percentage of time such individuals devote, on an estimated basis, to the business affairs of the Company). For three months ended September 30, 2024 and 2023, the Company incurred administrative fees of $ 0.1 million and $ 0.1 million, respectively. For nine months ended September 30, 2024 and 2023, the Company incurred administrative fees of $ 0.4 million and $ 0.5 million, respectively. As of September 30, 2024 such amounts were partially offset against amounts due from the Adviser in connection with the Expense Support and Conditional Reimbursement Agreement (the “Expense Support Agreement”), as described below. Investment Advisory Agreement On April 23, 2018, the Company entered into an Investment Advisory Agreement with the Adviser which was amended and restated on November 7, 2018 and further amended on July 9, 2019 (as amended, the “Investment Advisory Agreement”). On November 6, 2024, the Board unanimously approved the renewal of the Investment Advisory Agreement for a period of twelve months commencing on November 7, 2024. The amendments were each approved at the time by the Company’s sole stockholder. Under the terms of the Investment Advisory Agreement, the Adviser will be responsible for managing the Company’s business and activities, including sourcing investment opportunities, conducting research, performing due diligence on potential investments, structuring its investments, monitoring its portfolio companies and providing managerial assistance to portfolio companies. Under the terms of the Investment Advisory Agreement, the Company will pay the Adviser a base management fee and may also pay to it certain incentive fees. The base management fee is payable quarterly in arrears at an annual rate of 1.00% (1.50% if an exchange listing occurs) of the Company’s average gross assets, excluding cash and cash equivalents but including assets purchased with borrowed amounts, at the end of the two most recently completed calendar quarters . The management fee for any partial month or quarter will be appropriately prorated and adjusted for any share issuances or repurchases during the relevant month or quarter. For the three months ended September 30, 2024 and 2023 the Company incurred management fees of $ 0.3 million and $ 0.3 million, respectively. For the nine months ended September 30, 2024 and 2023, the Company incurred management fees of $ 1.0 million and $ 0.9 million, respectively. As of September 30, 2024, such amounts were partially offset against amounts due from the Adviser in connection with the Expense Support Agreement, as described below. The incentive fee consists of two parts, as follows: (i) The first component, the income incentive fee, payable at the end of each quarter in arrears, equals 100% of the pre-incentive fee net investment income in excess of a 1.50% quarterly preferred return but less than 1.76% (1.818% if an exchange listing occurs), the upper level breakpoint, and 15% (17.50% if an exchange listing occurs) of the amount of pre-incentive fee net investment income that exceeds 1.76% (1.818% if an exchange listing occurs) in any calendar quarter. For purposes of determining whether pre-incentive fee net investment income exceeds the hurdle rate, pre-incentive fee net investment income is expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter. (ii) The second component, the capital gains incentive fee, payable at the end of each calendar year in arrears, equals 15.0 % of cumulative realized capital gains from inception through the end of such calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gains incentive fee for prior periods. The Company accrues, but does not pay, a capital gains incentive fee with respect to unrealized capital appreciation because a capital gains incentive fee would be owed to the Adviser if the Company were to sell the relevant investment and realize a capital gain. For the three months ended September 30, 2024 and 2023, the Company incurred incentive fees of $ 0.3 million and $ 0.3 million, respectively. For the nine months ended September 30, 2024 and 2023, the Company incurred incentive fees of $ 0.9 million and $ 0.8 million, respectively. The Investment Advisory Agreement was initially in effect for a period of two years from its effective date and will remain in effect from year-to-year thereafter if approved annually by (i) the vote of the Board, or by the vote of a majority of the outstanding voting securities of the Company, and (ii) the vote of a majority of the Company’s Board who are not parties to the Investment Advisory Agreement or “interested persons” of the Company, of the Adviser or of any of their respective affiliates, as defined in the 1940 Act. The Investment Advisory Agreement may be terminated at any time, without the payment of any penalty, upon 60 days’ written notice and, in certain circumstances, upon 120 days’ written notice, by the vote of a majority of the outstanding voting shares of the Company or by the vote of the Board or by the Adviser. The Adviser may, from time to time, pay amounts owed by the Company to third-party providers of goods or services, including the Board, and the Company will subsequently reimburse the Adviser for such amounts paid on its behalf. Amounts payable to the Adviser are settled in the normal course of business without formal payment terms. Prior to the Company’s commencement of operations, the Adviser and its affiliates have incurred operating expenses on behalf of the Company in the amount of $ 1.2 million, including audit fees of $ 0.2 million, legal fees of $ 0.5 million, professional fees of $ 22.3 thousand, directors’ fees of $ 0.2 million, insurance of $ 0.2 million and other expenses of $ 62.4 thousand. The Company will have no responsibility for such costs until the Adviser submits such costs, or a portion thereof, for reimbursement. Co-investment Exemptive Relief As a BDC, the Company is subject to certain regulatory restrictions in making its investments. For example, BDCs generally are not permitted to co-invest with certain affiliated entities in transactions originated by the BDC or its affiliates in the absence of an exemptive order from the SEC. However, BDCs are permitted to, and may, simultaneously co-invest in transactions where price is the only negotiated term. On April 10, 2023, superseding a prior exemptive order granted on October 23, 2018, the SEC issued an order granting an application for exemptive relief to us and certain of our affiliates to co-invest, subject to the satisfaction of certain conditions, in certain private placement transactions, with other funds managed by the Adviser or its affiliates, including business development companies, registered closed-end funds, private funds, certain proprietary accounts of the Investment Adviser or its affiliates, and any future funds that are advised by the Adviser or its affiliated investment advisers. Under the terms of the exemptive order, in order for the Company to participate in a co-investment transaction a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Company’s independent directors must conclude that (i) the terms of the proposed transaction, including the consideration to be paid, are reasonable and fair to the Company and its stockholders and do not involve overreaching with respect of the Company or its stockholders on the part of any person concerned, and (ii) the proposed transaction is consistent with the interests of the Company’s stockholders and is consistent with the Company’s investment objectives and strategies and certain criteria established by the Board. Organization and Offering Costs Under the Investment Advisory Agreement and the Administrative Agreement, the Company, either directly or through reimbursements to the Adviser or its affiliates, is responsible for its organization and portfolio offering costs in an amount up to 1.50 % of total capital commitments. Prior to the Company’s commencement of operations, the Adviser funded the Company’s organization and offering costs in the amount of $ 1.4 million. The Company will have no responsibility for such costs until the Adviser submits such costs, or a portion thereof, for reimbursement, subject to a cap of 1.50 % of the Company’s total commitments and provided further that the Adviser or its affiliates may not be reimbursed for payment of excess organization and offering expenses that were incurred more than three years prior to the proposed reimbursement. For the three months ended September 30, 2024 and 2023 the Company accrued organization and offering costs of $ 0 thousand and $ 0 , respectively. For the nine months ended September 30, 2024 and 2023 , the Company accrued organization and offering costs of $ 0 and $ 30.0 thousand, respectively . Amounts due to the Adviser for the expected recoveries of organization, offering and operating expenses incurred on behalf of the Company, and amounts due from the Adviser under the Expense Support Agreement for such amounts are reflected on a net basis in amounts due to/from affiliates on the consolidated statements of assets and liabilities. Expense Support Agreement On August 22, 2019, the Company entered into the Expense Support Agreement with the Adviser, the purpose of which was to ensure that no portion of distributions made to the Company’s stockholders was paid from the Company’s offering proceeds or borrowings (the “Distribution Objective”). The Expense Support Agreement expired pursuant to its terms on September 26, 2022, other than with respect to reimbursement payments that the Adviser may be entitled to from the Company pursuant to the Expense Support Agreement, for a period of three years following the last business day of the calendar quarter in which the Adviser reimbursed the Company. Commencing with the fourth quarter of 2019 and on a quarterly basis thereafter, the Adviser would reimburse the Company for operating expenses in an amount sufficient to meet the Distribution Objective. Any payment so required to be made by the Adviser is referred to herein as an “Expense Payment.” The Adviser’s obligation to make an Expense Payment becomes a liability of the Adviser, and the right to such Expense Payment becomes an asset of the Company, no later than the last business day of the applicable calendar quarter. The Expense Payment for any calendar quarter shall, as promptly as possible, be: (i) paid by the Adviser to the Company in any combination of cash or other immediately available funds, and/or (ii) offset against amounts due from the Company to the Adviser. Pursuant to the Expense Support Agreement, “Available Operating Funds” means the sum of (i) the Company’s net investment company taxable income (including net short-term capital gains reduced by net long-term capital losses), (ii) the Company’s net capital gains (including the excess of net long-term capital gains over net short-term capital losses), and (iii) distributions paid to or otherwise earned by the Company on account of investments in portfolio companies (to the extent such amounts listed in clause (iii) are not included under clauses (i) and (ii) above.) Following any calendar quarter in which Available Operating Funds exceed the cumulative distributions paid to the Company’s stockholders in such calendar quarter (the amount of such excess being hereinafter referred to as “Excess Operating funds”), the Company shall pay such Excess Operating Funds, or a portion thereof in accordance with the stipulation below, as applicable, to the Adviser until such time as all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar quarter have been reimbursed or waived. Any payments required to be made by the Company pursuant to the preceding sentence are referred to herein as a “Reimbursement Payment.” The amount of the Reimbursement Payment for any calendar quarter is equal to the lesser of (i) the Excess Operating Funds in such calendar quarter, and (ii) the aggregate amount of all Expense Payments made by the Adviser to the Company within three years prior to the last business day of such calendar quarter that have not been previously reimbursed by the Company to the Adviser. The Company’s obligation to make a Reimbursement Payment becomes a liability to the Company, and the right to such Reimbursement Payment becomes an asset of the Adviser, no later than the last business day of the applicable calendar quarter. The Reimbursement Payment for any calendar quarter shall, as promptly as possible, be paid by the Company to the Adviser in any combination of cash or other immediately available funds. Any Reimbursement Payments shall be deemed to have reimbursed the Adviser for Expense Payments in chronological order beginning with the oldest Expense Payment eligible for reimbursement. For the three months ended September 30, 2024 and 2023, the gross Expense Reimbursement recoverable by the Adviser from the Company was zero and $ 0.2 million. For the nine months ended September 30, 2024 and 2023, the gross Expense Reimbursement recovered by the Adviser from the Company was zero and $ 1.4 million, respectively. The Expense Support Agreement expired pursuant to its terms on September 26, 2022, other than with respect to reimbursement payments that the Adviser may be entitled to from the Company pursuant to the Expense Support Agreement, for a period of three years following the last business day of the calendar quarter in which the Adviser reimbursed the Company. As of December 31, 2023, all eligible reimbursable expenses have been paid back to the Adviser and the Company no longer has any obligations under the Expense Support Agreement. Quarter Ended Expense Payment (1) Reimbursement Unreimbursed (1) Eligible for Reimbursement (1) March 31, 2020 346 346 — March 31, 2023 June 30, 2020 752 752 — June 30, 2023 September 30, 2020 68 68 — September 30, 2023 March 31, 2021 217 217 — March 31, 2024 $ 1,383 $ 1,383 $ — (1) The actual date that the estimated Expense Payment is eligible for reimbursement will be determined when such Expense Payment is actually made by the Adviser.

Investments and Fair Value Meas

Investments and Fair Value Measurements	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Investments and Fair Value Measurements	Note 4. Investments and Fair Value Measurements The following table summarizes the composition of the Company’s investment portfolio at amortized cost and fair value as of September 30, 2024: September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Senior Secured Loan $ 133,154 97.5 % $ 128,382 96.6 % Equity/Other 3,257 2.4 % 4,385 3.3 % Unsecured Note 81 0.1 % 81 0.1 % Total $ 136,492 100.0 % $ 132,848 100.0 % The following table summarizes the composition of the Company’s investment portfolio at amortized cost and fair value as of December 31, 2023: December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Senior Secured Loan $ 129,511 95.7 % $ 126,050 94.3 % Structured Note 3,840 2.8 % 3,860 2.9 % Equity/Other 1,981 1.5 % 3,765 2.8 % Total $ 135,332 100.0 % $ 133,675 100.0 % Generally, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned more than 25% of its voting securities or it had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. As of September 30, 2024 and December 31, 2023, the Company did not control any of its portfolio companies, each as defined in the 1940 Act. The following tables summarize the industry and geographic composition of the Company’s investment portfolio based on amortized cost and fair value as of September 30, 2024: September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Chemicals $ 1,726 1.3 % $ 1,722 1.3 % Communication Services 4,555 3.3 % $ 4,647 3.5 % Construction 1,981 1.6 % 1,980 1.5 % Consumer Discretionary 3,000 2.2 % 2,971 2.2 % Consumer Staples 12,585 9.2 % 12,300 9.3 % Financials 21,054 15.4 % 21,908 16.5 % Gaming 996 0.7 % 841 0.6 % Healthcare 23,094 16.9 % 22,764 17.1 % Industrials 24,054 17.6 % 24,024 18.1 % Information Technology 38,106 27.9 % 35,355 26.6 % Insurance Services 1,661 1.2 % 1,669 1.3 % Professional Services 1,750 1.3 % 1,750 1.3 % Transportation 1,930 1.4 % 917 0.7 % Total $ 136,492 100.0 % $ 132,848 100.0 % September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio United States $ 136,492 100.0 % $ 132,848 100.0 % International - 0.0 % — 0.0 % Total $ 136,492 100.0 % $ 132,848 100.0 % The following tables summarize the industry and geographic composition of the Company’s investment portfolio based on amortized cost and fair value as of December 31, 2023: December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Information Technology $ 52,690 38.9 % $ 50,152 37.5 % Industrials 21,413 15.8 % 21,520 16.1 % Financials 15,629 11.5 % 17,148 12.8 % Healthcare 23,105 17.2 % 23,119 17.3 % Consumer Staples 7,003 5.2 % 6,720 5.0 % Consumer Discretionary 3,066 2.3 % 3,056 2.3 % Collateralized Loan Obligation - Debt Class 3,840 2.8 % 3,860 2.9 % Gaming 1,723 1.3 % 1,710 1.3 % Communication Services 4,917 3.6 % 4,932 3.7 % Transportation 1,946 1.4 % 1,458 1.1 % Total $ 135,332 100 % $ 133,675 100 % December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio United States $ 128,830 95.2 % $ 127,153 95.1 % International 6,502 4.8 % 6,522 4.9 % Total $ 135,332 100.0 % $ 133,675 100.0 % The following table details investments in affiliates at September 30, 2024: ($ in thousands) Type of Investment Industry Affiliate Fair Value as of December 31, 2023 Transfers In/Out of Affiliates Purchases(sales) of or Advances/ Distributions Net Change in Unrealized Gain/(Loss) Affiliate Fair Value as of September 30, 2024 Affiliate Investment Income Great Lakes II Funding LLC (1)(3)(4) Equity/Other Financial Services $ 92 $ — $ ( 13 ) $ — $ 79 $ 27 Green Park M-1 Series (1)(2)(3)(4) Equity/Other Industrials 34 — — — 34 — GreenPark Infrastructure A Series (1)(2)(3) Equity/Other Industrials 100 — — — 100 — Princeton Medspa Partners LLC (1)(2)(3) Senior Secured Loans Professional Services — — 1,501 ( 9 ) 1,492 59 Princeton Medspa Partners LLC (1)(2)(3) Equity/Other Professional Services — — 250 8 258 — Princeton Medspa Partners LLC (1)(2)(3) Derivatives Professional Services — — — — — — Total Non-controlled affiliates $ 226 $ — $ 1,738 $ ( 1 ) $ 1,963 $ — $ 86 (1) Fair value of this investment was determined using significant unobservable inputs (2) Qualified asset for purposes of section 55(a) of the Investment Company Act of 1940 (3) Under the 1940 Act, the Company is deemed to be an “Affiliated Person” of, as defined in the 1940 Act, this portfolio company as the Company owns at least 5% of the portfolio company’s outstanding voting securities or is under common control with such portfolio company. (4) Security has an unfunded commitment in addition to the amounts shown in the Consolidated Schedule of Investments. See Note 8 for additional information on the Company’s commitments and contingencies. The following table summarizes the fair value hierarchy of the Company’s investment portfolio as of September 30, 2024: Fair Value Measurements Level 1 Level 2 Level 3 Total Senior Secured Loan $ — $ 36,331 $ 92,051 $ 128,382 Equity/Other — — 4,385 4,385 Unsecured Note — — 81 81 Total $ — $ 36,331 $ 96,517 $ 132,848 The following table summarizes the fair value hierarchy of the Company’s investment portfolio as of December 31, 2023 : Fair Value Measurements Level 1 Level 2 Level 3 Total Senior Secured Loan $ — $ 34,203 $ 91,847 $ 126,050 Structured Note — — 3,860 3,860 Equity/Other — — 3,765 3,765 Total $ — $ 34,203 $ 99,472 $ 133,675 Forward contracts — — — — Total $ — $ 34,203 $ 99,472 $ 133,675 The following is a reconciliation of the Company’s investment portfolio for which level 3 inputs were used in determining fair value for the nine months ended September 30, 2024. Senior Secured Structured Unsecured Note Equity/other Total Forward Balance as of January 1, 2024 $ 91,847 $ 3,860 $ — $ 3,765 $ 99,472 $ — Purchases of investments 22,310 — 81 1,297 23,688 — Proceeds from principal repayments and sales of investments ( 16,829 ) ( 3,900 ) — — ( 20,729 ) — Payment in-kind interest income 677 — — — 677 — Net accretion of discounts 294 — — — 294 — Net change in unrealized appreciation (depreciation) on investments ( 1,436 ) 40 — ( 656 ) ( 2,052 ) Net realized loss on investments ( 97 ) — — ( 21 ) ( 118 ) — Transfers into level 3 1,907 — — — 1,907 — Transfers out of level 3 ( 6,622 ) — — — ( 6,622 ) — Balance as of September 30, 2024 $ 92,051 $ — $ 81 $ 4,385 $ 96,517 $ — Net change in unrealized appreciation (depreciation) on Level 3 investments still held $ ( 1,494 ) $ — $ — $ ( 137 ) $ ( 1,631 ) $ — The following is a reconciliation of the Company’s investment portfolio for which level 3 inputs were used in determining fair value for the nine months ended September 30, 2023 : Senior Secured Structured Subordinated Structured Note Equity/other Total Forward Balance as of January 1, 2023 $ 76,242 $ 4,053 $ 281 $ 2,036 $ 82,612 $ ( 55 ) Purchases of investments 28,966 — — 146 29,112 — Proceeds from principal repayments and sales of investments ( 11,374 ) ( 319 ) ( 350 ) — ( 12,043 ) — Payment in-kind interest income 361 — — — 361 — Net accretion of discounts (amortization of premiums) 276 — — — 276 — Net change in unrealized appreciation (depreciation) on investments 1,134 17 52 142 1,345 Net realized loss on investments 121 87 17 — 225 — Transfers into level 3 — — — — — — Transfers out of level 3 ( 1,700 ) — — — ( 1,700 ) — Balance as of September 30, 2023 $ 94,026 $ 3,838 $ — $ 2,324 $ 100,188 $ ( 55 ) Net change in unrealized appreciation (depreciation) on Level 3 investments still held $ 1,153 $ 17 $ 52 $ 142 $ 1,364 $ ( 55 ) The valuation techniques and significant unobservable inputs used in the valuation of level 3 investments as of September 30, 2024 were as follows: Quantitative Information About Level 3 Fair Value Measurements Asset Category Fair Value Valuation Unobservable Range Equity/Other $ 3,000 Enterprise Valuation Average EBITDA Multiple 5.5 x- 13 x ( 10.1 x) Equity/Other 1,306 Discounted Cash Flows Market Yield 10.6 %- 21.8 % ( 16.2 %) Equity/Other 79 Enterprise Valuation Net Asset Value 103 Senior Secured Loan 88,349 Discounted Cash Flows Market Yield 5.7 % - 19.2 % ( 11.8 %) Senior Secured Loan 3,702 Recent Transaction Transaction Price 98 - 99 ( 98.6 ) Unsecured Note 81 Discounted Cash Flows Market Yield 10.3 % $ 96,517 Forward Contracts $ - Enterprise Valuation Average EBITDA Multiple 2.5 x The valuation techniques and significant unobservable inputs used in the valuation of level 3 investments as of December 31, 2023 were as follows: Quantitative Information About Level 3 Fair Value Measurements Asset Category Fair Value Valuation Unobservable Range Equity/Other $ 2,543 Enterprise Valuation Average EBITDA Multiple 1.6 x - 18 x ( 4.7 x) Equity/Other 226 Enterprise Valuation Net Asset Value 100 - 103 ( 101 ) Equity/Other 996 Recent Transaction Transaction Price 14.9 - 14.9 ( 14.9 ) Senior Secured Loan 81,864 Discounted Cash Flows Market Yield 6.1 % - 19.3 % ( 11.1 %) Senior Secured Loan 9,983 Recent Transaction Transaction Price 96.5 - 100 ( 98.2 ) Structured Note 3,860 Discounted Cash Flows Market Yield 11.9 %- 11.9 % ( 11.9 %) $ 99,472 As of September 30, 2024, the Company’s open forward contracts were as follows: Security Counterparty Settlement Date Par Unrealized Appreciation Princeton Medspa Partners LLC - Put option Princeton Medspa Partners LLC 5/31/2029 250 $ — $ — The Company may sell any of the referenced securities in whole or in part to any third-party prior to the settlement date of the forward contracts without consent of the counterparty. Upon such sale to a third-party, the Company and counterparty shall have no further obligations in respect of that specific amount of referenced security sold. The following table identifies the fair value amount of the forward contracts included on the consolidated statement of assets and liabilities at September 30, 2024. The following table also identifies the realized and unrealized gain and loss amounts included on the consolidated statement of operations for the nine months ended September 30, 2024. Type of Contract Derivative Derivative Realized Unrealized Depreciation Forward contracts - credit risk $ — $ — $ — $ — $ — $ — $ — $ —

Borrowings

Borrowings	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Borrowings	Note 5. Borrowings In accordance with the 1940 Act, with certain limitations, the Company is allowed to borrow amounts such that its asset coverage, as defined in the 1940 Act, is at least 200 % (or 150 % if certain conditions are met) after such borrowing. Our Board and initial stockholder have approved our ability to utilize the increased leverage limit, which requires asset coverage of at least 150 %. As of September 30, 2024 and December 31, 2023, the Company’s asset coverage was 199.0 % and 196.0 %, respectively. On December 16, 2019, the Company, through BCPL Funding, entered into a debt financing facility with UBS AG, London Branch (“UBS”), pursuant to which up to $ 50.0 million will be made available to the Company (the “Facility”). On March 12, 2021, the Facility was amended (the “Second A&R Facility”), pursuant to which the amoun t made available to the Company was increased from $ 50.0 million to $ 75.0 million. Pursuant to the Facility, the Company sold certain loans in its portfolio to BCPL Funding (the “Initial Loans”), in consideration for certain Class A Notes (the “Class A Notes”) issued by BCPL Funding. The Initial Loans secure the obligations of BCPL Funding under the Class A Notes, issued pursuant to an indenture between BCPL Funding and U.S. Bank National Association, as trustee (the “Indenture”). On March 12, 2021, in connection with the Second A&R Facility, BCPL Funding entered into a Supplemental Indenture with the trustee (the “Second A&R Indenture”). The Second A&R Indenture expands the asset eligibility criteria and allows for the issuance of additional Class A Notes. Pursuant to the Second A&R Indenture, BCPL Funding issued additional Class A Notes which were purchased by the Company pursuant to a Subscription Agreement between the Company and BCPL Funding, dated as of March 12, 2021. The obligations of BCPL Funding under the additional Class A Notes are secured by the Portfolio Assets to be sold by the Company to BCPL Funding from time to time pursuant to the A&R Issuer Sale and Contribution Agreement. Principal on the Class A Notes will be due and payable at maturity on December 18, 2029. The Class A Notes do not provide for interest payments. The Indenture contains events of default customary for similar transactions, including: (a) the failure to make principal payments on the Class A Notes at their stated maturity or redemption date or to make payments with respect to expenses due under the Indenture within three business days of when due; (b) an event of default occurs under the Repurchase Agreement (defined below); and (c) BCPL Funding is required to register as an investment company under the 1940 Act. In connection with the Second A&R Facility, the Company has entered into a Fifth Amended and Restated Confirmation with UBS, dated as of August 25, 2023 (the Fifth A&R Confirmation”). The Fifth A&R Confirmation is in respect of a repurchase transaction with UBS, which supplements, forms part of, and is subject to the SIFMA/ICMA Global Master Repurchase Agreement (2011 version), dated as of December 12, 2019 and amended on August 14, 2020 (including any annexes thereto, the “GMRA,” and such GMRA, as supplemented and evidenced by the Fifth A&R Confirmation, the “Repurchase Agreement”). Pursuant to the Repurchase Agreement, UBS purchased the Class A Notes held by the Company for an aggregate purchase price not to exceed $ 110.0 million, in connection with the purchase by UBS of the increased funded outstanding principal amount of the Class A Notes held by the Company. Such increases in the purchase price under the Repurchase Agreement are conditioned upon the satisfaction of certain criteria with respect to the characteristics and total value of the Portfolio Assets held by BCPL Funding, and composition of the Portfolio Assets, in each case as set forth in the Second A&R Indenture, among others, which criteria are customary for similar transactions. The scheduled Repurchase Date under the Fifth A&R Confirmation is December 19, 2024 . The financing fee under the Facility is equal to Term SOFR plus a spread of 2.91161 % per year for the relevant period. Pursuant to the Repurchase Agreement, the Company has made certain representations and warranties and is required to comply with various covenants, reporting requirements and other requirements customary for similar transactions. In addition to customary events of default included in similar transactions, the Repurchase Agreement also contains the following events of default, among others: (a) the failure to pay the repurchase price upon the applicable payment dates; (b) the failure to make a voluntary contribution of cash to BCPL Funding if the settlement for the commitment the Company made for the voluntary contribution of Portfolio Assets under the Contribution Agreement does not occur, each within the periods as set forth in the Repurchase Agreement, caused by negative changes in the value or composition of the Portfolio Assets that result in a failure to satisfy the criteria with respect thereto set forth in the Indenture; (c) the occurrence of an act by the Company that constitutes fraud or criminal negligence in respect of its investment activity pursuant to the Collateral Management Agreement; and (d) any officer or employee of the Company who has direct responsibility for the management of the Portfolio Assets is indicted for any act constituting fraud or criminal negligence in respect of investment activity and such person fails to be removed from such person’s managing the Portfolio Assets within the period as set forth in the Collateral Management Agreement. The Company had provided a make-whole guarantee to the lender in the event that the pledged assets were insufficient to satisfy the repayment of the Facility. Debt obligations consisted of the following as of September 30, 2024: September 30, 2024 Total Total Less Amount per Credit Facility $ 110,000 $ 73,000 $ ( 581 ) $ 72,419 Total Debt $ 110,000 $ 73,000 $ ( 581 ) $ 72,419 Debt obligations consisted of the following as of December 31, 2023: December 31, 2023 Total Total Less Amount per Credit Facility $ 110,000 $ 71,000 $ ( 663 ) $ 70,337 Total Debt $ 110,000 $ 71,000 $ ( 663 ) $ 70,337 Due to the short-term nature of the Facility, the outstanding principal balance approximates fair value. The fair value of the Facility would be categorized as Level 3. For the three and nine months ended September 30, 2024 and 2023 the components of interest expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Interest expense $ 1,533 $ 1,416 $ 4,602 $ 3,708 Amortization of deferred financing and debt issuance costs 27 27 82 82 Total Interest Expense $ 1,560 $ 1,443 $ 4,684 $ 3,790 Average debt outstanding 73,000 68,000 72,526 62,784 Weighted average interest rate 8.5 % 8.5 % 8.6 % 8.0 %

Share Transactions

Share Transactions	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Share Transactions	Note 6. Share Transactions The Company is authorized to issue 1,000,000,000 shares of common stock at $ 0.001 par value per share. On April 10, 2018, the Company issued 4,000 shares of common stock to an affiliate of the Adviser for aggregate proceeds of $ 100,000 . The Company has entered into subscription agreements (the “Subscription Agreements”) with investors, including the Adviser and its affiliates, providing for the private placement of shares of the Company’s common stock. Under the terms of the Subscription Agreements, investors are required to fund drawdowns to purchase shares of the Company’s common stock up to the amount of their respective capital commitment on an as-needed basis each time the Company delivers a drawdown notice to its investors with a minimum of 10 business days prior notice. As of September 30, 2024 and December 31, 2023, the Company had received capital commitments totaling $ 73.9 million a nd $ 68.5 million, respectively. The following tables summarizes the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements during the nine months ended September 30, 2024 and 2023: Capital Drawdown Notice Date Common Share Number of Aggregate May 24, 2024 June 10, 2024 44,623 $ 1,000 September 11, 2024 September 13, 2024 204,880 $ 4,450 Total 249,503 $ 5,450 Capital Drawdown Notice Date Common Share Number of Aggregate March 3, 2023 March 8, 2023 519,186 $ 11,500 May 9, 2023 May 9, 2023 228,519 5,000 Total 747,705 $ 16,500 Distributions The Company may fund its cash distributions to stockholders from any sources of funds available to it, including offering proceeds, borrowings, net investment income from operations, capital gains proceeds from the sale of assets, non-capital gains proceeds from the sale of assets, distributions paid to the Company on account of preferred and common equity investments in portfolio companies and expense reimbursements from the Adviser, which are subject to recoupment. The Company has not established limits on the amount of funds it may use from available sources to make distributions. During certain periods, the Company’s distributions may exceed its taxable earnings. As a result, it is possible that a portion of the distributions the Company makes may represent a return of capital. A return of capital generally is a return of a stockholder’s investment rather than a return of earnings or gains derived from the Company’s investment activities. The following tables summarizes the distribution declarations for the nine months ended September 30, 2024 and 2023: Date Declared Record Date Payment Date Amount Distributions March 11, 2024 March 25, 2024 April 2, 2024 $ 0.60 $ 1,822 May 7, 2024 May 22, 2024 May 31, 2024 0.60 1,834 August 7, 2024 August 22, 2024 September 5, 2024 0.60 1,873 Total distributions declared $ 1.80 $ 5,529 Date Declared Record Date Payment Date Amount Distributions March 6, 2023 March 20, 2023 March 29, 2023 $ 0.31 $ 853 May 9, 2023 May 22, 2023 May 31, 2023 0.31 927 August 8, 2023 August 22, 2023 August 31, 2023 0.31 930 Total distributions declared $ 0.93 $ 2,710 With respect to distributions, we have adopted an “opt out” dividend reinvestment plan (“DRP”) for common stockholders. As a result, in the event of a declared distribution, each shareholder that has not “opted out” of the DRP will have their distributions automatically reinvested in additional shares of our common stock rather than receiving cash distributions. Shareholders who receive distributions in the form of shares of common stock will be subject to the same U.S. federal, state and local tax consequences as if they received cash distributions. The following tables reflect the common stock issued pursuant to the dividend reinvestment plan during the nine months ended September 30, 2024 and 2023: Date Declared Record Date Payment Date Shares December 21, 2023 December 31, 2023 January 26, 2024 11,736 March 11, 2024 March 25, 2024 April 2, 2024 20,254 May 7, 2024 May 22, 2024 May 31, 2024 20,853 August 7, 2024 August 22, 2024 September 5, 2024 21,879 Total shares issued 74,722 Date Declared Record Date Payment Date Shares March 6, 2023 March 20, 2023 March 31, 2023 9,874 May 9, 2023 May 22, 2023 May 31, 2023 10,086 August 8, 2023 August 22, 2023 August 31, 2023 10,096 Total shares issued 30,056

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Note 7. Earnings Per Share The following table sets forth the computation of basic and diluted earnings per common stock for the three and nine months ended September 30, 2024 and 2023: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Increase in net assets resulting from operations per share - basic and diluted $ 349 $ 3,328 $ 2,541 $ 5,376 Weighted average shares of common stock outstanding - basic and diluted 3,168,711 3,003,201 3,092,149 2,755,930 Net increase (decrease) in net assets resulting from operations per share - basic and diluted $ 0.11 $ 1.11 $ 0.82 $ 1.95

Financial Highlights

Financial Highlights	9 Months Ended
	Sep. 30, 2024
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 8. Financial Highlights The following is a schedule of financial highlights for the nine months ended September 30, 2024 and 2023: For the Nine Months Ended September 30, 2024 2023 Per share data: Net asset value, beginning of period $ 22.53 $ 21.85 Results of operations: Net investment income (1) 1.69 1.16 Net realized and unrealized gain (loss) (6) ( 0.85 ) 0.71 Net increase (decrease) in net assets resulting from operations (1) 0.84 1.87 Stockholder distributions: (2) Distributions from net investment income ( 1.80 ) ( 0.93 ) Net decrease in net assets resulting from stockholder distributions ( 1.80 ) ( 0.93 ) Net asset value, end of period (8) $ 21.57 $ 22.79 Shares outstanding, end of period 3,349,201 3,009,895 Total return based on net asset value (3) 3.9 % 8.9 % Ratio/Supplemental Data: Net assets, end of period $ 72,237 $ 68,586 Ratio of net investment income to average net assets (5) 10.6 % 7.7 % Ratio of total expenses to average net assets, excluding Expense Support Agreements (5) 15.6 % 15.6 % Ratio of net expenses to average net assets, including Expense Support Agreements (4) 15.6 % 18.8 % Average debt outstanding $ 72,526 $ 62,784 Portfolio turnover 21.8 % 13.2 % Total amount of senior securities outstanding $ 73,000 $ 68,000 Asset coverage per unit (7) $ 1,990 $ 1,970 Total committed capital, end of period $ 73,940 $ 68,489 Ratio of total contributed capital to total committed capital, end of period 100.0 % 100.0 % (1) The per share data was derived by using the weighted average shares outstanding during the period. (2) The per share data for distributions reflects the actual amount of distributions paid during the period. (3) Total return based on net asset value is calculated as the change in net asset value per share during the period, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning net asset value per share. Total return is not annualized. (4) The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio includes the net expense support agreement amounts provided to or reimbursed by the Company during the period (5) The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio excludes the net expense support agreement amounts provided to or reimbursed by the Company during the period (6) The amount shown at this caption is the balancing figure derived from the other figures in the schedule. The amount shown at this caption is derived from total change in net asset value during the period and differs from the amount calculated using average shares because of the timing of issuances of the Company’s shares in relation to changes in net asset value during the period. (7) Asset coverage per unit is the ratio of the carrying value of the Company’s consolidated total assets, less liabilities and indebtedness not represented by senior (8) Represents the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the year or period and certain per share data on shares outstanding as of a year or period end or transaction date.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9. Commitments and Contingencies The Company enters into contracts that contain a variety of indemnification provisions. The Company’s maximum exposure under these arrangements is unknown; however, the Company has not had prior claims or losses pursuant to these contracts. The Adviser has reviewed the Company’s existing contracts and expects the risk of loss to the Company to be remote. From time to time, the Company may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of the Company’s rights under contracts with its portfolio companies. As of September 30, 2024, the Company is not aware of any pending or threatened litigation. The Adviser and its affiliates have incurred organization and offering costs and operating expenses on behalf of the Company in the amount of approximately $ 1.4 million and $ 1.2 million, respecti vely, from December 22, 2017 (inception) to October 2, 2019 (commencement of operations). The Company will have no responsibility for any organization and offering costs, nor operating expenses funded by the Adviser prior to the commencement of operations until the Adviser submits such costs, or a portion thereof, for reimbursement, subject to a cap of 1.50% of the Company’s total commitments for organization and offering costs and provided further that the Adviser or its affiliates may not be reimbursed for payment of excess organization and offering expenses that were incurred more than three years prior to the proposed reimbursement. For the period from October 2, 2019 (commencement of operations) through September 30, 2024, the Company accrued organization and offering costs of $ 0.8 million and recognized operating expenses funded by the Advisor prior to the Company’s commencement of operations of $ 1.2 million. As of December 31, 2023, the Company's unexpensed organization and offering costs associated with the commencement of operations have expired and are no longer reimbursable by the Company. See Note 3 for a discussion of the Company’s conditional reimbursement to the Adviser under the Expense Support Agreement. The Company may, from time to time, enter into commitments to fund investments. As of September 30, 2024 and December 31, 2023, the Company had the following outstanding commitments to fund investments in current portfolio companies: Portfolio Company Investment September 30, 2024 December 31, 2023 Accordion Partners LLC Senior Secured Loan $ — $ 1,632 AMCP PET HOLDINGS, INC. Senior Secured Loan — 175 Beta Plus Technologies R/C Senior Secured Loan 273 473 Great Lakes II Funding LLC Equity/Other 22 11 Green Park M-1 Series Equity/Other 366 366 Morae Global Inc Senior Secured Loan 292 292 PhyNet Dermatology LLC Senior Secured Loan 1,713 1,713 Princeton Medspa Partners LLC Senior Secured Loan 1,203 — Riddell, Inc Senior Secured Loan 364 — SePRO Corporation Senior Secured Loan 505 — SeQuel Response LLC Senior Secured Loan 100 — TA/WEG Holdings, LLC Senior Secured Loan 111 — Tactical Air Support, Inc Senior Secured Loan — 571 Tank Holding Corp Senior Secured Loan 185 249 VBC Spine Opco LLC Senior Secured Loan 574 1,080 Total Unfunded Portfolio Company Commitments $ 5,708 $ 6,562 The Company maintains sufficient capacity to cover outstanding unfunded portfolio company commitments that the Company may be required to fund.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
Subsequent Events	Note 10. Subsequent Events On November 6, 2024, the Board declared a quarterly distribution of $ 0.60 per share payable on December 5, 2024 to stockholders of record as of November 22, 2024.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited consolidated financial statements and notes should be read in conjunction with the audited consolidated financial statements and notes thereto appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the U.S. Securities and Exchange Commission (“SEC”) on March 12, 2024. The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) pursuant to the requirements for reporting on Form 10-Q and Regulation S-X, as appropriate. These consolidated financial statements reflect adjustments that in the opinion of the Company are necessary for the fair presentation of the financial position and results of operations as of and for the periods presented herein. The Company is an investment company under U.S. GAAP and therefore applies the accounting and reporting guidance applicable to investment companies. The Company has evaluated subsequent events through the date of issuance of the consolidated financial statements.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates, and such differences could be material.
Consolidation	Consolidation In accordance with U.S. GAAP guidance on consolidation, the Company will generally not consolidate its investment in a portfolio company other than an investment company subsidiary or a controlled operating company whose business consists of providing services to the Company. Accordingly, the Company consolidated the accounts of the Company’s wholly-owned subsidiaries in its consolidated financial statements. All significant intercompany balances and transactions have been eliminated in consolidation.
Segments	Segments In accordance with U.S. GAAP guidance on segment reporting, the Company has determined that its operations comprise a single reporting segment.
Cash and Restricted Cash	Cash and Restricted Cash Cash consists of deposits held at a custodian bank. Restricted cash consists of deposits pledged as collateral. Cash and restricted cash are held at major financial institutions and, at times, may exceed the insured limits under applicable law.
Investments	Investments Investment transactions are recorded on the trade date. Realized gains or losses on investments are calculated using the specific identification method as the difference between the net proceeds received (excluding prepayment fees, if any) and the amortized cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments charged off during the period, net of recoveries. Net change in unrealized appreciation or depreciation reflects the change in portfolio investment values during the reporting period, including any reversal of previously recorded unrealized appreciation or depreciation when gains or losses are recognized. Investments for which market quotations are available are typically valued at those market quotations. To validate market quotations, the Company will utilize a number of factors to determine if the quotations are representative of fair value, including the source and number of the quotations. Debt that is not publicly traded but for which there are external pricing sources available as of the valuation date is valued using independent broker-dealer, market maker quotations or independent pricing services. The valuation committee, comprised of members of the Adviser, (the “Valuation Committee”) subjects these quotes to various criteria including, but not limited to, the number and quality of quotes, the deviation among the quotes and information derived from analyzing the Company's own transactions in such investments throughout the reporting period. Generally, such investments are categorized in level 2 of the fair value hierarchy, unless the Valuation Committee determines that the quality, quantity or deviation among quotes warrants significant adjustment to the inputs utilized. The Board has designated the Adviser as its "valuation designee" pursuant to Rule 2a-5 under the 1940 Act, and in that role the Adviser is responsible for performing fair value determinations relating to all of the Company's investments, including periodically assessing and managing any material valuation risks and establishing and applying fair value methodologies, in accordance with valuation policies and procedures that have been approved by the Board. The Board remains ultimately responsible for fair value determinations under the 1940 Act and satisfies its responsibility through oversight of the valuation designee in accordance with Rule 2a-5. Investments that are not publicly traded or whose market prices are not readily available, as is expected to be the case for substantially all of the Company’s investments, are valued at fair value as determined in good faith by the Adviser, based on, among other things, input of independent third-party valuation firm(s). The Adviser undertakes a multi-step valuation process, which includes, among other procedures, the following: • The Company’s quarterly valuation process begins with each portfolio company or investment being initially valued using certain inputs, among others, provided by the investment professionals responsible for the portfolio investment in conjunction with the Company’s portfolio management team. The Company utilizes an independent valuation firm to provide valuation on each material illiquid security at least once every trailing 12-month period; • Preliminary valuations are reviewed and discussed with management of the Adviser and investment professionals; and • The Adviser will review the valuations and determine the fair value of each investment. Valuations that are not based on readily available market quotations will be valued in good faith based on, among other things, the input of, where applicable, third parties. As part of the valuation process, the Adviser may consider other information and may use valuation methods including but not limited to (i) market quotes for similar investments, (ii) recent trading activity, (iii) discounting forecasted cash flows of the investment, (iv) models that consider the implied yields from comparable debt, (v) third party appraisal, (vi) sale negotiations and purchase offers received from independent parties and (vii) estimated value of underlying assets to be received in liquidation or restructuring. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of our investments may fluctuate from period to period. Additionally, the fair value of such investments may differ significantly from the values that would have been used had a ready market existed for such investments and may differ materially from the values that may ultimately be realized. Further, such investments are generally less liquid than publicly traded securities and may be subject to contractual and other restrictions on resale. If the Company were required to liquidate a portfolio investment in a forced or liquidation sale, it could realize amounts that are different from the amounts presented and such differences could be material. In addition, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different than the unrealized gains or losses reflected herein. Under existing accounting guidance, fair value is defined as the price that the Company would receive upon selling an investment or pay to transfer a liability in an orderly transaction to a market participant in the principal or most advantageous market for the investment. This accounting guidance emphasizes valuation techniques that maximize the use of observable market inputs and minimize the use of unobservable inputs. Inputs refer broadly to the assumptions that market participants would use in pricing an asset or liability, including assumptions about risk. Inputs may be observable or unobservable. Observable inputs are inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the assumptions market participants would use in pricing an asset or liability developed based on the best information available in the circumstances. The Company classifies the inputs used to measure these fair values into the following hierarchy as defined by current accounting guidance: Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible to the Company. Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. Level 3: Significant inputs that are unobservable for an asset or liability. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Investments for which no external pricing sources are available as of the valuation date are included in level 3 of the fair value hierarchy.
Forward Contracts	Forward Contracts The Company may enter into forward purchase contracts primarily to manage credit risk. When entering into a forward purchase contract, the Company agrees to deliver a fixed quantity of securities for an agreed-upon price on an agreed future date. Forward contracts entered into by the Company are not designated as hedging instruments, and as a result, the Company presents changes in fair value through net change in unrealized appreciation (depreciation) on derivative instruments in the consolidated statements of operations. Realized and unrealized gains and losses of derivative instruments are included in the consolidated statements of operations. These instruments involve market risk, credit risk, or both kinds of risks. Risks arise from the possible inability of counterparties to meet the terms of their contracts and movements in fair value. The Company attempts to limit counterparty risk by only dealing with well-known counterparties.
Revenue Recognition	Revenue Recognition Interest income is recorded on an accrual basis and includes the accretion of discounts and amortization of premiums. Discounts from and premiums to par value on debt investments purchased are accreted/amortized into interest income over the life of the respective security using the effective interest method. The amortized cost of debt investments represents the original cost, including origination fees and upfront fees received that are deemed to be an adjustment to yield, adjusted for the accretion of discounts and amortization of premiums, if any. Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected in full. The Company considers many factors relevant to an investment when placing it on or removing it from non-accrual status including, but not limited to, the delinquency status of the investment, economic and business conditions, the overall financial condition of the underlying investment, the value of the underlying collateral, bankruptcy status, if any, and any other facts or circumstances relevant to the investment. Accrued interest is generally reversed when a loan is placed on non-accrual status. Payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability of the outstanding principal and interest. Non-accrual loans may be restored to accrual status when past due principal and interest is paid current and are likely to remain current based on management’s judgment. Dividend income on preferred equity securities is recorded on the accrual basis to the extent that such amounts are payable by the portfolio company and are expected to be collected. Dividend income on common equity securities is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly-traded portfolio companies. Loan origination fees, original issue discount and market discount are capitalized, and the Company amortizes such amounts as interest income over the respective term of the loan or security. Upon the prepayment of a loan or security, any unamortized loan origination fees and original issue discount are recorded as interest income. The Company records prepayment premiums on loans and securities as fee income when it receives such amounts.
Payment-in-Kind Interest	Payment-in-Kind Interest Payment-in-kind (“PIK”) interest, computed at the contractual rate specified in each loan agreement, is added to the principal balance of the loan and recorded as interest income and generally becomes due at maturity. To maintain the Company’s tax treatment as a RIC, this non-cash source of income may be required to be paid out to stockholders in the form of distributions, even though the Company has not yet collected the cash.
Deferred Financing Costs	Deferred Financing Costs Origination and other expenses related to the Company’s borrowings are recorded as deferred financing costs and amortized as part of interest expense using the straight-line method over the stated life of the debt instrument. Unamortized deferred financing costs are presented as a direct deduction to the respective debt instrument. There were no new financing costs related to the Company's borrowings during the nine months ended September 30, 2024 .
Organization and Offering Costs	Organization and Offering Costs Organization costs include, among other things, the cost of incorporating, including the cost of legal services and other fees pertaining to the Company’s organization. Costs associated with the organization of the Company are expensed as incurred. Offering costs include, among other things, marketing expenses and printing, legal fees, due diligence fees, and other costs in connection with the Company’s offering of shares of its common stock, including the preparation of the Company’s registration statement, and salaries and direct expenses of the Adviser’s personnel, employees of its affiliates and others while engaged in such activities. Offering costs are capitalized as deferred offering expenses and are amortized over twelve months from incurrence. There were no new organization and offering costs during the nine months ended September 30, 2024 .
Earnings per Share	Earnings per Share Basic earnings per share is calculated by dividing net income or loss attributable to common stockholders by the weighted average number of common stock outstanding during the period.
Income Taxes	Income Taxes The Company has elected to be treated for U.S. federal income tax purposes, and intends to qualify annually, as a RIC under Subchapter M of the Code. So long as the Company maintains its tax treatment as a RIC, it will generally not pay corporate-level U.S. federal income or excise taxes on any ordinary income or capital gains that it distributes at least annually to its stockholders as distributions. Any tax liability related to income earned and distributed by the Company represents obligations of the Company’s stockholders and will not be reflected in the consolidated financial statements of the Company. To qualify for and maintain status as a RIC, the Company must, among other things, meet certain source-of-income and asset diversification requirements. In addition, to qualify for RIC tax treatment, the Company must distribute to its stockholders, for each taxable year, at least 90 % of its “investment company taxable income” (which is generally its ordinary income plus the excess, if any, of its realized net short-term capital gains over its realized net long-term capital losses) and net tax-exempt income for that year. In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98 % of its ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2 % of its capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year, and (iii) any ordinary income and net capital gains for preceding years that were not distributed during such years and on which the Company paid no U.S. federal income tax. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4 % nondeductible U.S. federal excise tax on this income. The Company evaluates tax positions taken or expected to be taken in the course of preparing its consolidated financial statements to determine whether the tax positions are “more-likely-than-not” to be sustained by the applicable tax authority. Tax positions not deemed to meet the “more-likely-than-not” threshold are reserved and recorded as a tax benefit or expense in the current year. All penalties and interest associated with income taxes are included in income tax expense. Conclusions regarding tax positions are subject to review and may be adjusted at a later date based on factors including, but not limited to, on-going analyses of tax laws, regulations and interpretations thereof. The Company has analyzed the tax positions taken on federal and state income tax returns for all open tax years and has concluded that no provision for income tax for uncertain tax positions is required in the Company’s consolidated financial statements. The Company’s major tax jurisdictions are U.S. federal, New York State, and foreign jurisdictions where the Company makes significant investments. The Company’s federal and state income and federal excise tax returns for tax years for which the applicable statutes of limitations have not expired are subject to examination by the Internal Revenue Service and state departments of revenue.
Distributions to Common Stockholders	Distributions to Common Stockholders Distributions to the Company’s stockholders are recorded on the record date. The amount to be paid out as a distribution is determined by the Board and is generally based upon earnings estimated by the Adviser. Net realized capital gains, if any, would generally be distributed at least annually, although the Company may decide to retain such capital gains. The Company has adopted an “opt out” dividend reinvestment plan (“DRP”) for its stockholders. As a result, if the Company makes a cash distribution, its stockholders will have their cash distributions reinvested in additional shares of the Company’s common stock, including fractional shares as necessary, unless they specifically “opt out” of the DRP to receive the distribution in cash. Under the DRP, cash distributions to participating stockholders will be reinvested in additional shares of the Company’s common stock at a purchase price equal to the net asset value per share as of the last day of the calendar quarter immediately preceding the date such distribution was declared. The Company may distribute taxable distributions that are payable in cash or shares of its common stock, at the election of each shareholder. In accordance with certain applicable U.S. Treasury regulations and published guidance issued by the Internal Revenue Service, a publicly offered RIC may treat a distribution of its own stock as fulfilling the RIC distribution requirements if each shareholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash available to be distributed to all shareholders must be at least 20.0 % of the aggregate declared distribution. If too many shareholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any shareholder electing to receive cash receive less than 20.0 % of its entire distribution in cash. If these and certain other requirements are met for U.S. federal income tax purposes, the amount of the distribution paid in stock will be equal to the amount of cash that could have been received instead of stock. Taxable shareholders receiving such distributions will be required to include the amount of the distribution as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of the Company’s current or accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. shareholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. shareholder sells the stock it receives in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of the Company’s stock at the time of the sale. Furthermore, with respect to non-U.S. shareholders, the Company may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in common stock. The current published guidance that allows certain stock distributions of a RIC to fulfill the RIC’s own distribution requirements applies only to publicly offered RICs. The Company believes that it currently does not qualify as a publicly offered RIC, although the Company may qualify as a publicly offered RIC for future years.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2022, the Financial Accounting Standards Board issued Accounting Standards Update 2022-03, Fair Value Measurement (Topic 820) – Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions (ASU 2022-03). The accounting standard update clarifies the guidance in Topic 820 when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security and introduces new disclosure requirements for equity securities subject to contractual sale restrictions and measured at fair value in accordance with Topic 820. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Adopting this new accounting standard will have no material impact on the Company's consolidated financial statements. In November 2023, the Financial Accounting Standards Board issued Accounting Standards Update 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures. The accounting standard update clarifies the segment disclosure requirements in Topic 280 and requires public entities to disclose significant segment expenses, provide all annual disclosures about a reportable segment's profit or loss and assets in interim periods, and clarify the reporting of additional measures of segment profit or loss. The amendments aim to improve consistency and comparability in segment reporting. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company has evaluated the impact of adopting this new accounting standard and has concluded that the impact of the adoption will not be material to the consolidated financial statements.

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Quarter Ended Expense Payment (1) Reimbursement Unreimbursed (1) Eligible for Reimbursement (1) March 31, 2020 346 346 — March 31, 2023 June 30, 2020 752 752 — June 30, 2023 September 30, 2020 68 68 — September 30, 2023 March 31, 2021 217 217 — March 31, 2024 $ 1,383 $ 1,383 $ — (1) The actual date that the estimated Expense Payment is eligible for reimbursement will be determined when such Expense Payment is actually made by the Adviser. Potential Conflicts of Interest The members of the senior management and investment teams of the Adviser serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as the Company does, or of investment vehicles managed by the same personnel. In serving in these multiple and other capacities, they may have obligations to other clients or investors in those entities, the fulfillment of which may or may not be in the Company’s best interests or in the best interest of the Company’s stockholders. The Company’s investment objectives may overlap with the investment objectives of such investment funds, accounts or other investment vehicles.

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Portfolio at Amortized Cost and Fair Value	The following table summarizes the composition of the Company’s investment portfolio at amortized cost and fair value as of September 30, 2024: September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Senior Secured Loan $ 133,154 97.5 % $ 128,382 96.6 % Equity/Other 3,257 2.4 % 4,385 3.3 % Unsecured Note 81 0.1 % 81 0.1 % Total $ 136,492 100.0 % $ 132,848 100.0 % The following table summarizes the composition of the Company’s investment portfolio at amortized cost and fair value as of December 31, 2023: December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Senior Secured Loan $ 129,511 95.7 % $ 126,050 94.3 % Structured Note 3,840 2.8 % 3,860 2.9 % Equity/Other 1,981 1.5 % 3,765 2.8 % Total $ 135,332 100.0 % $ 133,675 100.0 %
Schedule of the Industry and Geographic Composition of the Company's Investment Portfolio	The following tables summarize the industry and geographic composition of the Company’s investment portfolio based on amortized cost and fair value as of September 30, 2024: September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Chemicals $ 1,726 1.3 % $ 1,722 1.3 % Communication Services 4,555 3.3 % $ 4,647 3.5 % Construction 1,981 1.6 % 1,980 1.5 % Consumer Discretionary 3,000 2.2 % 2,971 2.2 % Consumer Staples 12,585 9.2 % 12,300 9.3 % Financials 21,054 15.4 % 21,908 16.5 % Gaming 996 0.7 % 841 0.6 % Healthcare 23,094 16.9 % 22,764 17.1 % Industrials 24,054 17.6 % 24,024 18.1 % Information Technology 38,106 27.9 % 35,355 26.6 % Insurance Services 1,661 1.2 % 1,669 1.3 % Professional Services 1,750 1.3 % 1,750 1.3 % Transportation 1,930 1.4 % 917 0.7 % Total $ 136,492 100.0 % $ 132,848 100.0 % September 30, 2024 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio United States $ 136,492 100.0 % $ 132,848 100.0 % International - 0.0 % — 0.0 % Total $ 136,492 100.0 % $ 132,848 100.0 % The following tables summarize the industry and geographic composition of the Company’s investment portfolio based on amortized cost and fair value as of December 31, 2023: December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio Information Technology $ 52,690 38.9 % $ 50,152 37.5 % Industrials 21,413 15.8 % 21,520 16.1 % Financials 15,629 11.5 % 17,148 12.8 % Healthcare 23,105 17.2 % 23,119 17.3 % Consumer Staples 7,003 5.2 % 6,720 5.0 % Consumer Discretionary 3,066 2.3 % 3,056 2.3 % Collateralized Loan Obligation - Debt Class 3,840 2.8 % 3,860 2.9 % Gaming 1,723 1.3 % 1,710 1.3 % Communication Services 4,917 3.6 % 4,932 3.7 % Transportation 1,946 1.4 % 1,458 1.1 % Total $ 135,332 100 % $ 133,675 100 % December 31, 2023 Amortized Percentage of Fair Percentage of Cost Portfolio Value Portfolio United States $ 128,830 95.2 % $ 127,153 95.1 % International 6,502 4.8 % 6,522 4.9 % Total $ 135,332 100.0 % $ 133,675 100.0 %
Schedule of Investments in Affiliates	The following table details investments in affiliates at September 30, 2024: ($ in thousands) Type of Investment Industry Affiliate Fair Value as of December 31, 2023 Transfers In/Out of Affiliates Purchases(sales) of or Advances/ Distributions Net Change in Unrealized Gain/(Loss) Affiliate Fair Value as of September 30, 2024 Affiliate Investment Income Great Lakes II Funding LLC (1)(3)(4) Equity/Other Financial Services $ 92 $ — $ ( 13 ) $ — $ 79 $ 27 Green Park M-1 Series (1)(2)(3)(4) Equity/Other Industrials 34 — — — 34 — GreenPark Infrastructure A Series (1)(2)(3) Equity/Other Industrials 100 — — — 100 — Princeton Medspa Partners LLC (1)(2)(3) Senior Secured Loans Professional Services — — 1,501 ( 9 ) 1,492 59 Princeton Medspa Partners LLC (1)(2)(3) Equity/Other Professional Services — — 250 8 258 — Princeton Medspa Partners LLC (1)(2)(3) Derivatives Professional Services — — — — — — Total Non-controlled affiliates $ 226 $ — $ 1,738 $ ( 1 ) $ 1,963 $ — $ 86 (1) Fair value of this investment was determined using significant unobservable inputs (2) Qualified asset for purposes of section 55(a) of the Investment Company Act of 1940 (3) Under the 1940 Act, the Company is deemed to be an “Affiliated Person” of, as defined in the 1940 Act, this portfolio company as the Company owns at least 5% of the portfolio company’s outstanding voting securities or is under common control with such portfolio company. (4) Security has an unfunded commitment in addition to the amounts shown in the Consolidated Schedule of Investments. See Note 8 for additional information on the Company’s commitments and contingencies.
Schedule of Fair Value of Investments by Fair Value Hierarchy Levels	The following table summarizes the fair value hierarchy of the Company’s investment portfolio as of September 30, 2024: Fair Value Measurements Level 1 Level 2 Level 3 Total Senior Secured Loan $ — $ 36,331 $ 92,051 $ 128,382 Equity/Other — — 4,385 4,385 Unsecured Note — — 81 81 Total $ — $ 36,331 $ 96,517 $ 132,848 Fair Value Measurements Level 1 Level 2 Level 3 Total Senior Secured Loan $ — $ 34,203 $ 91,847 $ 126,050 Structured Note — — 3,860 3,860 Equity/Other — — 3,765 3,765 Total $ — $ 34,203 $ 99,472 $ 133,675 Forward contracts — — — — Total $ — $ 34,203 $ 99,472 $ 133,675
Schedule of the Company's Investment Portfolio for which Level 3 Inputs	The following is a reconciliation of the Company’s investment portfolio for which level 3 inputs were used in determining fair value for the nine months ended September 30, 2024. Senior Secured Structured Unsecured Note Equity/other Total Forward Balance as of January 1, 2024 $ 91,847 $ 3,860 $ — $ 3,765 $ 99,472 $ — Purchases of investments 22,310 — 81 1,297 23,688 — Proceeds from principal repayments and sales of investments ( 16,829 ) ( 3,900 ) — — ( 20,729 ) — Payment in-kind interest income 677 — — — 677 — Net accretion of discounts 294 — — — 294 — Net change in unrealized appreciation (depreciation) on investments ( 1,436 ) 40 — ( 656 ) ( 2,052 ) Net realized loss on investments ( 97 ) — — ( 21 ) ( 118 ) — Transfers into level 3 1,907 — — — 1,907 — Transfers out of level 3 ( 6,622 ) — — — ( 6,622 ) — Balance as of September 30, 2024 $ 92,051 $ — $ 81 $ 4,385 $ 96,517 $ — Net change in unrealized appreciation (depreciation) on Level 3 investments still held $ ( 1,494 ) $ — $ — $ ( 137 ) $ ( 1,631 ) $ — Senior Secured Structured Subordinated Structured Note Equity/other Total Forward Balance as of January 1, 2023 $ 76,242 $ 4,053 $ 281 $ 2,036 $ 82,612 $ ( 55 ) Purchases of investments 28,966 — — 146 29,112 — Proceeds from principal repayments and sales of investments ( 11,374 ) ( 319 ) ( 350 ) — ( 12,043 ) — Payment in-kind interest income 361 — — — 361 — Net accretion of discounts (amortization of premiums) 276 — — — 276 — Net change in unrealized appreciation (depreciation) on investments 1,134 17 52 142 1,345 Net realized loss on investments 121 87 17 — 225 — Transfers into level 3 — — — — — — Transfers out of level 3 ( 1,700 ) — — — ( 1,700 ) — Balance as of September 30, 2023 $ 94,026 $ 3,838 $ — $ 2,324 $ 100,188 $ ( 55 ) Net change in unrealized appreciation (depreciation) on Level 3 investments still held $ 1,153 $ 17 $ 52 $ 142 $ 1,364 $ ( 55 )
Schedule of Valuation Techniques and Significant Unobservable Inputs	The valuation techniques and significant unobservable inputs used in the valuation of level 3 investments as of September 30, 2024 were as follows: Quantitative Information About Level 3 Fair Value Measurements Asset Category Fair Value Valuation Unobservable Range Equity/Other $ 3,000 Enterprise Valuation Average EBITDA Multiple 5.5 x- 13 x ( 10.1 x) Equity/Other 1,306 Discounted Cash Flows Market Yield 10.6 %- 21.8 % ( 16.2 %) Equity/Other 79 Enterprise Valuation Net Asset Value 103 Senior Secured Loan 88,349 Discounted Cash Flows Market Yield 5.7 % - 19.2 % ( 11.8 %) Senior Secured Loan 3,702 Recent Transaction Transaction Price 98 - 99 ( 98.6 ) Unsecured Note 81 Discounted Cash Flows Market Yield 10.3 % $ 96,517 Forward Contracts $ - Enterprise Valuation Average EBITDA Multiple 2.5 x The valuation techniques and significant unobservable inputs used in the valuation of level 3 investments as of December 31, 2023 were as follows: Quantitative Information About Level 3 Fair Value Measurements Asset Category Fair Value Valuation Unobservable Range Equity/Other $ 2,543 Enterprise Valuation Average EBITDA Multiple 1.6 x - 18 x ( 4.7 x) Equity/Other 226 Enterprise Valuation Net Asset Value 100 - 103 ( 101 ) Equity/Other 996 Recent Transaction Transaction Price 14.9 - 14.9 ( 14.9 ) Senior Secured Loan 81,864 Discounted Cash Flows Market Yield 6.1 % - 19.3 % ( 11.1 %) Senior Secured Loan 9,983 Recent Transaction Transaction Price 96.5 - 100 ( 98.2 ) Structured Note 3,860 Discounted Cash Flows Market Yield 11.9 %- 11.9 % ( 11.9 %) $ 99,472
Schedule of Open Forward Contracts	As of September 30, 2024, the Company’s open forward contracts were as follows: Security Counterparty Settlement Date Par Unrealized Appreciation Princeton Medspa Partners LLC - Put option Princeton Medspa Partners LLC 5/31/2029 250 $ — $ —
Schedule of Realized and Unrealized Gain and Loss Amounts Included on Consolidated Statement of Operations	The following table also identifies the realized and unrealized gain and loss amounts included on the consolidated statement of operations for the nine months ended September 30, 2024. Type of Contract Derivative Derivative Realized Unrealized Depreciation Forward contracts - credit risk $ — $ — $ — $ — $ — $ — $ — $ —

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Summery Of Debt Obligations	Debt obligations consisted of the following as of September 30, 2024: September 30, 2024 Total Total Less Amount per Credit Facility $ 110,000 $ 73,000 $ ( 581 ) $ 72,419 Total Debt $ 110,000 $ 73,000 $ ( 581 ) $ 72,419 Debt obligations consisted of the following as of December 31, 2023: December 31, 2023 Total Total Less Amount per Credit Facility $ 110,000 $ 71,000 $ ( 663 ) $ 70,337 Total Debt $ 110,000 $ 71,000 $ ( 663 ) $ 70,337
Summery Of Components Of Interest Expense	For the three and nine months ended September 30, 2024 and 2023 the components of interest expense were as follows: Three Months Ended September 30, Nine Months Ended September 30, 2024 2023 2024 2023 Interest expense $ 1,533 $ 1,416 $ 4,602 $ 3,708 Amortization of deferred financing and debt issuance costs 27 27 82 82 Total Interest Expense $ 1,560 $ 1,443 $ 4,684 $ 3,790 Average debt outstanding 73,000 68,000 72,526 62,784 Weighted average interest rate 8.5 % 8.5 % 8.6 % 8.0 %

Share Transactions (Tables)

Share Transactions (Tables)	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Summary of total shares issued and proceeds received related to capital drawdowns delivered pursuant to Subscription Agreements	The following tables summarizes the total shares issued and proceeds received related to capital drawdowns delivered pursuant to the Subscription Agreements during the nine months ended September 30, 2024 and 2023: Capital Drawdown Notice Date Common Share Number of Aggregate May 24, 2024 June 10, 2024 44,623 $ 1,000 September 11, 2024 September 13, 2024 204,880 $ 4,450 Total 249,503 $ 5,450 Capital Drawdown Notice Date Common Share Number of Aggregate March 3, 2023 March 8, 2023 519,186 $ 11,500 May 9, 2023 May 9, 2023 228,519 5,000 Total 747,705 $ 16,500
Summary of distribution declared	The following tables summarizes the distribution declarations for the nine months ended September 30, 2024 and 2023: Date Declared Record Date Payment Date Amount Distributions March 11, 2024 March 25, 2024 April 2, 2024 $ 0.60 $ 1,822 May 7, 2024 May 22, 2024 May 31, 2024 0.60 1,834 August 7, 2024 August 22, 2024 September 5, 2024 0.60 1,873 Total distributions declared $ 1.80 $ 5,529 Date Declared Record Date Payment Date Amount Distributions March 6, 2023 March 20, 2023 March 29, 2023 $ 0.31 $ 853 May 9, 2023 May 22, 2023 May 31, 2023 0.31 927 August 8, 2023 August 22, 2023 August 31, 2023 0.31 930 Total distributions declared $ 0.93 $ 2,710
Schedule of common stock issued pursuant to the dividend reinvestment plan	The following tables reflect the common stock issued pursuant to the dividend reinvestment plan during the nine months ended September 30, 2024 and 2023: Date Declared Record Date Payment Date Shares December 21, 2023 December 31, 2023 January 26, 2024 11,736 March 11, 2024 March 25, 2024 April 2, 2024 20,254 May 7, 2024 May 22, 2024 May 31, 2024 20,853 August 7, 2024 August 22, 2024 September 5, 2024 21,879 Total shares issued 74,722 Date Declared Record Date Payment Date Shares March 6, 2023 March 20, 2023 March 31, 2023 9,874 May 9, 2023 May 22, 2023 May 31, 2023 10,086 August 8, 2023 August 22, 2023 August 31, 2023 10,096 Total shares issued 30,056

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share Basic and Diluted	The following table sets forth the computation of basic and diluted earnings per common stock for the three and nine months ended September 30, 2024 and 2023: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2024 2023 2024 2023 Increase in net assets resulting from operations per share - basic and diluted $ 349 $ 3,328 $ 2,541 $ 5,376 Weighted average shares of common stock outstanding - basic and diluted 3,168,711 3,003,201 3,092,149 2,755,930 Net increase (decrease) in net assets resulting from operations per share - basic and diluted $ 0.11 $ 1.11 $ 0.82 $ 1.95

Financial Highlights (Tables)

Financial Highlights (Tables)	9 Months Ended
	Sep. 30, 2024
Investment Company, Financial Highlights [Abstract]
Schedule of Financial Highlights	The following is a schedule of financial highlights for the nine months ended September 30, 2024 and 2023: For the Nine Months Ended September 30, 2024 2023 Per share data: Net asset value, beginning of period $ 22.53 $ 21.85 Results of operations: Net investment income (1) 1.69 1.16 Net realized and unrealized gain (loss) (6) ( 0.85 ) 0.71 Net increase (decrease) in net assets resulting from operations (1) 0.84 1.87 Stockholder distributions: (2) Distributions from net investment income ( 1.80 ) ( 0.93 ) Net decrease in net assets resulting from stockholder distributions ( 1.80 ) ( 0.93 ) Net asset value, end of period (8) $ 21.57 $ 22.79 Shares outstanding, end of period 3,349,201 3,009,895 Total return based on net asset value (3) 3.9 % 8.9 % Ratio/Supplemental Data: Net assets, end of period $ 72,237 $ 68,586 Ratio of net investment income to average net assets (5) 10.6 % 7.7 % Ratio of total expenses to average net assets, excluding Expense Support Agreements (5) 15.6 % 15.6 % Ratio of net expenses to average net assets, including Expense Support Agreements (4) 15.6 % 18.8 % Average debt outstanding $ 72,526 $ 62,784 Portfolio turnover 21.8 % 13.2 % Total amount of senior securities outstanding $ 73,000 $ 68,000 Asset coverage per unit (7) $ 1,990 $ 1,970 Total committed capital, end of period $ 73,940 $ 68,489 Ratio of total contributed capital to total committed capital, end of period 100.0 % 100.0 % (1) The per share data was derived by using the weighted average shares outstanding during the period. (2) The per share data for distributions reflects the actual amount of distributions paid during the period. (3) Total return based on net asset value is calculated as the change in net asset value per share during the period, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning net asset value per share. Total return is not annualized. (4) The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio includes the net expense support agreement amounts provided to or reimbursed by the Company during the period (5) The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio excludes the net expense support agreement amounts provided to or reimbursed by the Company during the period (6) The amount shown at this caption is the balancing figure derived from the other figures in the schedule. The amount shown at this caption is derived from total change in net asset value during the period and differs from the amount calculated using average shares because of the timing of issuances of the Company’s shares in relation to changes in net asset value during the period. (7) Asset coverage per unit is the ratio of the carrying value of the Company’s consolidated total assets, less liabilities and indebtedness not represented by senior (8) Represents the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the year or period and certain per share data on shares outstanding as of a year or period end or transaction date.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of Outstanding Commitments to Fund Investments in Current Portfolio Companies	As of September 30, 2024 and December 31, 2023, the Company had the following outstanding commitments to fund investments in current portfolio companies: Portfolio Company Investment September 30, 2024 December 31, 2023 Accordion Partners LLC Senior Secured Loan $ — $ 1,632 AMCP PET HOLDINGS, INC. Senior Secured Loan — 175 Beta Plus Technologies R/C Senior Secured Loan 273 473 Great Lakes II Funding LLC Equity/Other 22 11 Green Park M-1 Series Equity/Other 366 366 Morae Global Inc Senior Secured Loan 292 292 PhyNet Dermatology LLC Senior Secured Loan 1,713 1,713 Princeton Medspa Partners LLC Senior Secured Loan 1,203 — Riddell, Inc Senior Secured Loan 364 — SePRO Corporation Senior Secured Loan 505 — SeQuel Response LLC Senior Secured Loan 100 — TA/WEG Holdings, LLC Senior Secured Loan 111 — Tactical Air Support, Inc Senior Secured Loan — 571 Tank Holding Corp Senior Secured Loan 185 249 VBC Spine Opco LLC Senior Secured Loan 574 1,080 Total Unfunded Portfolio Company Commitments $ 5,708 $ 6,562

Significant Accounting Polici_3

Significant Accounting Policies (Additional Information) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Ordinary income, percentage	98%
Capital gains in excess of capital losses, percentage	98.20%
Nondeductible excise tax, percentage	4%
Minimum percentage of distribution in cash	20%
Deferred financing costs, net	$ 581,000		$ 663,000
New financing costs related to borrowings	0
Organization and offering costs	$ 0	$ 30,000
Minimum [Member]
Taxable income for shareholders, percentage	90%
Percentage of aggregate declared distribution	20%

Related Party Transactions (Add

Related Party Transactions (Additional Information) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Related Party Transaction [Line Items]
Termination of agreement, description			The Administration Agreement may be terminated at any time, without the payment of any penalty, upon 60 days’ written notice, by the vote of a majority of the outstanding voting shares of the Company or by the vote of the Board or by the Administrator.
Administrative fees	$ 149,000	$ 132,000	$ 427,000	$ 457,000
Management fees expense	336,000	329,000	1,021,000	898,000
Audit fees	55,000	50,000	165,000	165,000
Legal fees	100,000	107,000	282,000	324,000
Professional fees	70,000	147,000	226,000	330,000
Accrued organization and offering costs	0	0	$ 0	30,000
Expense Support Agreement expiration description			The Expense Support Agreement expired pursuant to its terms on September 26, 2022, other than with respect to reimbursement payments that the Adviser may be entitled to from the Company pursuant to the Expense Support Agreement, for a period of three years following the last business day of the calendar quarter in which the Adviser reimbursed the Company.
Third Party [Member]
Related Party Transaction [Line Items]
Operating expenses			$ 1,200,000
Audit fees			200,000
Legal fees			500,000
Professional fees			22,300
Director fee			200,000
Insurance			200,000
Other expense			62,400
Administration Agreement [Member]
Related Party Transaction [Line Items]
Administrative fees	100,000	100,000	$ 400,000	500,000
Investment Advisory Agreement [Member]
Related Party Transaction [Line Items]
Termination of agreement, description			The Investment Advisory Agreement may be terminated at any time, without the payment of any penalty, upon 60 days’ written notice and, in certain circumstances, upon 120 days’ written notice, by the vote of a majority of the outstanding voting shares of the Company or by the vote of the Board or by the Adviser.
Management fees, description			The base management fee is payable quarterly in arrears at an annual rate of 1.00% (1.50% if an exchange listing occurs) of the Company’s average gross assets, excluding cash and cash equivalents but including assets purchased with borrowed amounts, at the end of the two most recently completed calendar quarters
Management fees expense	300,000	300,000	$ 1,000,000	900,000
Incentive fees, description			the income incentive fee, payable at the end of each quarter in arrears, equals 100% of the pre-incentive fee net investment income in excess of a 1.50% quarterly preferred return but less than 1.76% (1.818% if an exchange listing occurs), the upper level breakpoint, and 15% (17.50% if an exchange listing occurs) of the amount of pre-incentive fee net investment income that exceeds 1.76% (1.818% if an exchange listing occurs) in any calendar quarter.
Percentage of cumulative realized capital gains			15%
Incentive fees	(300,000)	(300,000)	$ (900,000)	(800,000)
Organization and Offering Costs [Member]
Related Party Transaction [Line Items]
Organization and portfolio offering costs rate			1.50%
Accrued organization and offering costs			$ 1,400,000
Expense reimbursement recoverable/recovered by advisor	$ 0	$ 200,000	$ 0	$ 1,400,000

Related Party Transactions - Sc

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2024	Dec. 31, 2023
Related Party Transactions [Abstract]
Expense payment received from adviser	[1]	$ 217	$ 68	$ 752	$ 346	$ 1,383
Reimbursement payment made to adviser		217	68	752	346	$ 1,383
Unreimbursed expense payment	[1]	$ 0	$ 0	$ 0	$ 0		$ 0
Eligible for reimbursement through	[1]	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
[1] The actual date that the estimated Expense Payment is eligible for reimbursement will be determined when such Expense Payment is actually made by the Adviser.

Investments and Fair Value Me_3

Investments and Fair Value Measurements - Schedule Of Investment Portfolio At Amortized Cost And Fair Value (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Amortized cost	$ 136,492	$ 135,332
Percentage of Portfolio	100%	100%
Fair Value	$ 132,848	$ 133,675
Percentage of Portfolio	100%	100%
Senior Secured Loan - 193.2%
Summary of Investment Holdings [Line Items]
Amortized cost	$ 133,154	$ 129,511
Percentage of Portfolio	97.50%	95.70%
Fair Value	$ 128,382	$ 126,050
Percentage of Portfolio	96.60%	94.30%
Structured Note
Summary of Investment Holdings [Line Items]
Amortized cost		$ 3,840
Percentage of Portfolio		2.80%
Fair Value		$ 3,860
Percentage of Portfolio		2.90%
Equity/Other
Summary of Investment Holdings [Line Items]
Amortized cost	$ 3,257	$ 1,981
Percentage of Portfolio	2.40%	1.50%
Fair Value	$ 4,385	$ 3,765
Percentage of Portfolio	3.30%	2.80%
Unsecured Note
Summary of Investment Holdings [Line Items]
Amortized cost	$ 81
Percentage of Portfolio	0.10%
Fair Value	$ 81
Percentage of Portfolio	0.10%

Investments and Fair Value Me_4

Investments and Fair Value Measurements - Schedule of the industry and geographic composition of the Company's investment portfolio (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 136,492	$ 135,332
Percentage of Portfolio	100%	100%
Fair Value	$ 132,848	$ 133,675
Percentage of Portfolio	100%	100%
United States
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 136,492	$ 128,830
Percentage of Portfolio	100%	95.20%
Fair Value	$ 132,848	$ 127,153
Percentage of Portfolio	100%	95.10%
International
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 0	$ 6,502
Percentage of Portfolio	0%	4.80%
Fair Value	$ 0	$ 6,522
Percentage of Portfolio	0%	4.90%
Chemicals
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 1,726
Percentage of Portfolio	1.30%
Fair Value	$ 1,722
Percentage of Portfolio	1.30%
Information Technology
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 38,106	$ 52,690
Percentage of Portfolio	26.60%	38.90%
Fair Value	$ 35,355	$ 50,152
Percentage of Portfolio	27.90%	37.50%
Industrials
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 24,054	$ 21,413
Percentage of Portfolio	18.10%	15.80%
Fair Value	$ 24,024	$ 21,520
Percentage of Portfolio	17.60%	16.10%
Financials
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 21,054	$ 15,629
Percentage of Portfolio	16.50%	11.50%
Fair Value	$ 21,908	$ 17,148
Percentage of Portfolio	15.40%	12.80%
Healthcare
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 23,094	$ 23,105
Percentage of Portfolio	17.10%	17.20%
Fair Value	$ 22,764	$ 23,119
Percentage of Portfolio	16.90%	17.30%
Consumer Staples
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 12,585	$ 7,003
Percentage of Portfolio	9.30%	5.20%
Fair Value	$ 12,300	$ 6,720
Percentage of Portfolio	9.20%	5%
Consumer Discretionary
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 3,000	$ 3,066
Percentage of Portfolio	2.20%	2.30%
Fair Value	$ 2,971	$ 3,056
Percentage of Portfolio	2.20%	2.30%
Collateralized Loan Obligation - Debt Class
Summary of Investment Holdings [Line Items]
Amortized Cost		$ 3,840
Percentage of Portfolio		2.80%
Fair Value		$ 3,860
Percentage of Portfolio		2.90%
Gaming
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 996	$ 1,723
Percentage of Portfolio	0.60%	1.30%
Fair Value	$ 841	$ 1,710
Percentage of Portfolio	0.70%	1.30%
Communication Services
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 4,555	$ 4,917
Percentage of Portfolio	3.50%	3.60%
Fair Value	$ 4,647	$ 4,932
Percentage of Portfolio	3.30%	3.70%
Construction
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 1,981
Percentage of Portfolio	1.50%
Fair Value	$ 1,980
Percentage of Portfolio	1.60%
Insurance Services
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 1,661
Percentage of Portfolio	1.30%
Fair Value	$ 1,669
Percentage of Portfolio	1.20%
Professional Services
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 1,750
Percentage of Portfolio	1.30%
Fair Value	$ 1,750
Percentage of Portfolio	1.30%
Transportation
Summary of Investment Holdings [Line Items]
Amortized Cost	$ 1,930	$ 1,946
Percentage of Portfolio	0.70%	1.40%
Fair Value	$ 917	$ 1,458
Percentage of Portfolio	1.40%	1.10%

Investments and Fair Value Me_5

Investments and Fair Value Measurements - Schedule of Investments in Affiliates (Details) - Non-Controlled Affiliates [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	$ 226
Transfers In/Out of Affiliates	0
Purchases(sales) of or Advances/Distributions	1,738
Net Change in Unrealized Gain/(Loss)	(1)
Affiliate Fair Value, Ending Balance	1,963
Investments in Affiliates Investment Income	86
Great Lakes II Funding LLC [Member] | Equity/Other [Member] | Financial Services [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	92	[1],[2],[3]
Transfers In/Out of Affiliates	0	[1],[2],[3]
Purchases(sales) of or Advances/Distributions	(13)	[1],[2],[3]
Net Change in Unrealized Gain/(Loss)	0	[1],[2],[3]
Affiliate Fair Value, Ending Balance	79	[1],[2],[3]
Investments in Affiliates Investment Income	27	[1],[2],[3]
Green Park M-1 Series [Member] | Equity/Other [Member] | Industrials [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	34	[1],[2],[3],[4]
Transfers In/Out of Affiliates	0	[1],[2],[3],[4]
Purchases(sales) of or Advances/Distributions	0	[1],[2],[3],[4]
Net Change in Unrealized Gain/(Loss)	0	[1],[2],[3],[4]
Affiliate Fair Value, Ending Balance	34	[1],[2],[3],[4]
Investments in Affiliates Investment Income	0	[1],[2],[3],[4]
GreenPark Infrastructure A Series [Member] | Equity/Other [Member] | Industrials [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	100	[1],[3],[4]
Transfers In/Out of Affiliates	0	[1],[3],[4]
Purchases(sales) of or Advances/Distributions	0	[1],[3],[4]
Net Change in Unrealized Gain/(Loss)	0	[1],[3],[4]
Affiliate Fair Value, Ending Balance	100	[1],[3],[4]
Investments in Affiliates Investment Income	0	[1],[3],[4]
Princeton Medspa Partners LLC [Member] | Equity/Other [Member] | Professional Services [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	0	[1],[3],[4]
Transfers In/Out of Affiliates	0	[1],[3],[4]
Purchases(sales) of or Advances/Distributions	250	[1],[3],[4]
Net Change in Unrealized Gain/(Loss)	8	[1],[3],[4]
Affiliate Fair Value, Ending Balance	258	[1],[3],[4]
Investments in Affiliates Investment Income	0	[1],[3],[4]
Princeton Medspa Partners LLC [Member] | Senior Secured Loans [Member] | Professional Services [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	0	[1],[3],[4]
Transfers In/Out of Affiliates	0	[1],[3],[4]
Purchases(sales) of or Advances/Distributions	1,501	[1],[3],[4]
Net Change in Unrealized Gain/(Loss)	(9)	[1],[3],[4]
Affiliate Fair Value, Ending Balance	1,492	[1],[3],[4]
Investments in Affiliates Investment Income	59	[1],[3],[4]
Princeton Medspa Partners LLC [Member] | Derivative [Member] | Professional Services [Member]
Investments in and Advances to Affiliates [Line Items]
Affiliate Fair Value, Beginning Balance	0	[1],[3],[4]
Transfers In/Out of Affiliates	0	[1],[3],[4]
Purchases(sales) of or Advances/Distributions	0	[1],[3],[4]
Net Change in Unrealized Gain/(Loss)	0	[1],[3],[4]
Affiliate Fair Value, Ending Balance	0	[1],[3],[4]
Investments in Affiliates Investment Income	$ 0	[1],[3],[4]
[1] Fair value of this investment was determined using significant unobservable inputs Security has an unfunded commitment in addition to the amounts shown in the Consolidated Schedule of Investments. See Note 8 for additional information on the Company’s commitments and contingencies. Under the 1940 Act, the Company is deemed to be an “Affiliated Person” of, as defined in the 1940 Act, this portfolio company as the Company owns at least 5% of the portfolio company’s outstanding voting securities or is under common control with such portfolio company. Qualified asset for purposes of section 55(a) of the Investment Company Act of 1940

Investments and Fair Value Me_6

Investments and Fair Value Measurements - Schedule of Fair Value of Investments by Fair Value Hierarchy Levels (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	$ 132,848	$ 133,675
Senior Secured Loan | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	128,382	126,050
Structured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		3,860
Equity/Other [Member] | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	4,385	3,765
Unsecured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	81
Total Investments | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		133,675
Forward Contracts | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 1
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 1 | Senior Secured Loan | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 1 | Structured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 1 | Equity/Other [Member] | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 1 | Total Investments | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 1 | Forward Contracts | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 2
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	36,331	34,203
Fair Value, Inputs, Level 2 | Senior Secured Loan | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	36,331	34,203
Fair Value, Inputs, Level 2 | Structured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 2 | Equity/Other [Member] | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 2 | Total Investments | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		34,203
Fair Value, Inputs, Level 2 | Forward Contracts | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		0
Fair Value, Inputs, Level 3
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	96,517	99,472
Fair Value, Inputs, Level 3 | Senior Secured Loan | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	92,051	91,847
Fair Value, Inputs, Level 3 | Structured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		3,860
Fair Value, Inputs, Level 3 | Equity/Other [Member] | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	4,385	3,765
Fair Value, Inputs, Level 3 | Unsecured Note | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total	$ 81
Fair Value, Inputs, Level 3 | Total Investments | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		99,472
Fair Value, Inputs, Level 3 | Forward Contracts | Accounting Standards Update 2011-04 [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Fair Value Disclosure, Total		$ 0

Investments and Fair Value Me_7

Investments and Fair Value Measurements - Schedule of Company's investment portfolio for which level 3 inputs (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Net accretion of discounts	$ 566	$ 425
Fair Value, Inputs, Level 3 | Senior Secured Loan
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	91,847	76,242
Purchases of investments	22,310	28,966
Proceeds from principal repayments and sales of investments	(16,829)	(11,374)
Payment in-kind interest income	677	361
Net accretion of discounts	294	276
Net change in unrealized appreciation (depreciation) on investments	(1,436)	1,134
Net realized loss on investments	(97)	121
Transfers into level 3	1,907	0
Transfers out of level 3	(6,622)	(1,700)
Ending balance	92,051	94,026
Net change in unrealized appreciation (depreciation) on Level 3 investments still held	(1,494)	1,153
Fair Value, Inputs, Level 3 | Structured Note
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	3,860	4,053
Purchases of investments	0	0
Proceeds from principal repayments and sales of investments	(3,900)	(319)
Payment in-kind interest income	0	0
Net accretion of discounts	0	0
Net change in unrealized appreciation (depreciation) on investments	40	17
Net realized loss on investments	0	87
Transfers into level 3	0	0
Transfers out of level 3	0	0
Ending balance	0	3,838
Net change in unrealized appreciation (depreciation) on Level 3 investments still held		17
Fair Value, Inputs, Level 3 | Subordinated Structured Note
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance		281
Purchases of investments		0
Proceeds from principal repayments and sales of investments		(350)
Payment in-kind interest income		0
Net accretion of discounts		0
Net change in unrealized appreciation (depreciation) on investments		52
Net realized loss on investments		17
Transfers into level 3		0
Transfers out of level 3		0
Ending balance		0
Net change in unrealized appreciation (depreciation) on Level 3 investments still held		(52)
Fair Value, Inputs, Level 3 | Unsecured Note
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	0
Purchases of investments	81
Proceeds from principal repayments and sales of investments	0
Payment in-kind interest income	0
Net accretion of discounts	0
Net change in unrealized appreciation (depreciation) on investments	0
Net realized loss on investments	0
Transfers into level 3	0
Transfers out of level 3	0
Ending balance	81
Net change in unrealized appreciation (depreciation) on Level 3 investments still held	0
Fair Value, Inputs, Level 3 | Equity/Other
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	3,765	2,036
Purchases of investments	1,297	146
Proceeds from principal repayments and sales of investments	0	0
Payment in-kind interest income	0	0
Net accretion of discounts	0	0
Net change in unrealized appreciation (depreciation) on investments	(656)	142
Net realized loss on investments	(21)	0
Transfers into level 3	0	0
Transfers out of level 3	0	0
Ending balance	4,385	2,324
Net change in unrealized appreciation (depreciation) on Level 3 investments still held	(137)	142
Fair Value, Inputs, Level 3 | Total Investments
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	99,472	82,612
Purchases of investments	23,688	29,112
Proceeds from principal repayments and sales of investments	(20,729)	(12,043)
Payment in-kind interest income	677	361
Net accretion of discounts	294	276
Net change in unrealized appreciation (depreciation) on investments	(2,052)	1,345
Net realized loss on investments	(118)	225
Transfers into level 3	1,907	0
Transfers out of level 3	(6,622)	(1,700)
Ending balance	96,517	100,188
Net change in unrealized appreciation (depreciation) on Level 3 investments still held	(1,631)	1,364
Fair Value, Inputs, Level 3 | Forward Contracts
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Beginning balance	0	(55)
Purchases of investments	0	0
Proceeds from principal repayments and sales of investments	0	0
Payment in-kind interest income	0	0
Net accretion of discounts	0	0
Net realized loss on investments	0	0
Transfers into level 3	0	0
Transfers out of level 3	0	0
Ending balance	0	(55)
Net change in unrealized appreciation (depreciation) on Level 3 investments still held	$ 0	$ (55)

Investments and Fair Value Me_8

Investments and Fair Value Measurements - Schedule of valuation techniques and significant unobservable inputs used in the valuation of level 3 investments (Details) $ in Thousands	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Summary of Investment Holdings [Line Items]
Fair Value	$ 132,848	$ 133,675
Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	96,517	99,472
Equity [Member]
Summary of Investment Holdings [Line Items]
Fair Value	4,385	3,765
Equity [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 3,000	$ 2,543
Equity [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Average EBITDA Multiple [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.55	0.16
Equity [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Average EBITDA Multiple [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	1.3	0.18
Equity [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Average EBITDA Multiple [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	1.01	0.47
Equity One [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 1,306	$ 226
Equity One [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Net Asset Value [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	10.3
Equity One [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Net Asset Value [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		10
Equity One [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Net Asset Value [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		10.3
Equity One [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Net Asset Value [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		10.1
Equity One [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.106
Equity One [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.218
Equity One [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.162
Equity Two [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 79	$ 996
Equity Two [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Net Asset Value [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.149
Equity Two [Member] | Recent Transaction [Member] | Fair Value, Inputs, Level 3 [Member] | Transaction Price [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.149
Equity Two [Member] | Recent Transaction [Member] | Fair Value, Inputs, Level 3 [Member] | Transaction Price [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.149
Senior Secured Loan [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 88,349	$ 81,864
Senior Secured Loan [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.118	0.111
Senior Secured Loan One [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 3,702	$ 9,983
Senior Secured Loan One [Member] | Recent Transaction [Member] | Fair Value, Inputs, Level 3 [Member] | Transaction Price [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.98	0.965
Senior Secured Loan One [Member] | Recent Transaction [Member] | Fair Value, Inputs, Level 3 [Member] | Transaction Price [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.99	1
Senior Secured Loan One [Member] | Recent Transaction [Member] | Fair Value, Inputs, Level 3 [Member] | Transaction Price [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.986	0.982
Senior Secured Loan One [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.057	0.61
Senior Secured Loan One [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.192	0.193
Unsecured Note [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 81
Unsecured Note [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 81
Unsecured Note [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.103
Structured Note [Member]
Summary of Investment Holdings [Line Items]
Fair Value		$ 3,860
Structured Note [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value		$ 3,860
Structured Note [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Minimum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.119
Structured Note [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Maximum [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.119
Structured Note [Member] | Discounted Cash Flows [Member] | Fair Value, Inputs, Level 3 [Member] | Market Yield [Member] | Weighted Average [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)		0.119
Forward Contract [Member] | Fair Value, Inputs, Level 3 [Member]
Summary of Investment Holdings [Line Items]
Fair Value	$ 0
Forward Contract [Member] | Enterprise Valuation [Member] | Fair Value, Inputs, Level 3 [Member] | Average EBITDA Multiple [Member]
Summary of Investment Holdings [Line Items]
Range (Weighted Average)	0.25

Investments and Fair Value Me_9

Investments and Fair Value Measurements - Schedule of Open Forward Contracts (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Open Forward Contract [Line Items]
Unrealized Appreciation	$ 0
Put Option [Member] | Princeton Medspa Partners LLC [Member]
Open Forward Contract [Line Items]
Settlement Date	May 31, 2029
Par	$ 250
Unrealized Appreciation	$ 0

Investments and Fair Value M_10

Investments and Fair Value Measurements - Schedule of Realized and Unrealized Gain and Loss Amounts Included on Consolidated Statement of Operations (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Credit Derivatives [Line Items]
Derivative Assets	$ 0
Derivative Liabilities	0
Realized Gain (Loss)	0
Unrealized Depreciation	0
Forward Contracts Credit Risk [Member]
Credit Derivatives [Line Items]
Derivative Assets	0
Derivative Liabilities	0
Realized Gain (Loss)	0
Unrealized Depreciation	$ 0

Borrowings (Additional Informat

Borrowings (Additional Information) (Details) - USD ($) $ in Millions		9 Months Ended
	Mar. 12, 2021	Sep. 30, 2024	Dec. 31, 2023	Dec. 16, 2019
Debt Instrument [Line Items]
Asset coverage		199%	196%
Fourth A&R Facility [Member]
Debt Instrument [Line Items]
Financing Fee Per Year Spread Percentage		2.91161%
Debt Instrument Repurchase Date		Dec. 19, 2024
Maximum [Member] | UBS [Member]
Debt Instrument [Line Items]
Debt financing facility				$ 50
Maximum [Member] | Second A&R Facility [Member]
Debt Instrument [Line Items]
Debt financing facility	$ 75
Minimum [Member]
Debt Instrument [Line Items]
Asset coverage		150%
Minimum [Member] | Second A&R Facility [Member]
Debt Instrument [Line Items]
Debt financing facility	50
Minimum [Member] | 1940 Act [Member]
Debt Instrument [Line Items]
Asset coverage		200%
Class A Notes [Member] | Maximum [Member] | Fourth A&R Facility [Member]
Debt Instrument [Line Items]
Aggregate Purchase Price	$ 110

Borrowings - Summary of Debt ob

Borrowings - Summary of Debt obligations (Details) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Debt [Member]
Line of Credit Facility [Line Items]
Total Aggregate Borrowing Capacity	$ 110,000	$ 110,000
Total Principal Outstanding	73,000	71,000
Less Deferred Financing Costs	(581)	(663)
Amount per Consolidated Statements of Assets and Liabilities	72,419	70,337
Credit Facility [Member]
Line of Credit Facility [Line Items]
Total Aggregate Borrowing Capacity	110,000	110,000
Total Principal Outstanding	73,000	71,000
Less Deferred Financing Costs	(581)	(663)
Amount per Consolidated Statements of Assets and Liabilities	$ 72,419	$ 70,337

Borrowings - Summary of compone

Borrowings - Summary of components of interest expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Interest Expense [Abstract]
Interest expense	$ 1,533	$ 1,416	$ 4,602	$ 3,708
Amortization of deferred financing and debt issuance costs	27	27	82	82
Total Interest Expense	1,560	1,443	4,684	3,790
Average debt outstanding	$ 73,000	$ 68,000	$ 72,526	$ 62,784
Weighted average interest rate	8.50%	8.50%	8.60%	8%

Share Transactions (Additional

Share Transactions (Additional Information) (Details) - USD ($) $ / shares in Units, $ in Thousands		9 Months Ended		12 Months Ended
	Apr. 10, 2018	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, authorized		1,000,000,000		1,000,000,000
Common stock, par value		$ 0.001		$ 0.001
Common stock, issued	4,000	3,349,201		3,024,976
Proceeds from issuance of shares of common stock	$ 100,000	$ 5,450	$ 16,500
Capital commitments		73,940	$ 68,489
Subscription Agreements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Capital commitments		$ 73,900		$ 68,500

Share Transactions - Summary of

Share Transactions - Summary of total shares issued and proceeds received related to capital drawdowns delivered pursuant to Subscription Agreements (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Equity [Abstract]
Capital Drawdown Notice Date	May 24, 2024	Mar. 03, 2023
Capital Drawdown Notice Date1	Sep. 11, 2024	May 09, 2023
Common Share Issuance Date	Jun. 10, 2024	Mar. 08, 2023
Capital Drawdown Share Issuance Date 1	Sep. 13, 2024	May 09, 2023
Number of Common Shares Issued	44,623	519,186
Capital Drawdown Shares Issued 1	204,880	228,519
Total Number of Share Issued	249,503	747,705
Aggregate Offering Price	$ 1,000	$ 11,500
Capital Drawdown Shares Issued Offering Price 1	4,450	5,000
Total Aggregate Offering Price	$ 5,450	$ 16,500

Share Transactions - Summary _2

Share Transactions - Summary of distribution declared (Details) - $ / shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Date Declared	Mar. 11, 2024	Mar. 06, 2023
Date Declared	May 07, 2024	May 09, 2023
Date Declared	Aug. 07, 2024	Aug. 08, 2023
Record Date	Mar. 25, 2024	Mar. 20, 2023
Record Date	May 22, 2024	May 22, 2023
Record Date	Aug. 22, 2024	Aug. 22, 2023
Payment Date	Apr. 02, 2024	Mar. 29, 2023
Payment Date	May 31, 2024	May 31, 2023
Payment Date	Sep. 05, 2024	Aug. 31, 2023
Amount Per Share	$ 1.8	$ 0.93
Total distributions declared, amount per share	$ 1.8	$ 0.93
Distributions Declared	5,529	2,710
Total distributions declared	5,529	2,710
March 11, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share	$ 0.6
Total distributions declared, amount per share	$ 0.6
Distributions Declared	1,822
Total distributions declared	1,822
May 7, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share	$ 0.6
Total distributions declared, amount per share	$ 0.6
Distributions Declared	1,834
Total distributions declared	1,834
August 7, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share	$ 0.6
Total distributions declared, amount per share	$ 0.6
Distributions Declared	1,873
Total distributions declared	1,873
March 6, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share		$ 0.31
Total distributions declared, amount per share		$ 0.31
Distributions Declared		853
Total distributions declared		853
May 9, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share		$ 0.31
Total distributions declared, amount per share		$ 0.31
Distributions Declared		927
Total distributions declared		927
August 8, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Amount Per Share		$ 0.31
Total distributions declared, amount per share		$ 0.31
Distributions Declared		930
Total distributions declared		930

Share Transactions - Schedule o

Share Transactions - Schedule of common stock issued pursuant to the dividend reinvestment plan (Details) - shares	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Equity [Abstract]
Date Declared	Dec. 21, 2023	Mar. 06, 2023
Date Declared	Mar. 11, 2024	May 09, 2023
Date Declared	May 07, 2024
Date Declared	Aug. 07, 2024	Aug. 08, 2023
Record Date	Dec. 31, 2023	Mar. 20, 2023
Record Date	Mar. 25, 2024	May 22, 2023
Record Date	May 22, 2024
Record Date	Aug. 22, 2024	Aug. 22, 2023
Payment Date	Jan. 26, 2024	Mar. 31, 2023
Payment Date	Apr. 02, 2024	May 31, 2023
Payment Date	May 31, 2024
Payment Date	Sep. 05, 2024	Aug. 31, 2023
Shares Issued	11,736	9,874
Shares Issued	20,254	10,086
Shares Issued	20,853
Share Issued	21,879	10,096
Total shares issued	74,722	30,056

Earnings Per Share - Schedule O

Earnings Per Share - Schedule Of Earnings Per Share Basic And Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Earnings Per Share [Abstract]
Increase in net assets resulting from operations per share - basic and diluted	$ 349	$ 3,328	$ 2,541	$ 5,376
Weighted average shares of common stock outstanding - basic	3,168,711	3,003,201	3,092,149	2,755,930
Weighted average shares of common stock outstanding - diluted	3,168,711	3,003,201	3,092,149	2,755,930
Net increase (decrease) in net assets resulting from operations per share - basic	$ 0.11	$ 1.11	$ 0.82	$ 1.95
Net increase (decrease) in net assets resulting from operations per share - diluted	$ 0.11	$ 1.11	$ 0.82	$ 1.95

Income Tax (Additional Informat

Income Tax (Additional Information) (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Federal Income Tax [Member]
Operating Loss Carryforwards [Line Items]
Amortized cost of investment for income tax purposes	$ 136,492	$ 135,332

Financial Highlights - Schedule

Financial Highlights - Schedule of financial highlights (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended				9 Months Ended				12 Months Ended
		Sep. 30, 2024		Sep. 30, 2023		Sep. 30, 2024		Sep. 30, 2023		Dec. 31, 2023
Investment Company, Financial Highlights [Line Items]
Net asset value, beginning of period						$ 22.53		$ 21.85		$ 21.85
Net investment income	[1]					1.69		1.16
Net increase (decrease) in net assets resulting from operations	[1]					0.84		1.87
Distributions from net investment income	[2]					(1.8)		(0.93)
Net decrease in net assets resulting from stockholder distributions	[2]					(1.8)		(0.93)
Net asset value, end of period		$ 21.57	[3]	$ 22.79	[3]	$ 21.57	[3]	$ 22.79	[3]	$ 22.53
Shares outstanding, end of period		3,349,201		3,009,895		3,349,201		3,009,895
Total return based on net asset value	[4]					3.90%		8.90%
Net assets, end of period		$ 72,237		$ 68,586		$ 72,237		$ 68,586
Ratio of net investment income to average net assets	[5]					10.60%		7.70%
Ratio of total expenses to average net assets, excluding Expense Support Agreements	[5]					15.60%		15.60%
Ratio of net expenses to average net assets, including Expense Support Agreements	[6]					15.60%		18.80%
Average debt outstanding		73,000		68,000		$ 72,526		$ 62,784
Portfolio turnover						21.80%		13.20%
Total amount of senior securities outstanding		$ 73,000		$ 68,000		$ 73,000		$ 68,000
Asset coverage per unit	[7]					1,990		1,970
Total committed capital, end of period						$ 73,940		$ 68,489
Ratio of total contributed capital to total committed capital, end of period						100%		100%
Net realized and unrealized gain loss Member
Investment Company, Financial Highlights [Line Items]
Net realized and unrealized gain (loss)	[8]					$ (0.85)		$ 0.71
[1] The per share data was derived by using the weighted average shares outstanding during the period. The per share data for distributions reflects the actual amount of distributions paid during the period. Represents the impact of different share amounts used in calculating per share data as a result of calculating certain per share data based on weighted average shares outstanding during the year or period and certain per share data on shares outstanding as of a year or period end or transaction date. Total return based on net asset value is calculated as the change in net asset value per share during the period, assuming dividends and distributions, if any, are reinvested in accordance with the Company’s dividend reinvestment plan divided by the beginning net asset value per share. Total return is not annualized. The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio excludes the net expense support agreement amounts provided to or reimbursed by the Company during the period The computation of average net assets during the period is based on averaging net assets for the period reported. Ratio includes the net expense support agreement amounts provided to or reimbursed by the Company during the period Asset coverage per unit is the ratio of the carrying value of the Company’s consolidated total assets, less liabilities and indebtedness not represented by senior The amount shown at this caption is the balancing figure derived from the other figures in the schedule. The amount shown at this caption is derived from total change in net asset value during the period and differs from the amount calculated using average shares because of the timing of issuances of the Company’s shares in relation to changes in net asset value during the period.

Commitments and Contingencies_2

Commitments and Contingencies (Additional Information) (Details) - Advisor [Member] - USD ($) $ in Millions	9 Months Ended	21 Months Ended
	Sep. 30, 2024	Oct. 02, 2019
Long-Term Purchase Commitment [Line Items]
Offering costs	$ 0.8	$ 1.4
Operating expenses	$ 1.2	$ 1.2

Commitments and Contingencies -

Commitments and Contingencies - Summary of Outstanding Commitments to Fund Investments in Current Portfolio Companies (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	$ 5,708	$ 6,562
Accordion Partners LLC [Member] | Senior Secured Loan One [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	0	1,632
AMCP PET HOLDINGS, INC. [Member] | Senior Secured Loan Two [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	0	175
Beta Plus Technologies R/C [Member] | Senior Secured Loan Three [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	273	473
Great Lakes II Funding LLC [Member] | Equity/Other [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	22	11
Green Park M-1 Series [Member] | Equity/Other [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	366	366
Morae Global Inc [Member] | Senior Secured Loan Four [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	292	292
PhyNet Dermatology LLC [Member] | Senior Secured Loan Five [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	1,713	1,713
Princeton Medspa Partners LLC [Member] | Senior Secured Loan Six [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	1,203	0
Riddell, Inc [Member] | Senior Secured Loan Seven [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	364	0
SePRO Corporation [Member] | Senior Secured Loan Eight [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	505	0
SeQuel Response LLC [Member] | Senior Secured Loan Nine [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	100	0
TA/WEG Holdings, LLC [Member] | Senior Secured Loan Ten [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	111	0
Tactical Air Support, Inc [Member] | Senior Secured Loan Eleven [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	0	571
Tank Holding Corp [Member] | Senior Secured Loan Twelve [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	185	249
VBC Spine Opco LLC [Member] | Senior Secured Loan Thirteen [Member]
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Total Unfunded Portfolio Company Commitments	$ 574	$ 1,080

Subsequent Events (Additional I

Subsequent Events (Additional Information) (Details)	Nov. 07, 2024 $ / shares
Subsequent Event [Line Items]
Dividends Payable, Amount Per Share	$ 0.6
Dividend Payable Date	Dec. 05, 2024